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Abstract 
 
Background 
Sickle cell disorders (SCD) are serious genetic blood conditions affecting mainly 
people of Black African origin. The disease is associated with serious physical 
complications and some affected persons have increased psychological difficulties. 
Self-perceived stigma is a putative risk factor for psychological distress in SCD but 
this had not been studied.  
 
Aim 
The primary aim is to estimate the prevalence of self-perceived stigma in young 
people with SCD and to explore its associations with psychosocial and illness 
variables. A secondary aim is to explore associations of other measures of 
psychological adjustment with illness and social indicators. 
 
Methodology 
Cross-sectional questionnaire survey of 93 young people with SCD aged 10-19 years 
(Mean 14 years). Questions on self-perceived distancing by others were used to assess 
stigma. Psychological difficulty was assessed with self-report Strengths and 
Difficulties Questionnaire (SDQ), Depressive symptoms were measured with the 
Short Mood and Feelings Questionnaire, self-esteem was assessed with the Rosenberg 
Self-Esteem Scale, and Family function was measured with the Family Assessment 
Device. 
 
Results: 
The respondents were evenly split in gender and almost all were of Black ethnicity 
(95%). However, they had better socioeconomic profile compared with average black 
families in the UK. Only 15% had self-perceived stigma. 
 
Consistent with stigma theory, frequent ward admissions (i.e. measure of 
disruptiveness) and presence of leg ulcer (i.e. measure of visibility) predicted more 
self-perceived stigma. Self-perceived stigma in turn predicted more psychological 
difficulty (Total SDQ score).  
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Psychological symptoms were also associated with poor attitudes towards SCD, and 
by problematic family function.  
 
Conclusion 
To my knowledge, this is the first study to show that stigma theory applies to SCD 
and that self-perceived stigma is a significant predictor of psychological difficulty in 
this disorder. Thus, alleviating stigma could benefit psychological well-being in SCD.  
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Introduction 
 
Sickle cell disorders (SCDs) are blood disorders that predominantly affect people of 
black African ancestry as well as people of Mediterranean, Middle Eastern and Asian 
origins (Weatherall and Clegg, 2001). They are among the most common genetic 
conditions worldwide (Modell and Darlison 2008) and constitute the commonest 
monogenic diseases in the world (Weatherall 2008). SCDs are disorders of 
haemoglobin with the primary abnormality being distortion of the normal spherical 
shape of red blood cells into sickle shapes. 
 
SCDs are associated with several, sometimes life-threatening physical complications. 
The primary pathogenesis of the complications is ischaemia caused by the trapping of 
sickle-shaped red blood cells in the microvasculature. Depending the affected organ, 
the consequent complications include ischaemic pain (which is the most typical and 
most distressing symptom) (Wethers 2000), bone necrosis, stroke, chronic leg 
ulceration, renal disease, and priapism. Other complications include acute chest 
syndrome, cholelithiasis, overwhelming infections, acute splenic sequestration, 
haemolytic and aplastic crises, and nocturnal enuresis (Dick 2008).  
 
Treatment advances in developed countries have led to mitigation of some of these 
complications and hugely improved physical outcomes. This is exemplified by 
improved life expectancy from 14 years in the 1970s to more than 50 years currently 
(Claster & Vichinsky, 2003).Efforts are also being made in some developed countries 
(e.g. the UK) to use standards and guidelines to improve nation-wide access to 
evidence-based care for affected persons (Dick 2008). Unfortunately, as with most 
disorders, these advances have yet to filter to developing countries where most 
affected persons live. Consequently, life expectancy remains as low as 5 years in 
some areas (Serjeant 2005) such as sub-Saharan Africa where half of all affected 
children die before the age of 5 years (WHO 2006). 
 
We know from many large scale epidemiological studies such as the Isle of Wight 
study (Rutter et al 1976) (consistently replicated since) that children with chronic 
physical disorders like SCDs are at increased risk of psychosocial difficulties. The 
risk is particular high for disorders involving the brain, of which SCDs is an example.  
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The ecological model of child development suggests that factors within the child and 
with the child’s environment are likely to contribute separately to the risk of mental 
disorder (Bronfenbrenner, 1979). Consistent with this model, several studies have 
shown that factors in the child such as severity or stage of disease are associated with 
psychosocial adjustment in children with SCD (Key et al 2001). Environmental 
factors, especially family function have also been linked with psychosocial 
adjustment in affected children (Barbarin et al 1999). Peer and broader social 
relationships are also important, including the way children view themselves in 
relation to others, and the stigma linked to illness may be expected to have an effect 
on children’s adjustment. 
 
However, despite the plethora of studies on the psychosocial aspects of SCD in 
children, the potential primary role of stigma is yet to be studied. Stigma is an 
important aspect of the social environment, which could have significant influence on 
the adjustment of children affected by SCDs. Studies of other chronic physical 
disorders like epilepsy have shown the importance of stigma (Westbrook et al 1992).  
 
Thus the primary objective of this study is to explore the level of perceived stigma 
among children with SCD. The second objective is to identify any associations 
between stigma and disease and psychosocial outcomes.  
 
The role of psychological intervention in SCDs is increasingly being recognised and a 
guideline for this is being developed in the UK (Dick 2008). There is some evidence 
that Cognitive Behavioural Therapy may be helpful as an adjunct in pain 
management. However, despite encouraging results of psychological interventions in 
SCDs (Anie 2005), the evidence base is still limited (Anie and Green 2002). Thus 
identification of a wider range of putative risk factors for psychological distress in 
people with SCD could lead to new and more effective targeting of psychological 
interventions. Stigma is an example of a putative environmental risk factor that is yet 
to be studied in SCD; hence it is the focus of this study. As far as I am aware, this is 
the first study to specifically and directly examine self-perceived stigma in children 
with SCDs.  
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A cross-sectional questionnaire-based survey was the methodology chosen to achieve 
the objectives of the study. This methodology was considered appropriate and 
adequate given that the study is exploratory and the logistics of an alternative 
longitudinal design would be prohibitive.  
 
To build on previous work and allow for comparison, I adopted the definition and 
measurement strategies for self-perceived stigma, which had been used reliably in two 
previous studies of children with epilepsy (Westbrook et al 1992) and stuttering 
(Blood et al 2003). 
 
The Thesis is structured into seven Chapters. The focus of each Chapter is outlined 
next. 
 
In Chapter 1, I will discuss the biological aspects of SCDs. I will also present the 
epidemiology, course, treatment and physical complications of the disorder. The 
chapter will highlight the variability in the course and the huge differences in outcome 
in developed and developing countries. The Chapter will highlight improving 
international recognition of the huge burden of SCDs, which will hopefully translate 
into devotion of more resources to affected persons especially in developing 
countries. 
 
In Chapter 2, I will discuss the concept of stigma and the development and 
elaboration of the term since the first seminal work on the subject by Goffman (1963). 
I will explore the concept of “stigma dimensions”, which are the attributes known to 
engender stigma when associated with a disorder or condition. I will show that two 
stigma dimensions (visibility and disruptiveness) could be applicable to SCDs. I will 
review the literature on stigma and SCDs, which showed very limited pre-existing 
data on the subject. I will also explore the methodological difficulties associated with 
studying stigma (such as socially desirable responding) and how this can be 
minimised.  
 
In Chapter 3, I will explore the literature on psychopathology and psychosocial 
adjustment in SCDs. The chapter will apply both the bio-psycho-social and ecological 
models of adjustment to the literature. Given the particular clinical significance of 
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depression, I will devote a section to explore the risk factors, diagnostic difficulties 
and prevalence of depression in children with SCD. I will highlight differences in the 
data between developed and developing countries. 
 
In Chapter 4, I will discuss the detailed aims of the study and the four specific 
hypotheses I will test. I will describe the full study methodology including sample 
size calculations, recruitment strategies and the measurements used. 
 
Results will be presented in Chapter 5 starting with descriptive results and ending 
with multivariate analyses including tests for the four study hypotheses. 
 
In Chapter 6, I will discuss the main results in the light of the literature on stigma and 
previous data on the psychosocial adjustment of children affected by SCDs, and 
methodological limitations of the study. 
 
I used the final Chapter (7) to draw conclusions from the entire work and make 
recommendations for both clinical work and future research directions. 
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Chapter 1 
Sickle cell disorders:  
Biology, epidemiology, course, complications and treatment 
 
1.1. Introduction 
Sickle cell disorders (SCDs) are among the most common genetic conditions 
worldwide (Modell and Darlison 2008) and the commonest monogenic diseases in the 
world (Weatherall 2008). SCDs are disorders of haemoglobin, which distort the 
normal spherical shape of red blood cells into sickle shapes; hence the name. The 
majority of affected persons are of black African ancestry but cases are seen among 
people of Mediterranean, Middle Eastern and Asian origins (Weatherall and Clegg, 
2001). In this chapter, I will discuss the basic biology, epidemiology, course, 
complications and treatment of SCDs.  
 
1.2. Biology 
Haemoglobin comprises of four globin chains. Adult haemoglobin has two Alpha and 
two Beta globin chains while foetal haemoglobin has two alpha and two gamma 
chains. Mutations in the amino acid sequence of haemoglobin can result either in the 
production of abnormal globin chains (haemoglobinopathy) or reduced or inability to 
produce normal globin chains (thalassemia). SCDs are haemoglobinopathies, which 
are qualitative abnormalities of haemoglobin function. On the other hand, 
Thalaseamias are quantitative abnormalities of insufficient haemoglobin production. 
Haemoglobinopathies (e.g. SCDs) can co-exist with thalaesaima (e.g. HbSThal). The 
more common and clinically significant haemoglobin variants include haemoglobin S, 
C, D, E, β thalasemia.  
 
Haemoglobin gene variants are recessively inherited and heterozygous carriers are 
usually asymptomatic. This explains why affected children are usually born to 
asymptomatic parents. The serious haemoglobin disorder seen in SCD occurs in 
people who inherit harmful combinations of gene variants (Modell and Darlison 
2008). The most common and severe SCD is HbSS. Other common combinations 
include HbSC and Hbβthalasaemia. Persons who inherit one abnormal haemoglobin 
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gene variant but whose other copy of the gene is normal are asymptomatic carriers 
(e.g. HbAS).  
 
The fundamental pathology in SCD is that when deoxygenated, the abnormal 
haemoglobin variant deforms red blood cells into a crescent-shape. The abnormally 
shaped red blood cells become trapped in the microvasculature causing sludge and 
blockage. The impaired circulation results in ischaemic damage, which underlies the 
common complications in SCD. Affected individuals typically present with painful 
ischaemic crisis, which is the most distressing symptom (Wethers 2000). Severe 
forms of the disease are associated with serious and sometime life threatening 
complications including, severe anaemia, overwhelming infections, acute splenic 
sequestration, haemolytic and aplastic crises, acute chest syndrome, strokes, 
cholelithiasis, bone necrosis, chronic leg ulceration, and renal disease (Wethers 2000). 
 
1.3. Epidemiology 
Modell and Darlison (2008) have carried out the most recent and most comprehensive 
review of haemoglobin disorders I am aware of. Using a wide range of sources of 
epidemiological information, they showed that haemoglobin disorders constitute a 
significant health problem in 71% of countries including those that account for 89% 
of worldwide births. Their analysis also showed that over 300,000 infants are born per 
annum with these disorders of which the vast majority (83%) have sickle cell 
disorders. They concluded that haemoglobin disorders account for 3.4% of deaths in 
children less than 5 years of age (6.4% in Africa). Mordell and Darlison (2008) 
highlight that 5.2% of the world population and 7% of pregnant women carry a 
significant haemoglobin variant. Their analyses indicate that although HbS accounts 
for 40% of carriers, it causes 80% of disorders because of very high carrier prevalence 
in some areas. 
The substantial global burden of SCD suggested by Modell and Darlison (2008) is 
supported by other country specific estimates of prevalence. For example, the 
American National Heart, Lung and Blood Institute estimates that SCD affects 70,000 
– 100,000 persons in United States. They estimate a prevalence of 1 in 500 among 
African American births and 1 in 36,000 Hispanic American births. About 2 million 
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Americans (including 1 in 12 African Americans) carry the sickle cell trait 
http://www.nhlbi.nih.gov/health/dci/Diseases/Sca/SCA_WhoIsAtRisk.html. 
Nigeria has the highest prevalence of SCDs world wide because it is the most 
populous Black Country. About 25% of Nigerian adults carry the sickle cell gene and 
up to 150,000 babies are born per year with SCDs (WHO 2006, Akinyanju 1989).  
 
In the UK, estimates of the number of affected persons range from 6500 to 12,500 
(Bennett 2005). The new-born screening programme in England has produced more 
accurate birth prevalence data. Between 2004-2005, the screening programme 
identified 250 babies with SCDs and 6500 carriers of the sickle cell trait in England. 
The birth prevalence was 1:1500. The authors estimated that when UK-wide data 
becomes available, the national birth prevalence of SCD will be about 1:2000-
1:2,500. They noted that SCDs are as common as cystic fibrosis in England although 
SCD cases are concentrated in London and other urban areas (Streetly et al 2008). 
 
The natural geographical distribution of sickle cell trait mirrors that of endemic 
malaria. Heterozygous carrier status for the sickle cell gene provides some protection 
against malaria (Crompton et al 2008). Thus, given the significant mortality 
associated with malaria, the protective advantage for carriers leads to their selective 
survival, which results in continuing propagation of the gene. 
 
Developed countries have much fewer numbers of people with SCD. They also have 
access to more advanced treatments and prenatal screening programmes (Weatherall 
2008). On the converse, low income countries, particularly those of Sub-Saharan 
Africa and Asia have some of the highest prevalence of SCDs and very limited 
expertise and resources for managing these disorders. Without greater recognition of 
the serious and large scale burden of SCDs by governments and international health 
agencies, an ever increasing numbers of people in many low income countries will 
continue to lack access to effective treatment and screening programme, resulting in 
avoidable suffering and death. However, SCDs are now attracting the level of public 
attention they deserve. For example, the United Nations General Assembly adopted a 
resolution on 22nd December 2008 to recognise SCDs as public health problems and 
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declared that 19th June of each year would be Sickle Cell World Day 
http://www.undemocracy.com/A-RES-63-237.pdf (accessed 31st January 2010).  
 
1.4. Course and outcome of SCD 
The course of SCDs is variable with some individuals severely disabled and others 
running a mild course. It is difficult to predict the course for particular individuals. 
The largest longitudinal study of SCDs (The Cooperative Study of Sickle Cell 
Disease) reported that dactylitis, severe anaemia, and leucocytosis in very young 
children with sickle cell disease (SCD) predicted a more severe course and increased 
the risk of later adverse outcomes. However, this finding has not been validated in 
other studies. For example, a recent cohort study in USA which followed 168 children 
with SCDs for 7 years (Quinn et al 2008) found no relationship between early clinical 
predictors and later adverse outcomes. Most subjects who experienced adverse events 
during this study were actually predicted to be at low risk for those events. The study 
found that no subject who was predicted to be at high risk actually experienced an 
adverse outcome.  
 
Although more affected individuals are surviving for longer, in low income countries, 
SCDs is still responsible for a considerably high proportion of under 5 mortality. This 
amounts to 5% of under 5 deaths in Africa and up to 16% in some West African 
countries. In some areas of sub-Saharan Africa, half of all affected children die before 
the age of 5 years usually from anaemia and infections (WHO 2006). 
 
Medical advances have improved life expectancy of people affected by SCDs in 
developed countries from 14 years in the 1970s to more than 50 years currently 
(Claster & Vichinsky, 2003). In the United State, average life expectancy in 1994 was 
42 years for men and 48 years for females (Platt et al 1994). The outcome is not 
universally poor in all low income countries. For example, in Jamaica, life expectancy 
for people with SCD in 2001 was 53 years for men and 58 years for women 
(Wierenga et al 2001). On the contrary, life expectancy for people affected by SCDs 
in some low income countries can be as low as 5 years (Serjeant 2005).  
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1.5. Complications and treatment 
Complications in SCDs arise principally from ischaemic damage from blockage of 
small blood vessels by sickle shaped red cells. Affected individuals typically present 
with painful ischaemic crisis, which is the most distressing symptom (Wethers 2000). 
The disorder is associated with serious and sometimes life threatening complications 
including overwhelming infections, acute splenic sequestration, haemolytic and 
aplastic crises, acute chest syndrome, stroke, cholelithiasis, bone necrosis, chronic leg 
ulceration, and renal disease, priapism, and nocturnal enuresis (Dick 2008). SCD 
complications involving the brain are significant. Up to 11% of affected persons 
suffer overt strokes and up to 20% have evidence of ischaemic brain damage on MRI 
by the age of 20 years (Pegelow et al 2002).  
 
Due to the high contribution of pneumococcal infections and malaria to mortality in 
SCDs, routine treatment includes pneumococcal immunisation and prophylactic 
penicillin and antimalarials (in malarious areas). Because of the high turnover of red 
blood cells and increased haemopoiesis, folic acid supplementation is also routinely 
advised. Adequate nutrition and fluid intake is helpful. Specific treatments for 
complications such as analgesia for pain, blood transfusions for anaemia are 
sometimes required. In the UK, standards and guidelines for clinical care have been 
introduced to improve access to evidence-based care for people affected persons by 
SCDs throughout the country (Dick 2008). 
 
For suitable patients, allogeneic haematopoietic cell transplantation (HCT) is 
currently the only treatment with curative potential for SCDs (Michlitsch and Walters 
2008). Recent studies of HCT show an event-free survival of 85% after human 
leucocyte antigen (HLA)-identical sibling transplantation for SCDs (Michlitsch and 
Walters 2008). However, HCT is limited by the risk of serious complications 
including graft failure, recurrent disease, graft-versus-host-disease (GVHD), and 
infections. Also the availability of expertise and supportive treatment limit this 
intervention to few centres in developed countries.  
 
Hydroxyurea has been shown to reduce the clinical severity of SCDs in adults 
(Odievre et al 2008). The mechanism of action is thought to be related to increased 
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production of foetal haemoglobin. A recent review of trials of hydroxyurea in children 
found that the medication increased foetal haemoglobin in most children and reduced 
the number of vaso-occlusive crises, hospitalisations, frequency of acute chest 
syndrome and rate of blood transfusion. The medication was well tolerated in the 
long-term. It was noted that response to hydroxyurea in children did not always 
correlate with foetal haemoglobin levels suggesting that other mechanisms may be 
involved in its therapeutic effect. The main side effect of hydroxyurea is myelo-
suppression. The risk of malignancy with long term use is a concern although there is 
no evidence of this in people taking the medication for SCDs. 
 
As already noted, patients in developed countries with better access to these advanced 
treatments have substantially improved life expectancy and quality of life.  
 
The role of psychological intervention in SCDs is recognised and a guideline for this 
is being developed in the UK (Dick 2008). There is some evidence that Cognitive 
Behavioural Therapy may be helpful as an adjunct in pain management. However, 
despite encouraging results of psychological interventions in SCDs (Anie 2005), the 
evidence base is still limited (Anie and Green 2002). Thus identification of a wider 
range of putative risk factors for psychological distress in people with SCD (such as 
perceived stigma) could lead to new and more effective targeting of psychological 
interventions. Stigma is a good example of putative risk factors that are yet to be 
explored in SCD. 
 
1.6. Summary 
SCDs affect a large number of people worldwide. Although these disorders are much 
more common in developing countries, particularly in sub-Saharan Africa, migration 
means more cases are increasingly being seen in developed countries and in all parts 
of the world. Thus awareness of the physical treatment and psychosocial 
complications is essential in all countries. While SCDs carry risk of serious and 
sometimes life threatening complications, the severity is variable; hence some 
affected persons can lead a relatively healthy life. Recent treatment advances have 
improved life expectancy although most of this benefit is still limited to developed 
countries. The most distressing symptom is painful ischaemic crisis, and there is some 
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evidence that psychological interventions can be helpful in managing these. A better 
understanding of psychological factors associated with SCD could lead to new and 
effective targeting of psychological interventions. 
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Chapter 2. 
 
Literature review (1): Stigma and sickle cell disease. 
 
2.1. Introduction 
In this chapter, I discuss the concept of stigma and the dimensions that determine the 
stigmatising potential of disorders. I apply the stigma dimensions to SCDs to explore 
to what extent they are applicable to this condition. I review the literature for 
empirical evidence of stigma in SCDs and interactions with other types of social 
disadvantages. The chapter includes a discussion of the social model of disability as a 
critique of discourses of stigma, which could unwittingly present stigmatised persons 
as victims. The chapter is not intended as an exhaustive sociological or 
anthropological exploration of the concept of stigma. Instead, I have prioritised 
aspects of the concept that are relevant and applicable to SCDs. 
 
2.2. Concept of stigma 
Worldwide, the contribution of stigma to the burden of physical disorders is 
increasingly being recognised (ILAE/IBE/WHO 2003). For disorders such as SCDs 
that are already associated with potentially serious physical complications, any 
additional social and psychological distress engendered by stigma is likely to 
substantially increase associated disability and hardship.  
 
It is customary to commence discussions of stigma with reference to Erving 
Goffman’s seminal work on the subject. Goffman (1963) described stigma as an 
attribute that is deeply discrediting. He described how possessing the stigmatising 
attribute fundamentally intrudes on how others perceive the individual. In the ensuing 
transaction, the person with the attribute subsequently internalises the associated 
discredit thereby changing his or her own perception of the attribute. The stigmatised 
person feels he has been transformed from a normal to a tainted person. For example, 
the person with the attribute may start to anticipate discriminatory behaviour from 
others and may experience a reshaping of their emotions and beliefs about themselves 
and society. Goffman also described how the stigma process could extend to other 
 30
people without the attribute but who are connected to the stigmatised person (e.g. 
relatives). He referred to this as courtesy stigma.  
 
Since Goffman’s work, other sociologists have extended the characterisation of 
stigma. Of the several types of stigma that have been described, the concepts of 
Enacted and Perceived stigma described by Jacoby (1994) appear most relevant to the 
work presented in this thesis. These two types of stigma are particularly important in 
understanding the impact of stigma on affected individuals and in thinking of 
appropriate interventions.  
 
According to Jacoby (1994), enacted stigma describes the actual experience of 
negative and discriminatory behaviour by others against the person with the 
stigmatising attribute. The resulting distress in the affected individual is clearly linked 
to an actual experience of ill-treatment. Thus interventions to reduce enacted stigma 
would be more effective if directed at changing the negative and stereotypical 
attitudes of the perpetrators.  
 
On the contrary, Jacoby (1994) described perceived stigma as a subjective belief or 
anticipation that having the stigmatising condition will lead to discrimination by 
others. The belief may be related to previous experiences of enacted stigma or may 
not be founded on actual experience (Scrambler 2004). According to Heatherton and 
colleagues, even when the stigmatising attribute is not obvious, those who perceive 
themselves to be stigmatised often experience psychological distress and have a 
negative view of themselves (Heatherton, et al., 2003). It is as if the affected persons 
develop a different view of the world and different way of interpreting events and 
experiences influenced by possession of the stigmatising attribute (Scambler 2004). 
 
Perceived stigma can have serious disabling consequences due to the tendency by 
affected individuals to take, sometimes, extra-ordinary measures to conceal their 
attribute (Scambler 2004; Scambler and Hopkins 1986). Typical consequences of 
these efforts to avoid disclosure include isolation and loss of social and economic 
opportunities (Leary et al 1998). The importance of recognising perceived stigma lies 
in the potential for psychological treatment. For example, because the underlying 
mechanism in perceived stigma may involve distorted cognitive appraisal, the 
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associated psychological distress and avoidance could be amenable to Cognitive 
Behavioural Therapy (Kent 2000).  
The impact of perceived stigma can be serious on affected persons. Even for life 
threatening diseases, perceived stigma could lead affected individuals to make 
deliberate and seemingly irrational decision not to seek help (Sadavoy et al 2004). 
Consistent with Goffman’s work, both enacted and perceived stigma can also apply to 
third parties with links to the stigmatised individual (courtesy stigma).  
However, it is important to recognise that despite the possibility of more negative 
self-appraisal by some stigmatised persons, this is by no means universal. On the 
contrary, other stigmatised persons show resilience and are able to ward off negative 
threats to their self esteem (Heatherton, et al., 2003). 
Stigma is a ubiquitous and diffuse concept (Weiss et al. 2001), which lends it use to a 
wide range of diverse processes that have in common a sense of social rejection 
(Coker 2005). Related concepts, which are sometimes used loosely to infer stigma 
include, social rejection, negative attitude, prejudice, discrimination, and social 
embarrassment. Also stigma has cultural and situational dynamism; hence what is 
considered stigmatising in a particular historical or cultural context may not be at a 
different time or place and could even become a positive attribute.  
 
This thesis is focused on “Felt or Perceived” stigma. This is in part because 
examining this type of stigma could potentially lead to development of individually 
targeted psychological interventions for people with SCDs. While proponents of the 
social model of disability would argue that the distress associated with stigma is due 
to societal attitudes and that interventions should therefore focus on changing societal 
perceptions, there is good evidence from conditions like epilepsy (Westbrook et al 
1992) to suggest that self-perceived stigma is also associated with direct 
psychological distress to affected persons. This association justifies studying and 
intervening directly against self-perceived stigma.  
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2.3. Impact of stigma 
Stigma associated with mental and physical illnesses have adverse impact on a range 
of outcomes. The serious impact of stigma is probably best illustrated with reference 
to HIV-AIDS. Several studies have shown a close association between HIV-AIDS 
related stigma (measured by desire for social distance) and reduced utilisation of 
voluntary counselling and testing (VCT) services (Hutchinson and Mahlalela 2006, 
Iliyasu et al 2006, Babalola 2006), and disclosure of HIV status (Kilewo et al 1999). 
This combination of reduced VCT and disclosure have serious implications for 
controlling HIV transmission. Uys (2003) found that in South Africa, relatives of 
patients with terminal AIDS could not be given appropriate emotional support 
because the terminally ill patients had refused permission to discuss their HIV-AIDS. 
Stigma also interferes with grieving. Frohlich (2005) noted that in South Africa, some 
relatives of patients who have died from HIV-AIDS avoid grieving openly for fear of 
courtesy stigma. Cluver and Gardner (2007) found that in addition to other stressors 
like bereavement, physical abuse, poverty and loss of contact with remaining family 
members, enacted stigma was a significant contributor to the distress of children 
orphaned by HIV-AIDS in South Africa. 
 
With respect to conditions more comparable to SCDs, several studies have shown 
associations between self-perceived stigma and higher levels of psychological and 
emotional distress in psoriasis (Richards et al 2001, Leary et al 1998), vitiligo (Kent 
2000), and epilepsy (Westbrook et al 1992; Austin et al 2004; Adewuya et al 2006). 
 
2.4. Epilepsy as a model for stigma in chronic physical disorders like 
SCD 
Epilepsy presents a good model for exploring stigma in chronic conditions like SCD. 
Several studies of epilepsy in both adults and children have demonstrated that the 
condition is highly stigmatising. These findings apply to studies that explored both 
enacted and self-perceived stigma (Jacoby 1994) and those that measured social 
distance (Austin et al 2002), and prejudice (Fernandes et al 2007) against people with 
epilepsy. Also the findings have been shown in both developed (Westbrook et al 
1992) and developing (Adewuya et al 2006) countries. The world-wide recognition of 
the prevalence and adverse impact of stigma on people with epilepsy prompted the 
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international campaign “Out of the shadows” by the World Health Organisation, 
International League Against Epilepsy, and International Bureau for Epilepsy  in 1997 
(ILAE/IBE/WHO 2003). This thesis is not intended for detailed discussion on 
epilepsy; hence only illustrative literature on children is highlighted. 
 
In a test of theoretical model of stigma among children with epilepsy in United States, 
Westbrook and colleagues found a high prevalence of self-perceived stigma and 
adverse impact on self esteem (Westbrook et al 1992). This study demonstrated a 
reliable methodology for assessing self-perceived stigma, which I adapted for this 
study. Also in United States, a large scale survey of school children found significant 
social distance towards peers with epilepsy. For example, 69% of the sample would 
not date an affected person (Austin et al 2002). 
 
A recent study in Nigeria found a negative association between self-perceived stigma 
and school achievement of adolescents affected by epilepsy (Adewuya et al 2006). 
Also, a review from the same region in Africa (Baskind and Birbeck 2005) found 
epidemiological, anthropologic and sociologic evidence that epilepsy attracts a very 
negative public perception.  
 
Other reviews of the literature on epilepsy and stigma in adolescence have found that 
stigma is common and adversely affects the quality of life of affected young people 
(e.g. MacLeod and Austin 2003). 
 
2.5. Stigma dimensions and application to SCDs 
Stigma dimensions predict how others are likely to respond to the possession of a 
potentially stigmatising attribute. Thus these dimensions help to understand why 
certain attributes and not others become stigmatising. Katz (1981) and Jones et al 
(1984) described several interrelated stigma dimensions including: Visibility, Threat 
or Peril, Chronicity, Responsibility, and Disruptiveness. 
 
The dimension “Visibility” refers to the extent the attribute is obvious, concealable, or 
aesthetically challenging to others. In general, stigma theory predicts that the more 
visible and disfiguring an attribute the more stigmatising it is likely to be. Some 
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people with SCD have easily recognisable physical manifestations such as jaundice, 
leg ulcers, and delayed physical development (Dick 2008). Severe cases, especially 
where effective treatments are not widely available, may be associated with gross 
physical signs such as gnathopathy (Wessberg et al. 1980), and bossing of the 
forehead (Acquaye et al. 1985). While widespread access to disease–modifying 
treatments (Atweh and Schechter, 2001) has made these gross signs uncommon in 
Western countries, they are still common signs in many developing countries where 
the vast majority of people with SCD live. Thus the visibility of the physical signs of 
SCDs increases the potency for stigma. 
 
The stigma dimension of “Threat or Peril” is to do with the perceived danger posed to 
others by virtue of a person possessing the attribute. Consistent with this dimension, it 
is well recognised that having a potentially fatal infectious disease such as 
Tuberculosis is stigmatising. In some non-Western societies, inaccurate beliefs that 
associate SCD with peril are still common. For example, a recent survey of secondary 
school students in Nigeria found that 9% of the students believed that SCDs are 
infectious (unpublished data). Also in Nigeria, 8% of relatives attributed SCDs to 
malevolent spirits of reincarnation ((Ohaeri and Shokunbi 2001; Nzewi 2001). SCDs 
are therefore likely to be stigmatised in these settings where a significant proportion 
of the society hold threat-promoting views about the condition. Hinshaw (2005) 
suggests that the kind of demonological attributions described above are associated 
with increased stigma. 
 
The dimension of “Chronicity” predicts that long lasting conditions would be more 
stigmatising than acute short-lived disorders that leave no permanent marks. SCD 
disease is essentially a chronic life-long disorder with only a small chance of cure for 
a minority of affected persons (through bone marrow transplantation). Although some 
affected persons are able to enjoy prolonged periods of good health, the underlying 
genetic disorder does not change (except for a minority who undergo successful bone 
marrow transplantation). Atkin and Ahmad (2001) found that among young people 
with SCDs, even when they are stable and free from acute events, they still worry 
about their future health. This partly explains why the treatment paradigm for the 
condition is sometimes described in principles of palliative care (Bevan 1998; Ballas 
2005). The chronic nature of SCDs therefore suggests increased likelihood of stigma. 
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The stigma dimension of “Disruptiveness” describes the extent to which possessing 
the attribute interferes with interpersonal relationships. Disruptiveness is also related 
to other dimensions like Chronicity, as more severe and long-standing disorders tend 
to be also more disruptive. Although the course of SCDs are variable and many 
affected persons live relatively healthy undisrupted lives, a proportion require 
frequent hospitalisation as a result of different acute illness episodes particularly pain 
(Wethers 2000). In addition, some experience even more frequent but less severe 
episodes not requiring hospital admission but nonetheless necessitating rest at home. 
The limitations imposed by these illness episodes could be disruptive to schooling, 
employment, and social encounters (Atkins and Ahmad 2001). Also disruptions make 
concealment more difficult and increase the potential for both enacted and self-
perceived stigma. The resulting threat of unwanted disclosure could be a source of 
dysphoria for affected persons. 
 
The dimension of “Responsibility” refers to the assumption that people are more 
likely to experience stigma if they are considered in some way personally responsible 
for acquiring the negative attribute. Although people affected by SCDs are clearly not 
responsible for acquiring the disorders, in communities where misinformation about 
the disorder is prevalent, affected persons may be blamed unfairly. The previous 
reference associating SCDs with malevolent spirits in Nigeria (Nzewi 2001) is a good 
example.  
 
2.6. Evidence of stigma in sickle cell disease 
Although Goffman’s seminal work on stigma was based mainly on mental disorders, 
the dimensions and characterisations of stigma have been successfully applied to a 
wide range of physical disorders such as epilepsy (Westbrook et al 1992) and 
stuttering (Blood et al 2003). 
 
2.6.1. Literature search strategy 
The literature on stigma in SCD is extremely limited. For the literature search, five  
electronic databases (Medline, Embase, PsycINFO, CINAHL, and Social Science 
Citation Index) were searched from their inception to June 2009. Specific MeSH 
terms were used for searching Medline and EMTREE terms were used to search 
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Embase. The search terms were divided into two groups. The first group had search 
terms related to sickle cell (sickle, sickle cell disease, sickle cell anaemia, sickle cell 
disorders, and haemoglobinopathy). The second group of search terms had terms 
related to stigma (stigma, discrimination, stereotype, negative attitude, prejudice, and 
disadvantage). Terms from each group were searched in combination using the OR 
function (for same group) and combined with the search outcome of terms from the 
other group using the AND function. The initial selection criteria focused on studies 
that: 
• examined self-perceived stigma, and 
• whose subjects had sickle cell disease 
 
The search was filtered by age group (children) and language (English). The first 
search identified no study that met these criteria. The search criteria were therefore 
extended to include any study on any aspect of stigma or related subject on people 
with sickle cell disease of all ages (including carers), and in any language.  
 
These new and very wide search criteria identified only four studies of direct 
relevance. The reference lists of the studies identified were also searched but this 
yielded no additional studies of relevance. Of the four studies identified, one 
involved mothers of children with SCDs (Burnes et al 2008), the second involved 
adults with SCDs (Sanker et al 2006) and the third and fourth studied young people 
with SCDs (Adedoyin 1992, Atkin and Ahmad 2001). 
 
2.6.2. Discussion of identified studies 
Burnes and colleagues conducted in-depth interviews with ten Canadian mothers of 
African and Caribbean origin whose children had SCDs (Burnes et al 2008).  The 
mothers were recruited from a specialty SCDs clinic. The interviews explored the 
mother’s coping strategies as well as their perceptions of negative attitudes towards 
SCDs. All but one of the mothers had experienced SCDs-related stigma. The mothers 
were keen to keep their child’s sickle cell disorder secret for fear the children would 
be stigmatised. They reported negative public perceptions including beliefs that SCDs 
are infectious, or represent an ancestral curse on the family. Some of the mothers 
reported being blamed for knowingly conceiving an ill child. This study was limited 
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by the fact that it did not seek information about stigma from the children with SCD 
or their fathers. Also the findings are difficult to generalise given that respondents 
were all recruited from a specialist clinic for SCD.  
   
In a study to explore the relationship between genetic aetiology and potential for 
stigma, Sankar and colleagues interviewed eighty American subjects made up of 
people with SCDs, cystic fibrosis, cancer and deafness (Sankar et al 2006). The 
respondents were recruited from support groups, clinics and through community 
meetings. The study found that contrary to common belief, genetic aetiology did not 
automatically or universally confer stigma on affected individuals. Instead, stigma 
appeared more related to the varied experiences of particular individuals. The authors 
compared people with cystic fibrosis with those with SCDs and noted that the latter 
group were more likely to report negative experiences or feelings about their 
condition even though the physical outlook is more favourable for SCDs in that 
setting. One limitation of this study is that it failed to account for confounding factors 
such as racism. Given that most people with SCD are of Black ethnicity and people 
from this ethnic group are at more risk of experiencing racism, the more negative 
experiences reported by the SCD group compared with the Cystic Fibrosis group may 
be in part due to racial discrimination.  
 
Adedoyin (1992) explored the attitudes of Nigerian adolescents with SCDs towards 
having the disorder. The study found that the dysphoric adolescents attributed their 
unhappiness to a range of disease related life limitations including “a sense of shame 
in public”. The study was not designed to primarily examine stigma; hence the subject 
was not explored in any detail. 
 
In a qualitative study of 26 young people with SCDs and 25 with thalassemia major, 
Atkin and Ahmad (2001) found that those in their mid teens resisted anything that 
marked them out as different including adherence to their treatment regimes. They 
report that young people with these conditions felt that due to ignorance, “disablism” 
and racism, people in their wider social network were insensitive to their concerns. 
Atkin and Ahmad did not explore stigma in detail as it was not the main focus of their 
study. 
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Other recent psychosocial reviews on SCD acknowledge the likely adverse impact of 
stigma (Anie 2005; Helps et al. 2003). Additional evidence comes from social-
anthropological studies and everyday life examples. I explore these next.  
 
2.7. Social anthropological evidence 
Weiss and colleagues have highlighted the importance of cultural perspectives in 
considering stigma (Weiss et al. 2001). In many societies where SCD is prevalent, the 
condition and the associated high-infant-attrition rate is attributed to malevolent 
spirits (Onwubalili 1983; Nzewi 2001). In Nigeria – the country with the highest 
prevalence of SCD, local terms associated with the condition (e.g. Ogbanje) connote 
malevolent spirits linked with reincarnation (Nzewi 2001). Historically, such 
demonologic views tend to attract harsh and punitive responses (Hinshaw 2005). In 
Nigeria for example, the evil-spirit link with SCD results in practices that includes 
amputation and mutilation of newborn babies suspected of possessing the attribute 
(Nzewi 2001). The mutilation marks are intended to assist with identifying the child 
with the malevolent spirit in the event of his/her reincarnation.  
 
In my personal experience, (which includes childhood, medical training and working 
as a doctor in Nigeria), the local term stated earlier (Ogbanje) is well recognised as 
deeply discrediting. In fact, ordinary children use the term as “swear word” to put-
down peers who are non-sickle cell sufferers. Also the association with malevolent 
spirit of reincarnation is so pervasive and powerful that surviving children in affected 
families gradually acquire names with themes of death (Nzewi 2001). In the study by 
Sankar and colleagues, some respondents with SCD reported similar childhood 
experiences in which their peers used SCD to “say the cruellest things” about the 
respondents’ families (Sankar et al. 2006). 
 
The presence of even one obvious sign of SCDs could be associated with a 
disproportionate impact on the life of affected individuals. For example, Alleyne and 
colleagues assessed the psychological, social and economic impact of leg ulceration 
on people with SCDs in Jamaica. Compared with a control group with no leg 
ulceration, the ulcer-affected group experienced wide ranging adverse psychosocial 
effects including on education, employment, and marriage (Alleyne et al. 1976). 
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However, it is also possible that leg ulcer is a marker for severity and or other socio-
economic disadvantages that could explain the adverse impact on education, 
employment and other psychosocial variables. Also the social circumstances in 
Jamaica may have changed substantially in the past 30 years as to question the current 
relevance of this finding.  
 
Another evidence of stigma in SCDs comes from everyday language. People with 
SCD are sometimes referred to as “Sicklers” both in general language and in 
published literature (Akuse 1996). This description, which identifies the individual 
with their disorder, increases stigma (Slovenko 2001). Although intended to describe 
a person with SCD, the term “Sickler” also unwittingly conveys the impression of 
someone who is frequently ill. Coincidentally, this can be the reality for some people 
with severe forms of SCDs. 
 
2.8. Sickle cell disease stigma and disadvantage.  
Stigma may be related to some of the physical and psychosocial disadvantages 
associated with SCD. Access to pain control may be a good example. Although I am 
not aware of any good evidence to suggest malicious practice or deliberate 
discrimination in the clinical care of people with SCD, Anionwu (1996) has suggested 
that some hospital staff view patients with SCD as “difficult” and that staff’s 
stereotypical beliefs can unwittingly result in inadequate management of SCD 
patients’ painful crisis. While acknowledging the legitimate risk of iatrogenic opiate 
dependence, concerns about less optimal opiate prescribing for pain management in 
SCD have been noted (Bevan et al. 1996).   
 
Despite well-intentioned legislative frameworks aimed at protecting people with 
disabilities from discrimination, many examples of discriminatory practices against 
people with SCD are still noted in access to jobs and health insurance in the United 
States (Kass et al. 2004) and the UK (Atkins and Ahmad 2001). These may be 
indicative of persisting high levels of prejudice against people with SCD. Also if, as is 
sometimes reported to be case, people with SCDs have to literally fight for necessary 
services and allowances, the resulting frustration could accentuate the perception of 
stigmatisation by affected individuals. 
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There is recent evidence suggesting inappropriate use of SCD by Criminal Justice 
Systems to explain death of Black people in custody. Dyson and Boswell (2006) 
reviewed ten cases of sudden deaths among Black people in custody in United States 
and United Kingdom. Their findings suggested that SCD was misused to explain all 
ten deaths. The authors reviewed another seven deaths of people with SCD while in 
custody and suggested that inadequate SCD-care while in custody contributed to these 
fatalities. It is however uncertain whether these adverse events were borne out of the 
law enforcement officers’ ignorance of the needs of this client group or actual 
prejudice. 
 
Sickle cell disease stigma may also interact with racism. Just like racism, stigma 
processes are thought to be consistent with concepts of class and command (Scambler 
2004). Parker and Aggleton (2003) point out that stigmatisation functions at the point 
of intersection between culture and power. As a result, they highlight the importance 
of understanding the framework that promotes the interests of dominant groups and 
differential understanding of values and worth, which are the processes that facilitate 
stigmatisation (Parker and Aggleton 2003). Interaction of stigma and racism could be 
particularly important in SCD as the disorder affects predominantly people of Black 
African origin – a minority group who are already at significant risk of racial 
stereotyping (Kushnick 1988). Explicit and deprecatory racial attitudes are no longer 
widely expressed, but subtle and implicit racial stereotyping is still common (Hinshaw 
2005). Racial factors may have contributed to the more negative experiences reported 
by SCD sufferers compared with cystic fibrosis patients in the study by Sankar and 
colleagues cited earlier (Sankar et al. 2006). 
 
2.9. Courtesy stigma 
Relatives of a person with the stigmatising attribute can experience “courtesy stigma” 
(Goffman 1963). Courtesy stigma is known to worsen the subjective burden of care 
on relatives. Fear of courtesy stigma results in concealment and secrecy, which limits 
access to family support (Hinshaw 2005).  
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In pure genetically determined conditions like SCD, parents and siblings are more 
likely to receive courtesy stigma (Hinshaw 2005). Parents may be unfairly blamed by 
their immediate community (Sankar et al. 2006; Burnes et al 2008) or blame 
themselves resulting in high levels of guilt (Murray 1976). As siblings of people with 
SCD could be heterozygous carriers of the sickle cell gene, their peers may over look 
them when considering long-term relationships (Bamisaiye et al. 1974).  
 
2.10. Special consideration for adolescents with SCD 
As this project focused mostly on adolescents with SCDs, it is important to consider 
the particular and special implications for SCDs stigma in this age group. For several 
reasons, there is concern that adolescents with SCD may be particularly vulnerable to 
stigma. It is already a major challenge for some adolescents to effectively negotiate 
the complex biological and social transitions associated with this age group 
(Dornbusch et al 1991). The concern is that superimposing the demands of a serious 
and potentially stigmatising illness like SCD on such a complex system complicates 
an already difficult process (Hilton et al 1997). 
In some people, SCD is associated with pubertal delay (Pinckney and Stuart 2004). 
Many studies have shown that for boys in particular, delayed puberty is stigmatising 
and associated with low self-esteem (Alsaker 1996). For example, in a study of young 
adults with SCD in Jamaica, low body mass index was a feature in all the male 
subjects with a psychiatric disorder (Hilton et al 1997). Because adolescence is a 
critical time for development of self-identity (Alsaker 1996), stigma engendered low 
self-esteem at this stage of development could have significant long-term adverse 
impact.  
Individuating from families and formation of other long-term relationships is one of 
the key tasks of adolescence (Alsaker 1996). The genetic basis for SCD and the 
potential stigma engendered by this could make this task challenging for both people 
with SCD and their siblings (Sosan 2006). Concealment is often the stigma 
management strategy of choice for people with stigmatising conditions (Link et al. 
1991). While this limits the risk of experiencing prejudice, it also results in isolation 
and missing of important social opportunities especially in adolescence. The Jamaican 
study cited previously (Hilton et al 1997) found that compared with non-SCD 
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controls, young adults with SCDs were less likely to be in stable relationships or to 
have children.  
 
2.11. Resilience 
Although research on chronic health problems is often driven by deficit models 
(Reynolds 1992), which emphasise maladjustment and difficulties, it is important to 
recognize that negative outcome in SCD is not inevitable. There is evidence of 
resilience in both affected persons and their families (Robinson et al. 1995; Ohaeri 
and Shokunbi, 2002).  
 
While SCD is a chronic illness, the course is characterised by episodes of acute 
illnesses separated by periods of relative well-being (Smith 1991). Many people with 
mild SCD disease can have lengthy periods of well being (Thomas et al. 1997). Also, 
the use of disease-modifying treatments such as Hydroxyurea is increasingly keeping 
many people with SCD free from acute events for longer periods (Atweh and 
Schechter, 2001). Research to document and highlight the course and positive 
outcomes in SCD could therefore help to challenge the therapeutic nihilism that might 
be contributing to stigma in SCD. 
 
2.12. Methodological issues in the assessment of stigma 
Enacted stigma can be assessed either from the perspective of the person with the 
stigmatising condition or from the perspective of people without the condition. From 
the former point of view, enacted stigma is commonly measured by enquiring from 
affected persons about actual experiences of discrimination and prejudice attributable 
to possessing the stigmatising condition. From the latter perspective, enacted stigma is 
assessed by measuring self reported attitudes such as social distance or behavioural 
rejection using fictional vignettes portraying or role playing the stigmatising 
condition. The Social Distance Scale originally developed by Borgadus is a 
commonly used example of this type of measurement.  Versions of the original scale 
have been adapted to measure attitudes towards a wide range of situations and the 
measures generally show good reliability. However, there are two major threats to 
their validity. First, as the scenarios given to respondents are hypothetical, it is 
uncertain if they would give the same responses in similar but real situations. 
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Secondly, the validity is limited by the respondent’s tendency to provide socially 
desirable responses to controversial questions (van de Mortel 2008). For example, in 
an extensive review of over 14,000 studies measuring attitudes, van de Mortel (2008) 
found that only 31 studies (0.2%) attempted to identify socially desirable responding 
and of these, nearly half found that socially desirable responding influenced their 
results. Similarly, Hinshaw (2005) argues that changing social norms have made overt 
racist responses unlikely even though over-learned and hidden racial prejudices are 
still held by many individuals.  
 
Thus the validity of Social Distance Scales can be enhanced by simultaneous 
measurement of the social desirability of the respondent’s answers. This measure can 
be used to eliminate respondents with unacceptably high socially desirable responses 
or social desirability can be controlled for using partial correlation or hierarchical 
regression techniques (Nederhof 1985). A commonly used reliable measure of social 
desirability is the Marlowe-Crowne Social Desirability Scale (Crowne and Marlowe 
1960) and its shorter versions (e.g. Loo and Thorpe 2000). 
 
Another method to minimise the threat of socially desirable responding in the 
assessment of enacted stigma by people without the stigmatising condition is the use 
of measures that are less overt than self reported behavioural rejection. The more 
subtle, less conscious and implicit measures (e.g. Implicit Association Test) 
(Teachman et al 2006) are recognised to be less prone to eliciting socially desirable 
responses. 
 
The assessment of self perceived stigma typically involves eliciting the beliefs and 
perceptions of affected persons on how non-affected persons would behave in 
different interactional situations. This methodology is subject to limitations including 
that any perceived negative attitude reported by affected persons is likely to be 
simultaneously influenced by a myriad of other personal (e.g. pre-existing depressive 
illness) and ecological (e.g. social support) factors. Such reports are also likely to be 
prone to recall bias whereby a person with the stigmatising condition that has 
experienced discrimination would be more likely to interpret and report other neutral 
behaviours as discriminatory. Being a measure of attitude, the difficulties already 
noted regarding socially desirable responding would also apply. 
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2.13. Social model of disability applied to SCDs 
The social model of disability argues that for disabling conditions like SCDs, the real 
cause of disability are social barriers and negative attitudes rather than the actual 
physical impairments that may be associated with the condition. The social disability 
model argues against explanatory models, which they see as unwittingly victimising 
affected persons by locating the difficulties associated with their condition entirely 
within the affected person. For example, in relation to stigma and negative attitudes, 
the social model of disability would argue that instead of people with SCDs adjusting 
to cope with negative attitudes, it is other people who should be adjusting their 
negative attitudes towards people with SCDs (Atkin and Ahmad 2001). Proponents of 
the social disability model attempt to distinguish this model from paradigms that 
focus on the individual impairments or deficits associated with the condition – 
sometimes referred to as the medical model. They argue that discourses of SCDs 
should not stop at the level of the individual but encompass social and political 
aspects. However, in reality, both the social disability model and so called medical 
model offer useful and practical understanding of the difficulties experienced by 
people living with chronically impairing and disabling conditions like SCDs. A good 
example is the frequent association between greater severity of disease and greater 
disability. 
 
2.14. Summary 
I have shown in this chapter that models of stigmatisation can be applied to SCDs. 
Specifically, several stigma dimensions show a good fit with the bio-medical and 
psychosocial aspects of SCDs. Despite paucity of direct empirical research, some 
evidence from everyday life and socio-anthropological studies suggest that people 
affected by SCDs may be at risk of stigmatisation. 
 
Although I have argued that stigma dimensions developed in studies of mental and 
other physical illnesses are applicable to SCD, this remains to be tested. There is 
inadequate research into the perception and or actual experiences and impact of 
stigmatisation on people affected by SCDs and their families. This is a crucial gap 
given the evidence from other stigmatising physical conditions (e.g. epilepsy) 
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indicating both high prevalence and adverse impact of stigma. The project completed 
for this thesis is designed to start filling this gap by exploring the prevalence and 
psychosocial associations between SCDs and self-perceived stigma.  
 
It is appropriate to recognise the valid critique of the concept of self-perceived stigma 
by proponents of the social model of disability (e.g. Atkin and Ahmad 2001), who 
argue that while SCDs are physical disorders, self-perceived stigma is a socially 
constructed concept that could imply that people with SCDs are victims. However, 
there is also good evidence from conditions like epilepsy (Westbrook et al 1992) to 
suggest that self-perceived stigma is a valid phenomenon that is associated with direct 
psychological distress to affected persons. This association justifies studying and 
where appropriate intervening directly against self-perceived stigma.  
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Chapter 3. 
 
Literature review (2): Psychosocial adjustment and 
psychopathology in sickle cell disorders 
 
3.1. Introduction 
This chapter is focused on exploring the factors that contribute to psychological 
adjustment in children with SCDs. As the focus is on children, the evidence examined 
to quantify the level of psychological difficulties is limited to studies involving this 
age group. Studies assessing levels of general psychopathology in children with SCDs 
are discussed first. Due to hypothesised differences in levels of psychopathology 
between children with SCDs living in developing and developed countries, the 
evidence is examined separately for these two regions. In addition to general 
measures of psychopathology, I have included an extended discussion of depression. 
This is because of the seriousness of depression in terms of impairment and risk of 
suicide. Risk factors and the prevalence of depression in children with SCDs are 
explored. Evidence is drawn from studies of both children and adults with SCDs to 
discuss general principles or mechanisms. However, evidence used to quantify the 
problem is limited to studies of children. 
 
3.1.1. Literature search strategy 
Four electronic databases (Medline, Embase, PsycINFO, and CINAHL) were 
searched from their inceptions to June 2009. Specific MeSH terms were used for 
searching Medline and EMTREE terms were used to search Embase. The search 
terms were divided into two groups. The first group had search terms related to sickle 
cell (sickle, sickle cell disease, sickle cell anaemia, sickle cell disorders, and 
haemoglobinopathy). The second group had search terms related to psychopathology 
(psychological, psychosocial, psychiatric, mental health, mental illness, depression, 
anxiety, and self esteem). Terms from each group were searched in combination using 
the OR function (for same group) and combined with the outcome of search with 
terms from the other group using the AND function. The search was filtered with 
language (English) and age group (children). Although only publications in English 
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language were sought, one publication in French was included because it came from 
Africa where studies on SCD are very limited. 
 
For purposes of quantifying the burden of psychological difficulties and depression in 
studies were selected if: 
• subjects were children with SCD 
• used an explicit measure of psychopathology or psychological function 
• had a control group or used measures with established population norms 
 
The reference lists of identified studies were searched for additional relevant 
publications. 
 
3.2. Determinants of psychosocial adjustment in children with SCDs 
Several factors are known to contribute to the psychosocial well-being of young 
people with SCDs. These factors could be explored using either the bio-psychosocial 
model or ecological models of aetiology (Bronfenbrenner, 1979). Using the bio-
psychosocial approach, the factors could be categorised into three domains – 
biological (e.g. disease process), psychosocial (e.g. personal attitude to disease), and 
social (e.g. family function) (see Figure 1). The ecological approach (Figure 2) would 
consider individual factors (e.g. disease severity, temperament), factors in the 
immediate family environment (e.g. socio-economic status, family function) and 
factors in the wider environment (e.g. societal attitudes, availability of treatments). 
Although these models are primarily heuristic and illustrative, they have good face 
validity and are supported by empirical data. 
 
While it is helpful to consider both models separately, in reality, they overlap. For 
example, the “social/environmental” component of the bio-psycho-social model 
incorporates the family and environmental aspects of the ecological model. It is also 
important to recognise that the relationships within the models are not linear and 
unidirectional. Instead, the components of both models have complex interactional 
and multidirectional properties. For example, parental relationship could be strained 
by the stress on parents supporting the needs of a child with a very severe form of 
SCD. On the other hand, parental marital problems not related to the child’s SCD 
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could nonetheless lead to a worsening of the child’s health if parents become too 
preoccupied by the conflict between them and neglect to administer the child’s 
treatments or keep hospital appointments. Another factor to consider in evaluating 
these models is that each domain contains not only risk factors but also resilience and 
protective factors. Thus the actual likelihood of psychopathology is dependent on the 
balance between risk and protective factors. For example, a child with a severe form 
of SCD may thrive psychologically in a very supportive and nurturing family and 
school environment.  
 
Figure 3.1. Bio-psycho-social frame 
work 
Risk of psychopathology increases with additional factors
in each domain 
Biological
factors
Social/Environmental 
factors
Psychological
factors
Most risk for psychopathology
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Figure 3.2. Ecological Framework for aetiology 
Wider environmental factors
Factors in the family
Factors in the individual
 
 
3.2.1. Biological 
It is recognised that children with more severe indices of SCDs are at more risk of 
psychological complications. However, this association is not inevitable as some 
young people with SCDs show resilience and hardiness. For example, in a 
longitudinal study of children with SCDs, Getzoff (2005) found that disease severity 
did not contribute significantly to long-term emotional outcomes.  
 
Apart from overall severity, the presence of specific physical complications are 
known to increase the risk of maladjustment in SCDs. For example, in a study in 
Jamaica, Alleyne and colleagues found a significant positive association between the 
presence of leg ulceration in people with SCDs and psychological distress (Alleyne et 
al. 1976). The neurological complications of SCDs are now well recognised. Up to 
11% of affected persons suffer overt strokes and up to 20% have evidence of 
ischaemic brain damage on MRI by the age of 20 years (Pegelow et al 2002). Given 
that brain ischemia is a recognised independent precursor of psychological and 
cognitive difficulties, people with SCDs and ischaemic complications would be at 
increased risk. 
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3.2.2. Psychological 
Several psychological and temperamental factors are known to contribute to 
adjustment in people with chronic physical disorders such as SCD. As part of the 
Cooperative Multi-site Study of SCD in United States of America, Burlew and 
colleagues assessed 90 American adolescents with SCD to determine the relative 
contributions of psychosocial and biomedical factors to the adolescents’ adaptation to 
SCD. The subjects were randomly selected from among patients with HbSS genotype 
enrolled in the Cooperative Study of SCD. The study showed that psychological 
factors such as self-esteem and assertiveness predicted adjustment while biomedical 
factors (indices of medical severity) did not (Burlew et al 2000). However, this 
conclusion needs to be considered cautiously as the finding may have arisen from use 
of inadequately sensitive biomedical indices in the study. The study was also limited 
by reliance on self report psychological measures. As already highlighted, people with 
SCD are at a substantially increased risk of ischaemic strokes, which could lead to a 
wide range of neuro-cognitive deficits and behavioural difficulties (Bonner et al 
1999). 
 
3.2.3. Social /environmental factors 
Families, peers and schooling experiences play an important role in children’s 
adjustment to SCDs. In a study of 182 young people with SCD, Barbarin and 
colleagues found that the best predictors of the affected child’s psychological 
adjustment included parental psychological function and relationships with parents 
and siblings (Barbarin et al 1999). The study cited earlier (Burlew et al 2000) also 
found that social ecological factors such as family relationships and social support 
were better predictors of adjustment compared with biomedical factors.  
 
An important aspect of the social environment that could mediate disease adjustment 
in SCDs is area of residence. Even in the same country or region, urban or rural 
residence could make a difference to people with SCDs. For example, in a recent 
study in Jamaica, Asnani and colleagues found that living in a rural location compared 
with an urban area was associated with better self-rated quality of life among people 
with SCDs (Asnani et al 2008). This finding was contrary to the researchers’ 
expectation.  
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Although people with SCDs living in developed countries have obvious advantage 
over those in poorer countries with respect to access to advanced treatments, this does 
not always translate into psychological advantages. For example, when Thomas and 
colleagues (Thomas et al 2001) compared 30 patients with SCDs in London with an 
equivalent number in Jamaica, they found that those in Jamaica were less anxious and 
had lower levels of perceived pain and emotional response to pain. While this finding 
is useful, it is possible that the difference arose from inadequate baseline matching 
between the two groups. It is also possible that relative lack of pain relief had 
conditioned the Jamaican cohort to perceive pain less readily. 
 
One important aspect of the social environment which is increasingly being 
recognised is the attitude of unaffected persons towards people with SCDs. There is 
good evidence that stigma contributes to psychosocial difficulties among children 
with chronic physical conditions such as epilepsy (Westbrook et al 1992 and 
Adeweya et al 2006). Although a similar impact could be hypothesised for SCDs, the 
evidence is very limited (see chapter 2). The study undertaken for this thesis aims to 
explore this evidence.  
 
3.3. Psychopathology in children with SCDs 
Epidemiological studies of childhood mental disorders such as the Isle of Wight study 
(Rutter et al 1976) and the British Survey of the mental health of children and 
adolescents (Meltzer et al 2000) consistently find increased risk of psychopathology 
among children with chronic physical conditions particularly disorders that involve 
the brain. In fact, Meltzer and colleagues found that having any physical health 
complaint increased the odds of a having a mental disorder by 82% (Meltzer et al 
2000). Research data suggest that these findings may be applicable to SCDs (Anie 
2005). Some studies of children with SCDs have shown increased rates of emotional 
difficulties, disruptive behaviour, and low self esteem among children with SCD 
(Helps et al 2003). However, Helps and colleagues suggested that recent 
improvements in the physical care of people with SCDs might have resulted in 
reduced rates of psychopathology in this group. While this may be the case in 
developed countries where advanced treatments are more widely available, a recent 
review found no evidence of reducing psychopathology in SCDs in developing 
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countries (Ani and Hodes 2006). Giving the differences between developed and 
developing countries in terms of access to treatments, the literature on 
psychopathology will be discussed separately for both parts of the world.  
 
More recent studies in developed countries appear to consistently show closer to 
normative levels of psychopathology in SCDs. For example, a recent study of children 
with SCDs in USA (Noll et al 2007) found no differences in measures of emotional 
wellbeing compared with their unaffected peers. In this questionnaire based which 
compared 43 children with SCD and an equal number of healthy controls, teachers 
described the children with SCDs as more prosocial and less aggressive. These results 
are similar to what the authors found 10 years earlier (Noll et al 1996). These studies 
have many strengths including use of muti-informant data collection. However, the 
positive outcome described might be related to the fact that they included only 
children with SCDs who had not had an overt stroke. Also the studies recruited 
children with HbSS, HbSC, and HbBthal but the varying severity associated with 
these gentotypes was not accounted for in the analysis. The two studies (Noll et al 
1996 and Noll et al 2007) were both limited by small sample sizes. Also the 
representativeness of the sample is limited by the fact that all the children with SCD 
were selected from a reputable nationally funded Centre with a comprehensive SCD 
service. Finally, the authors included five white children in the control group because 
there were no suitable black controls. 
. 
  Another study of 36 adolescents with SCDs in USA (McElligott 2006) found that the 
young people did not record higher than normative scores in different measures of self 
esteem, anxiety, depression and behavioural difficulties. Further, a longitudinal study 
in USA, which followed up 48 children with SCDs and 49 healthy controls for up to 
10 years found no differences in measures of depression, self worth and internalising 
symptoms between the two groups either cross-sectionally or longitudinally (Getzoff 
2005). In an earlier study in the UK involving 39 children with SCD and 24 controls, 
Midence and colleagues found no significant differences between the two groups on 
depression and self esteem (Midence et al 1996). However, the SCD group had a 
significant reduction in intellectual ability and an increase in behaviour problems. 
While these studies benefitted from multi-informant data collection, they were all 
limited by sole reliance of questionnaires to ascertain psychopathology. 
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Unlike the above studies from developed countries, studies in developing countries 
consistently show increased rates of psychopathology among children with SCDs. 
Most studies of psychopathology in developing countries have been conducted in 
Nigeria. An early case-control study of 84 children with SCD matched with 84 
healthy controls found parent and teacher-rated psychiatric morbidity using the 
Rutter’s scale in 27% of the children with SCD compared with 5% of the controls 
(Iloeje 1991). Another Nigerian study which compared 100 children with SCD with 
75 children with asthma and 75 children with other acute non-SCD medical 
conditions also using the Rutter scales found higher rates of psychiatric morbidity in 
children with SCD (30%) compared with children with asthma (25%) or acute 
medical illnesses (20%) although these differences were not statistically significant 
(Ayinmode and Adelekan 2005). The most recent study of 135 children (45 with 
SCD, 45 with Juvenile-onset Insulin Dependent Diabetes Mellitus and 45 healthy 
controls) also from Nigeria (Bakare et al 2008) found increased rates of DSM-IV 
emotional disorders in the SCD group (38%) compared with healthy controls (11%). 
This is the only study of psychopathology in SCDs from Africa based on structured 
interview for DSM-IV diagnoses. Incidentally the children with SCDs had lower rates 
of emotional disorders compared with children with juvenile-onset Insulin Dependent 
Diabetes Mellitus (42%). However, the authors noted that 20% of the children with 
SCDs had experienced suicidal ideation in the previous year compared with 11% of 
the diabetics and none of the healthy controls. The high level of psychopathology 
among children with SCD in this study may be partly explained by the fact that only 
children with homozygous HbSS genotype were included. This genotype is the most 
severe form of SCDs. Also the authors did not assess for, hence could not exclude 
children with cerebral involvement. 
 
In summary, recent evidence from developed countries suggest improving 
psychological adjustment for children with SCDs compared with non-affected 
children or siblings. It has been suggested that this improvement might be secondary 
to the hugely advanced physical care available in these regions, which has in turn led 
to improved physical, social and psychological well-being and longevity. 
Unfortunately, the opposite is the case in many developing countries where advanced 
physical care is lacking. It is not surprising that increased risk of psychological 
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distress continues to be demonstrated in these regions albeit in common with other 
chronic conditions. 
 
3.3.1. Depression in sickle cell disease 
In addition to considering studies of general psychopathology in SCD, it is important 
to give specific consideration to depression because of its association with significant 
impairment and risk of mortality from suicide. Given the similarity between SCDs 
and epilepsy in terms of chronic disease model, the significance of depression in 
SCDs could parallel that in epilepsy where life-time prevalence of depression is up to 
30% making it the commonest co-morbid mental illness in that condition (Kanner 
2003). In this section, I will explore difficulties with recognising depression in SCDs, 
the potential risk factors, and review the evidence for depression in children with 
SCDs. The literature on adults with SCDs is drawn on where appropriate to illustrate 
general principles and mechanisms. However only literature on children with SCDs is 
considered in the examination of evidence for depression in this age group. 
 
3.3.2. Diagnostic issues for depression in SCDs 
Before exploring studies of depression in SCDs, it is helpful to contextualise the 
disorder to SCDs. In particular, an understanding of the difficulties in diagnosing 
depression in people with SCDs is essential.  
 
Depression is typically diagnosed in the presence of a combination of psychological 
and physical symptoms that are sustained over a period of time – usually two weeks 
or more. The psychological symptoms include low mood, anhedonia, inappropriate 
guilt, low self worth, poor concentration and suicidal ideation, while physical 
symptoms include lethargy, poor sleep and appetite and reduced libido.  
 
The first difficulty in assessing depression in SCD is the overlap between some of the 
physical symptoms of depression and SCDs (e.g. lethargy) (Alao and Cooley 2001). 
A study by Yang and colleagues illustrates this well (Yang et al 1994). These 
researchers administered the Child Depression Inventory (CDI) to children with SCDs 
and controls and compared the risk of depression from CDI scores with the outcome 
of a diagnostic clinical interview for both groups of children (Yang et al 1994). They 
found high rates of depressive symptoms on the CDI among children with SCDs 
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(29%) compared with controls (12%). However, clinical interview found no 
difference in rates of depressive disorder between the two groups. Further analysis 
found that questions relating to fatigue and physical complaints in the CDI accounted 
for the high false positive rates for depression among children with SCDs. 
 
These findings also raise a general need for caution in interpreting studies where 
depression is measured with self-report questionnaires, which are designed to screen 
for but are not diagnostic of depression. The use of questionnaires also raises issues 
about what is appropriate cut-off. This difficulty is illustrated by Schaeffer and 
colleagues who used the Center for Epidemiologic Studies-Depression Scale (CES-D) 
to screen for depression in adults with SCDs. They noted that the percentage of 
patients categorised as depressed dropped from 43% to 18% following a minor 
change in the cutoff used (Schaeffer et al 1999).  
 
However, despite the limitations in the use of screening questionnaires, their 
simplicity and ease of application to a large number of subjects make them attractive. 
Also, when properly applied and validated, and when appropriate cut-off is chosen, 
questionnaires can have good agreement with diagnoses made with clinical interview 
in SCDs (Grant et al 2000).The vast majority of studies discussed in this chapter used 
questionnaires to assess depression. 
 
The second difficulty with diagnosing depression in SCDs is the transitory association 
between depressive symptoms and acute episodic complications of SCDs such as 
painful ischaemic crises. Although the symptoms may be very distressing and 
impairing, the transitory nature of the experience may not meet the duration criteria 
for a depressive disorder. For example, in a qualitative study of adolescents with 
SCDs and Thalasaemia, Atkin and Ahmad (2001) found that although most young 
people go through periods of feeling low and despondent, such periods were generally 
transitory and often triggered by life circumstances. They found no evidence of the 
sort of sustained withdrawal from family and peer relationships that characterise 
established depressive disorder. Following cessation of the stressor such as a hospital 
admission, the young people were able to successfully rebuild their coping strategies 
and sense of normalcy.  
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The transitory nature of depressive symptoms in SCDs raises another concern that 
genuine depressive disorder may not be accorded the appropriate significance it 
deserves in SCDs. The risk is that both clinicians and patients could see intermittent 
depressive symptoms as part of the “normal course” of having serious life-threatening 
disorders like SCDs. As a result, patients may not seek help even when their 
depressive symptoms are sustained as in genuine depressive disorder. Similarly, 
clinicians may be reluctant to enquire or to pursue a fuller enquiry when patients 
volunteer history suggestive of a depressive disorder. Thus for some people with 
SCDs, unrecognised and untreated depressive disorder could impair their quality of 
life over and above the direct physical complications of SCDs. Again using epilepsy 
as a model, it has been shown that for people with refractory seizures, depression was 
a more important variable in their quality of life than the seizure frequency or severity 
(Kanner 2003).  
 
3.3.3. Why people with SCDs could be at increased risk of depressive disorder. 
Using the bio-psycho-social model of adjustment to chronic diseases, depression in 
SCD could result from the disease process (e.g. severity, specific complications, and 
the unpredictable nature of some complications), psychological aspects of the 
individual (e.g. lack of acceptance or negative attitude to SCDs) and social factors 
(e.g. lack of social support, the need to make frequent adjustments in life-style, and 
negative attitude of others). These are explored in more details next. 
 
3.3.3.1. Pain and depression in SCDs 
Painful crisis is the hallmark physical complication in SCDs (Wethers 2000). Bearing 
this in mind, there is evidence from other disorders indicating that chronic pain is an 
independent risk factor for depression (Wolfe and Michaud 2009). A link between 
pain and depression is also supported by evidence that treatment for one improves the 
other (Kanai and Okamoto 2007). Evidence from studies of pain and mood in SCDs 
supports these conclusions.  
 
In a 6 months prospective study of 308 adults with SCDs, Levenson and colleagues 
found that 28% of the subjects were depressed. Compared with the non-depressed 
subjects, the depressed respondents had higher mean pain rating on more days and 
more distress and interference from pain (Levenson et al 2008). However, it is 
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important to note that although this study was prospective, it does not prove a 
causative link between pain and depression in SCD. Hasan and colleagues found in 
their study of 50 adults with SCDs, that 44% were depressed and the depressed 
subjects were more likely to have poor pain control and frequent ischaemic crises 
(Hasan et al 2003). Another study of 440 adults with SCDs found that patients who 
reported more frequent painful episodes were more likely to report depressive 
symptoms (Schaeffer et al 1999). Although this study had an impressively large 
sample size, it was limited by the fact that depression was not confirmed with 
structured clinical interviews. A study of the relationship between mood, pain and 
sleep in 20 children with SCDs found that mood mediates the relationship between 
pain and poor sleep (Valrie et al 2008). A general limitation of all the studies 
reviewed is the absence of firm evidence of causal association between pain and 
depression in SCDs. 
 
In summary, evidence from SCDs suggest that as is the case with other chronic 
painful conditions, pain as a specific physical complication in SCDs could have a 
depressogenic effect although its causal role is unclear.  
 
3.3.3.2. Depression and other physical markers of severity 
The evidence is generally suggestive that people with more severe forms of SCDs are 
at more risk of depression. Segbena and Sangare (1994) used the Hamilton 
Depression Rating Scale to assess 30 adult patients with SCDs and 31 heterozygous 
carriers of the sickle gene. Although no subject in either group scored above the 
threshold for moderate depression, the level of anaemia and the number of sickle-cell 
crises per year was associated with depressive symptoms in the SCDs group. The 
study by Hasan and others cited earlier also showed that patients who made more 
frequent use of accident and emergency department and had more frequent blood 
transfusions (both surrogate markers of severity) were more likely to be depressed 
(Hasan et al 2003). However, it is worth noting that disease severity alone is not a sole 
determinant of mood or function in SCDs. For example, Grant et al (2000) 
investigated depression in 44 patients with SCDs using Structured Clinical Interview 
and found that disease severity alone did not explain the level of patient’s mood or 
level of impairment.  
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3.3.3.3. Depression and psychosocial factors 
Carpentier et al (2009) have shown that personal psychological characteristics such as 
behavioural inhibition are associated with depression in SCDs. They examined 
behavioral inhibition and depression among 30 adolescents with SCDs and found that 
the adolescents who rated themselves high on behavioural inhibition displayed higher 
levels of depression than those with low behavioural inhibition. The study by Hasan 
and others cited earlier also found that adult patients with SCDs were more likely to 
be depressed if they had low family income (<$ 10,000), less than high school 
education, were female, or had inadequate social support (Hasan et al 2003). 
Similarly, Schaeffer and colleagues found in their study of 440 adults with SCDs that 
female gender and low family income were positively and significantly associated 
with depressive symptoms (Schaeffer et al 1999). This is an important study as it had 
one of the largest samples of people with SCD.  
 
3.3.3.4. Depression and neurological complications 
There is ample evidence that cerebral ischaemia increases the risk of depression 
(Hackett et al 2008). The risk of cerebral ischemia is now well recognised in SCDs 
and it is estimated that up to 11% of affected persons suffer overt strokes and up to 
20% have evidence of ischaemic brain damage on MRI by the age of 20 years 
(Pegelow et al 2002). The impact of brain infarction on intellectual decline in children 
with SCDs is also well demonstrated (Schatz et al 2002). Given the high prevalence 
of ischaemic brain pathology in SCDs and the association between brain ischaemia 
and depression, it is reasonable to hypothesise increased rates of depression in people 
with SCD who have brain ischemia. However, I am not aware of any studies that have 
examined for depression in children with SCDs and brain infarction. 
  
3.3.4. Paradoxical depression 
Paradoxical depression is known to occur in epilepsy in response to a phenomenon 
called “forced normalisation”. This phenomenon refers to patients with epilepsy who 
develop psychiatric disorders when their seizures cease (Robertson 1998). While I am 
not aware of any studies of depression in SCDs following cure with successful bone 
marrow transplantation, this phenomenon of “forced normalisation” needs to be borne 
in mind. A colleague recently worked with a patient with SCDs who became 
depressed and suicidal after returning to her place of origin in Africa following 
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successful bone marrow transplantation in the UK. She described feeling guilty for 
being cured while many of her peers in Africa were still suffering from complications 
of SCDs with no hope of a cure or effective treatment. 
 
3.3.5. Could any relationship between SCDs and depression be bidirectional? 
While there are risk factors for depression in SCDs as outlined above, the available 
evidence is limited and mostly drawn from cross-sectional data. Bearing this in mind, 
it is possible to hypothesise an opposite direction of association whereby depression 
increases the risk of complications in SCDs. It is conceivable that depression in SCDs 
could lead to poorer treatment adherence; hence increasing the likelihood of more 
physical complications. For example, in a study of 46 adults with SCDs, Belgrave and 
Molock (1991) found that depression was associated with increased likelihood of 
emergency treatment and hospital admissions. However as this study was also cross-
sectional, the opposite hypothesis could be true. Longitudinal study designs would be 
the most appropriate method to resolve the clarity about direction of association 
although structural equation modeling techniques could be helpful when applied to 
cross-sectional data.  
 
3.3.6. Prevalence of depression in children with SCDs 
This section aims to quantify the burden of depression in children with SCDs. As 
previously indicated (see 3.1.1), studies were included if the respondents were 
children, had a specific quantitative or categorical measure for depression that is 
compared with a controlled group or an established norm. The discussion was not 
separated into developing and developed countries because only one study from a 
developing country met the above inclusion criteria (Bakare et al 2008). 
 
Benton et al (2007) and Kelch-Oliver et al (2007) have recently conducted reviews of 
depression in SCDs. Both reviews also included studies of other emotional disorders 
such as anxiety and other psychosocial difficulties. The reviews both noted that the 
data on the psychological aspects of children with SCDs are limited, of poor quality 
and conflicting. My examination of the literature on depression in this patient group 
came to similar findings. 
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3.3.6.1. Studies showing increased depressive symptoms in SCD 
Three studies (Key et al 2001; Brown et al 1993; Morgan and Jackson 1986) found 
higher levels of depression in children with SCDs compared with control groups.  
 
Key et al (2001) compared 125 adolescents (13-18 years) with chronic illnesses 
including SCDs, Cystic Fibrosis, Insulin Dependent Diabetes Mellitus, Spina Bifida, 
and Asthma with 21 healthy controls and the normative population on self-reported 
symptoms of depression. They found that in general, a higher proportion of the 
adolescents with chronic illnesses reported symptoms of moderate to severe 
depression compared with both the control group and normative data. However, 
among the group with chronic illnesses, the adolescents with SCDs and those with 
Asthma had the highest frequency of caseness for depression symptoms. The severity 
of depression among the children with chronic illnesses  correlated positively with 
their own rating of the severity of their physical illness. However, this study was 
limited by reliance on questionnaire to determine depression caseness. 
 
Brown et al (1993) compared 61 young people with SCDs (6-17 yrs) with their 
healthy siblings as controls (6-26 yrs). They found that the group with SCDs had 
more depressive symptoms. As in the previous study by Key et al (2001), severity of 
depression correlated with severity of SCDs. Another study by Morgan and Jackson 
(1986) in which 24 adolescents with SCDs were compared with the same number of 
controls matched for age, race, gender and socio-economic group found more 
depressive symptoms in the SCDs group. This study assessed depression with the 
Children’s Depression Inventory, which has four questions on somatic symptoms of 
depression (e.g. fatigue) which overlap with physical symptoms of SCD. Thus the 
authors checked if the excess depressive symptoms in the SCD group could be 
attributed to their scores on these four somatic items. Incidentally, a secondary 
analysis in which the four somatic items were removed found that the SCD group still 
had statistically significant more depressive symptoms than controls albeit with a 
smaller p value (Morgan and Jackson 1986). 
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3.3.6.2. Studies showing no increase in depression in SCD 
The other seven studies that met the inclusion criteria did not find higher levels of 
depression in children with SCDs. One of the studies was conducted in a developing 
country (Bakare et al 2008) and the remaining six (Simon et al 2009, Lee et al 1997, 
and Yang et al 1994, Getzoff 2005, McElligott 2006, Midence et al 1996) in 
developed countries. 
 
In a study from Nigeria, Bakare et al (2008) compared the rate of emotional disorders 
in 45 children with SCDs with equal numbers with Juvenile Diabetes Mellitus and 
healthy controls all aged 9-17 years. The Diagnostic Interview Schedule (DISC) was 
used to generate DSM-IV diagnoses. They found low levels of Major Depressive 
disorder in all three groups (2.2%, 6.7% and 2.2% respectively). However, they also 
found that 20% of the children with SCDs and 11% of those with Juvenile Diabetes 
Mellitus but none of the healthy controls expressed suicidal ideation in the past year. 
The low level of Major Depressive Disorder in this SCDs group in a developing 
country is a significant finding. However, the disproportionately higher levels of 
suicidal ideation among the children with SCDs suggest that this group may have had 
higher levels of depression but the assessment process was not sensitive enough to 
pick this up. In support of this possibility, the study also found that when all 
emotional disorders were pooled, children with SCDs and Juvenile Diabetic Mellitus 
both had significantly higher levels than controls (38%, 42% and 11% respectively). 
The main strength of this study is the use of structured diagnostic interview rather 
than questionnaire to assess for depression. A second strength is the use of a 
homogenous sample of children with HbSS genotype. This strategy limited the 
variations associated with disease severity that arise from different genotypes of 
SCDs. 
 
Simon et al (2009) compared 44 American adolescents with SCDs with 15 healthy 
siblings and found that depression scores for the SCDs group did not differ 
significantly from their siblings and were not in the clinical range of normative data. 
Similarly, Lee et al (1997) compared American young people with SCDs with healthy 
siblings. Surprisingly and contrary to expectation, these researchers found higher 
depression scores among the non-diseased siblings than in the SCDs group. These 
studies both had relatively small sample sizes. So the absence of a difference in the 
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study by Simon and colleagues (Simon et al 2009) could be due to Type II error. 
However, Type II error would not explain the findings of Lee and colleagues (Lee et 
al 1997) which found less depressive symptoms in the SCD group. 
 
Yang et al (1994) compared 38 children with SCDs (aged 6-18 years) with 34 age, 
gender and race-matched healthy controls. Depression was measured with both a self 
report questionnaire (Children’s Depression Inventory) and Clinical Psychiatric 
interview. Yang and colleagues found a significant difference in the groups’ scores on 
the Children's Depression Rating Scale (27.1 and 22.1 respectively P = 0.007). 
Twenty-nine percent of the children with SCDs and 12% of the controls had scores 
suggesting a high risk for depression. However, clinical assessment by child 
psychiatrists found 13% of the SCDs group and 15% of controls to have a depressive 
disorder. Further analysis showed that items in the Children's Depression Rating Scale 
such as excessive fatigue and physical complaints contributed to the high false-
positive rate. An important strength of this study is that DSM-IV diagnosis of 
depression was reached through two independent psychiatric interviews and 
agreement by consensus.  
 
A longitudinal study, which followed up 48 children with SCDs in USA for up to 10 
years and compared them with 49 healthy controls found no differences in depression 
(measured with Children’s Depression Inventory and Beck Depression Inventory) 
either cross-sectionally or longitudinally (Getzoff 2005). Another study of American 
adolescents with SCDs (McElligott 2006) found normative scores in depression. An 
earlier study in the UK involving 39 children with SCD and 24 controls (Midence et 
al 1996) found no significant differences between the two groups on depression. 
However, all the foregoing studies were limited by small samples sizes which raise 
concerns that their negative findings might be due to Type II error.  
 
3.3.7. Summary of depression in children with SCDs 
The evidence for depression in children with SCDs is limited. For example, of the ten 
studies reviewed, seven (including the only study from sub-Saharan Africa) did not 
show increased prevalence of depression in children with SCD. Helps and colleagues 
have suggested that the psychosocial adjustment of people with SCD has improved 
probably as a result of vastly improved physical care in SCDs (Helps et al 2003) in 
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this region. The finding of no increased depression in SCD could also be due to 
increasing levels of psychological resilience and hardiness among children with SCDs 
(Mckellop 2001). Another reason is the possibility that the evidence is limited 
because of methodological problems including the difficulties described earlier in 
relation to diagnosis of depression in children with SCDs. Another difficulty is the 
heterogeneous nature of SCDs. For example, children the HbSS genotype are 
generally more severely affected compared with those with HbSC. However, few 
studies (e.g. Bakare et al 2008) used homogenous samples of HbSS while others had a 
mixture of children with both genotypes, which makes interpreting their findings 
difficult.  
 
3.3.8. Conclusion 
There are theoretical models based on the biology and psycho-social contexts of 
children with SCDs that suggest increased risk of general psychopathology and 
depression. However, the research evidence is limited and conflicting. There are 
several putative reasons for this (Molock and Belgrave 1994). Some symptoms of 
depression and SCDs overlap to make diagnosis of the former difficult. Many studies 
were underpowered, and included children with heterogeneous genotypes of SCDs. 
For example, children with HbSS genotype are generally more severely affected 
compared with those with HbSC. Some studies had a mixture of children with both 
genotypes, which would make interpreting their findings difficult. The episodic nature 
of complications in SCDs probably makes associated psychological distress 
transitory, which increases the difficulty in recognising discreet depressive episodes. 
Although the evidence is limited, it appears that for children with SCDs in developed 
countries, the historical trend is towards less psychopathology. The situation in 
developing countries remains difficult with most studies indicating increased 
psychopathology. This distinctive regional difference appears to do with access to 
improved physical care in developed countries. 
 
While acknowledging that the current evidence does not support increased prevalence 
of depression in children with SCD especially in developed countries, there could be 
sub-groups of children at risk. Identifying possible characteristics of such sub-groups 
could be helpful in targeting screening and interventions. This study aims to 
contribute to the identification of such predictive factors. 
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Chapter 4. 
Aims and Methodology 
This chapter is discussed under the following subheadings. 
• Reasons for study 
• Aims of study 
• Hypotheses 
• Study design  
• Sample size  
• Recruitment  
• Response rate 
• Measurements and reliability 
• Analytical strategy  
• Difficulties with recruitment 
 
4.1. Reasons for study 
Chapter 2 of this Thesis argued that stigma theory could be applicable to SCDs. 
Evidence from studies of children with other chronic physical conditions such as 
epilepsy suggests high prevalence of perceived stigma and a contribution of stigma to 
psychological distress in affected children (Westbrook et al 1992). Given the 
similarity between SCDs and epilepsy in terms of chronic disease model, a similar 
association between stigma and psychological distress can be hypothesised for SCDs. 
However, unlike in epilepsy where there is empirical support, there is no good data in 
SCDs to test this hypothesis. Thus the main aim of this study is to quantify the level 
of perceived stigma in children with SCDs and to explore any links between self-
perceived stigma and psychological distress.  
 
Chapter 3 of this Thesis found inconsistent evidence for increased levels of 
psychopathology in children with SCDs in developed countries with a tendency for 
less psychopathology in more recent studies. Given the inconsistency of the evidence, 
it is possible that there are some children with SCDs in developed countries who 
could be at increased risk of psychopathology. Bearing this in mind, there is a need to 
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continue to identify new and more precise predictors of psychological distress in 
children with SCDs. Such predictors could be used to identify high risk sub-groups or 
become incorporated into screening questions and algorithms to ease the identification 
and treatment of children with SCDs who have comorbid mental disorders. This study 
aims to explore self-perceived stigma and other factors as new potential predictors of 
psychopathology in children with SCDs. Although results of psychological 
interventions in SCD are encouraging (Anie 2005), the evidence base is still limited 
(Anie and Green 2002). Thus identification of more specific predictors of 
psychological distress in children with SCD could lead to new and more effective 
targeting of psychological interventions. 
 
Most research on stigma has often focused on enacted stigma by people who do not 
have the stigmatising condition. This is usually assessed with measures of social 
distance or behavioural rejection towards people affected by the stigmatising 
condition. These studies have been criticised for not focusing on the experience of 
people with the stigmatising condition and for potentially reinforcing stereotypes by 
privileging the perspective of people without the stigmatising condition over those 
bearing the burden of the condition (Sankar et al 2006). In order to address this 
imbalance in stigma research, this study is focused on stigma as perceived by children 
with SCDs themselves.  
 
4.2. Aims of the study 
1. To estimate the prevalence of self-perceived stigma in young people with SCD. 
2. To explore associations between self-perceived stigma and psychosocial, socio-
demographic, and SCD-related variables. 
 
4.3. Study hypotheses 
The study hypotheses to be tested are: 
1. Measures of disruptiveness (e.g. frequency of admissions) and visibility (e.g. 
presence of leg ulcer) will significantly and independently predict levels of 
self perceived stigma.  
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2. Self perceived stigma will significantly and independently predict scores on 
the Total difficulties scale of the Strengths and Difficulties Questionnaire 
(SDQ) 
3. Self perceived stigma will significantly and independently predict Depressive 
symptoms measured by the short Mood and Feelings Questionnaire (SMFQ) 
4. Self perceived stigma will significantly and independently predict Self Esteem 
measured by Rosenberg Scale  
The process of exploring the above primary hypotheses led to a secondary objective, 
which was to explore additional associations between each dependent variable and 
other psychological, illness, and social predictor variables over and above self-
perceived stigma.  
 
4.4. Study design 
The study design is a cross sectional questionnaire survey of young people aged 11-19 
years with SCDs. A cross-sectional survey design was chosen because it is 
appropriate for achieving the primary objective of this study, which is to estimate the 
prevalence of self-perceived stigma among children with SCDs. The limitation of the 
design in exploring associations between stigma and other psychosocial variables is 
recognised in so far as a cross-sectional design would not be able to identify causal 
relationships. A longitudinal study design was considered as it would both achieve the 
main objective of the study and facilitate causal inferences by identifying the temporal 
direction of association between stigma and other variables. However, the expense 
and huge logistics that would be engendered by longitudinal design made it 
impractical for this study. 
 
4.5. Sample size / power calculations 
Two sample size calculations were carried out - the first based on the main objective 
and the second based on one of the secondary objectives. 
 
4.5.1. Sample size required to estimate the prevalence of self-perceived stigma 
EPI-INFO Statistical package Version 6, was used to estimate the sample size 
required to identify a prevalence of 40% for self-perceived stigma in SCD with 95% 
confidence and 10% margin of error. The estimated sample was 92 children with 
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SCDs. The expected prevalence of self-perceived stigma of 40% was based on two 
previous studies of epilepsy (Westbrook et al 1992) and stuttering (Blood et al 2003) 
which used similar methodology to assess self-perceived stigma as in this study.  
 
4.5.2. Sample size required to identify significant difference in mean scores on the 
SDQ 
The minimum sample size to detect a significant difference in psychological difficulty 
(Total difficulties score on the SDQ) between participants who are classified as 
having self-perceived stigma AND those not so classified is given by the Formula 
below. 
              2Fσ2 
n  ≥                                                (Wade 1997) 
        d2 
Where: 
n = size of each of the two groups (i.e. total sample = 2n if the groups are equal) 
σ  = standard deviation 
d = smallest difference expected between the groups. 
 
With respect to the Total Difficulties Score on the self-report version of the SDQ, σ  = 
5.2 for UK norm http://www.sdqinfo.com/bba1.pdf    (accessed 5/2/10) 
 
Assuming  
d = 2.6 (i.e. half a standard deviation difference between the two groups1) 
F = 7.85 (a constant based on 80% power and 5% level of significance) (Wade 1997) 
 
The minimum sample size required to identify 0.5 (half) standard deviation difference 
in Total Difficulties Score on the SDQ with 80% power and 5% level of significance 
is: 
 
        2 x 7.85 x 5.22 
n  ≥                          = 62 (i.e. a total of 133 taking into account the hypothesised group ratio of 40:60). 
   2.62 
 
Assuming a 50% response rate2, the target sample to be approached was doubled to 
266 with the aim of recruiting 133. 
 
The final sample of 93 recruited for the study was about the same as the first sample 
size of 92, which was calculated (above) as required to identify a 40% prevalence of 
stigma with 95% confidence level and an error margin of 10%. Incidentally, given 
                                                 
1 A difference of half a standard deviation between the two groups is possible given that Iloeje (1991) 
found differences of up to one standard deviation between children with SCD and healthy controls on 
the Rutter Scale (forerunner of the SDQ) albeit in Nigeria. Also, among a UK community sample 
(comparing child mental health clinic attendees and a general population sample) (Goodman et al 
2003), the two groups differed on the SDQ by as much as 1.4 standard deviations. 
2 A recent postal survey of people with rheumatoid arthritis (another chronic medical condition) in the 
UK reported a response rate of 57.3% (Neame and Hammond 2005). 
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that the actual prevalence of self perceived stigma in the study was 15% (compared 
with the hypothesised level of 40%), a sample as low as 52 would have been 
sufficient to identify this prevalence (15%) with 95% confidence and 10% error 
margin. 
 
A sample of 133 was calculated as required to identify 0.5 or more standard deviation 
difference in measure of psychological difficulty (Total Difficulties Score on the 
SDQ) between the respondents who perceived stigma and those who did not. As 
explained above, this sample size was based on 80% power and 5% level of 
significance with an assumption of 40% prevalence of stigma. However, the final 
sample size of 93 proved sufficient to identify significant differences in SDQ Total 
Difficulties Score (see Table 5.34) between the respondents who perceived stigma and 
those who did not. Thus, this smaller sample size was still adequately powered. The 
reason for this is because the actual difference between the respondents who 
perceived stigma and those who did not was twice higher than expected (more than 
1.0 standard deviation compared with 0.5 standard deviation used for the sample size 
calculations).  
 
In summary, although the final study sample size of 93 was less than planned (133), 
the study was still sufficiently powered to answer the main research questions.  
 
4.6. Inclusion criteria: 
1. Children and young people with all forms of SCD (HbSS, HbSC, HbSThal). 
Despite the recognised difficulty with including heterogeneous genotypes in 
psychological research on SCDs, I was advised that this study was unlikely to 
be able to recruit the desired sample size if inclusion was limited to children 
with homozygous SCDs (HbSS). Even with including all types of SCDs, it 
was still not possible to recruit the target sample size of 133. 
2. Aged 11- 18 years. We targeted this age group because the development of 
self-identity and peer relationships is important during this period; hence self-
perceived stigma could have serious impact on psychosocial function and self 
esteem if it is experienced in this age group. One respondent who was 18 years 
old at the time of collecting the research pack turned 19 years by the time of 
 70
completing the questionnaire. Also one ten year old completed the 
questionnaire; hence the final age range was 10-19 years. 
3. Consent by child and parent (for ages 10 - 15 years) and by young person (for 
16 years and above). 
4. Not currently acutely unwell (e.g. not admitted to the ward due to acute 
illness) 
5. Adequate command of English language to complete the questionnaires. 
 
4.7. Recruitment procedure 
Subjects were recruited through the Sickle Cell Society and from three paediatric 
haematology clinics in London (Central Middlesex, North Middlesex, and St Mary’s 
Hospitals).  
 
Postal questionnaires were sent to families who were members of the Sickle Cell 
Society who had an affected child within the age range of the study. A pack was sent 
to the family containing an invitation letter, separate information sheets for children 
and parents, consent forms for parents and assent forms for children under 16 years 
and consent forms for young people 16 years or older, the study questionnaire, 
telephone slip and a prepaid-addressed-envelope. Having consented, the child was 
invited to complete and return the questionnaire in the prepaid reply envelope 
enclosed in the pack. Children were also given the choice of having the questionnaire 
completed on their behalf by me through a telephone interview. However, no child 
took up this offer. The full content of the research pack are attached to this Thesis as 
Appendix 1. 
 
The information sheet for children encouraged them to discuss the research with their 
families. Also the information sheet for parents/guardians contained the sentence “we 
expect that your child will complete the questionnaire himself/herself although he/she could 
ask you for help in remembering factual information to help them answer the questions”. It is 
therefore likely that some of the children may have had help from parents in 
completing the questionnaire. However, the data collection made no provision to 
identify if a parent helped or not. 
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The postal questionnaire of participants recruited through the Sickle Cell Society met 
with considerable difficulties. Two hundred questionnaires were mailed out as 
described earlier. However, it subsequently emerged that the membership database of 
the Sickle Cell Society was not up to date and the filtering mechanism was not 
accurate. As a result, some of the questionnaires were mailed to members who did not 
have SCDs or who had SCDs but were outside the study age criterion. Membership of 
the Sickle Cell Society is open to everyone including people without SCDs. A total of 
25 young people responded to the postal questionnaires mailed out by the Sickle Cell 
Society. However, due to the technical difficulties described above, it was not 
possible to ascertain an accurate response rate from this source. 
 
Recruitment from the three haematology clinics was carried out by an assistant 
psychologist or a research nurse who were trained and supervised by me. Families 
were approached as they attended routine out-patient appointments. The families were 
given an explanation about the research and those who showed interest were given the 
research pack, which had the same content as the postal questionnaire (i.e. invitation 
letter, separate information sheets for children and parents, consent form for parents 
and children 16 years and older, assent form for children younger than 16 years, study 
questionnaire, prepaid and addressed return envelope, and telephone slip). The family 
were informed that the children could consent and complete the questionnaire in the 
clinic or take the pack home to complete the consent forms and questionnaire at their 
convenience and return them in a prepaid reply envelope included in every pack. Most 
children opted for the latter. Families who decided to participate in the study during 
their clinic attendance completed the consent and assent forms and the child 
completed the questionnaire in the clinic waiting room either before or immediately 
after seeing the clinician. The assistant psychologist and research nurse were available 
to clarify any questions, but their assistance was rarely sought. The questionnaire pack 
was also posted to patients who were not due a clinic appointment soon. Each 
respondent was given £10 worth of shopping vouchers for completing the 
questionnaire. The vouchers were given in person to the children who completed the 
questionnaire in clinic and posted to others on receipt of their questionnaire. The 
number of children recruited from each clinic is outlined below (Table 4.1). 
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Table 4.1. Number of respondents recruited from each site 
 
Centre Number of subjects recruited 
 
Central Middlesex Hospital Park Royal/Brent 
Sickle Cell and Thalassaemia 
36 
North Middlesex Hospital Edmonton 
 
19 
St Mary’s Hospital Paddington 
 
13 
Sickle Cell Society 
 
25 
Total 
 
93 
 
Chapter 5 will explore differences between respondents recruited from the Sickle Cell 
Society compared with those recruited from the three haematology clinics. 
 
4.8. Reliability 
For quality control, the medical records of 10 randomly selected participants at 
Central Middlesex Hospital were reviewed to check the accuracy of their responses 
for age, presence of leg ulcers, and prescription for hydroxyurea. These three 
questions were chosen because they represent “hard data” such that any discrepancy 
between the questionnaire and the medical records is not likely to be attributable to 
natural variability in the illness. This reliability check found 100% concordance 
between the questionnaire responses and medical records.  
 
Also in Central Middlesex Hospital, basic demographics and sickle cell variables of 
10 randomly selected respondents were compared with10 randomly selected non-
respondents. The comparison is shown below. 
Table 4.2. Comparison of responders and non-responders 
 
Variable Respondents 
 
Non respondents 
Age (mean) 15.0 
 
15.1 
Gender (M:F) 6:4 
 
5:5 
Admissions in past year (mean) 2.0 
 
0.7 
Leg ulcer 0 
 
0 
Hydroxyurea  2 
 
1 
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As shown in Table 4.2, the respondents had three times more admissions in the 
previous year compared with non respondents. This suggests the respondents may 
have been more unwell. Also there were more males than females in this sample of 
respondents (6:4). However, note that the gender proportion in the full sample is 
almost equal (M:F = 51%:49% – see Table 5.2). 
  
Central Middlesex Hospital was also the site with records that could be examined to 
ascertain response rate. Five children who were registered with the haematology clinic 
at Central Middlesex Hospital had responded to the postal questionnaire through the 
Sickle Cell Society. If these five children are added to the 36 children who were 
recruited directly from the Central Middlesex Hospital, then 45% of the eligible 
young people in that site participated in the study. 
 
I planned to administer the questionnaire twice (two weeks apart) to 20 participants to 
assess the Test-Retest reliability of the component measures. However, due to the 
huge difficulty we had with recruitment, no respondent agreed to participate twice. A 
second £10 shopping voucher was offered for anyone completing the questionnaire 
again but this was not taken up. 
 
My general experience with this client group suggests that they are over-researched. 
Many young people and their families commented that they are always being asked to 
take part in a research project. While many did not mind, others found this 
burdensome. This accounted for the major challenge I had with recruitment. Even the 
offer of £10 shopping voucher was not sufficient motivation for some children and 
their families.  
 
The information sheet for the study indicated that families can register their refusal to 
participate in the study by returning the uncompleted questionnaire in the prepaid 
reply envelope enclosed in each research pack. Only 4 families registered their refusal 
with this method. Two of the families did not give a reason for their refusal. One 
family commented that the questionnaire was too long. Another stated that the 
questions were too negative and could undo the work the family had done to improve 
the self-confidence of their child. As a result of the latter comment and additional 
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feedback by a sickle cell counsellor regarding the wording of the “Study Title” in the 
Information Sheets and other documents in the research pack, the “Study Title” was 
changed from: 
“Research project to examine whether young people with sickle cell disease feel 
shame and embarrassment as a result of their health problems”, 
to  
“Research project to examine whether young people with sickle cell disease feel they 
are treated differently by other people as a result of their health problems” 
The amendment was approved by the Ethics Committee (See Appendix II).   
 
The study and all subsequent amendments were approved by the South West 
Multicentre Research Ethics Committee. Approvals were also obtained from the 
Research and Development Departments of the three clinical sites where children 
were recruited from (Appendix II).  
 
4.9. Measurements and data collection 
A questionnaire was constructed by assembling several standardised and validated 
instruments measuring the variables essential to achieve the objectives of the study. 
The questionnaire was designed to obtain information from the young people 
themselves. A copy of the questionnaire is attached as part of Appendix 1. The 
specific measures in the questionnaires and their validity and reliability are discussed 
below. The introduction to the questionnaire reassured the young people of the 
confidentiality of their responses. They were encouraged to answer truthfully and that 
there were no right or wrong answers. Data collection started in October 2006 and 
ended in April 2009. Before the study commenced, the questionnaire was reviewed 
and considered appropriate by clinicians working with children with SCDs.  
 
4.9.1. Questionnaire Reliability 
As stated above, ten of the respondents whose answers were checked against their 
medical records showed 100% concordance indicating good reliability. The instruments 
included in the questionnaire all showed good internal consistency (Cronbach’s Alpha) 
(Cronbach, 1960). These are reported below for each instrument. Another evidence to 
support reliability of the responses is that the variables correlated in a sensible manner.  
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4.9.2. Socio-demographic details 
Standard background socio-demographic information was obtained. Gender was 
coded as 1=Male, and 2=Female. The occupation of the head of household was used 
to assign an OPCS socio-economic class. Given that multiple indicators for 
socioeconomic assessment have been used reliably among ethnic minorities in 
London (Stansfeld et al 2004), I gathered additional information on ownership of a 
land telephone, and a car. However, this data was not sufficiently discriminatory in 
analysis probably due to ceiling effect as most respondents came from families with 
high ownership of these items.  
 
4.9.3. Self-perceived stigma 
This was assessed with items adapted from a previous study of stigma in young 
people with epilepsy (Westbrook et al 1992). This study, which was based on stigma 
theory, presented a methodology for studying stigma in adolescents with chronic 
conditions. A subsequent study in adolescents who stutter demonstrated the 
adaptability of the methodology and confirmed the original factor structure (Blood et 
al 2003). The adapted questions are shown Table 4.3 below.  
 
Respondents were categorised as having high self perceived stigma if they answered 
“Often” or “Sometimes” to one or more of the three “stigma questions” shown below 
(Table 4.3). Four additional questions on “disclosure of stigma” were used to measure 
avoidance behaviour, which is an indirect index of self-perceived stigma (Westbrook 
et al 1992, Blood et al 2003).  
 
To maximise the analytical power of the measures of stigma, a dimensional stigma 
variable was created from the sum of the stigma questions. The resulting “stigma 
rating scale” had a good internal consistency (Cronbach Alpha 0.8). As predicted, 
Factor Analysis of the stigma and disclosure questions in the present study extracted 
two factors, which provides further support for the reliability of the questions. Higher 
scores on the stigma rating scale indicates more self-perceived stigma. 
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Table 4.3. Stigma and disclosure questions 
 
Stigma Questions 
 
1. Do you think that having Sickle Cell affects whether people want to be friends with 
you? 
 
2. Do you think that having Sickle Cell affects whether people like you or not? 
 
3. Do you think that having Sickle Cell affects whether or not you are invited to 
people’s homes or to parties? 
 
 
Disclosure Questions 
 
1. When you can, do you keep your sickle cell a secret from others? 
 
2. How frequently do you talk to people about your sickle cell? 
 
3. Do any of your friends know that you have sickle cell? 
 
4. When people find out you have sickle cell, it is usually because 
a. You tell them 
b. They see you have a sign of sickle cell and then you explain 
c. Someone else tells them about it 
 
 
4.9.4. Emotional and behaviour problems (psychological difficulty) 
The self-report form of the Strengths and Difficulties Questionnaire (SDQ) was used 
to measure psychological difficulty. This is a well validated 25-item screening 
instrument for childhood psychopathology used widely in routine clinical practice and 
research in the UK and internationally (Goodman et al 2003). The SDQ produces a 
Total Difficulties Scale in addition to five other subscales (Emotional, Hyperactivity, 
Conduct, Peer problems, and Prosocial). The questionnaire has versions for parents, 
teachers and self-report by young people. The self-report version was standardised on 
young people aged 11-16 years (Goodman et al 1998), however, for pragmatic 
reasons, we extended its use to 18 years in this study. SDQ was used in a large 
national survey of child and adolescent mental health in the UK (Meltzer et al 2000), 
which included 4228 self reports. The UK norms from the Self report SDQ are given 
below (http://www.sdqinfo.com/bba1.pdf) (accessed 5/2/10). Except for the prosocial 
scale, higher scores in the other SDQ subscales indicate more difficulties. 
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Total Difficulties scale = 10.3 (SD 5.2). Borderline = 16-19, Abnormal ≥ 20 
Emotional subscale = 2.8 (SD 2.1). Borderline = 6, Abnormal ≥ 7 
Conduct subscale = 2.2 (SD 1.7). Borderline = 4, Abnormal ≥ 5 
Hyperactivity subscale = 3.8 (SD 2.2). Borderline = 6, Abnormal ≥ 7 
Peer problems subscale = 1.5 (SD 1.4). Borderline 4-5, Abnormal ≥ 6 
Prosocial subscale = 8.0 (SD 1.7). Borderline = 5, Abnormal ≤ 4 
 
In the standardisation study for the self report version (Goodman et al 1998), 5% of 
the community sample and 31% of a clinic sample (children attending a mental health 
service) scored within the abnormal range (≥ 20) on the Total Difficulties Scale, 18% 
and 28% respectively scored within the borderline range while 77% and 41% scored 
within the normal range respectively. In the national survey of child and adolescent 
mental health in the UK (Meltzer et al 2000), 5.3% of the total sample scored above ≥ 
20 on the self report version of the SDQ. 
 
Although a cut-off score of 20 or more on the Total Difficulties Scale is recommended 
for the self-report version of the SDQ to define caseness in clinical practice 
http://www.sdqinfo.com/bba1.pdf  (accessed 5/2/10) (Goodman et al 1998), in this 
study, a cut-off of 18 and above was used for the self report SDQ to define caseness. 
This is because this cut-off gave prevalence figures in the British Child and 
Adolescent Mental Health Survey (Meltzer et al 2000) that were equivalent to the 
prevalence found using data from multiple sources including parents and teachers. 
Given that the same cut-off of 18 and above was used in a study of school children in 
East London (Stansfeld et al 2004), adopting this cut-off means that my data could be 
compared not only with UK-wide prevalence but also with a more ethnically 
appropriate sample. In fact Stansfeld and colleagues (Stansfeld et al 2004) provided 
specific data on SDQ caseness for black boys and girls in East London, which in the 
context of SCD makes it the most appropriate data to be compared with my sample. 
 
4.9.5. Depressive symptoms 
Depressive symptoms were measured with the Short Mood and Feelings 
Questionnaire (SMFQ) (Angold et al 1995).This is a brief (13-item) self-report rating 
scale with good psychometrics. The child responds to each directly framed statement 
with “True”, “Sometimes”, or “Not True” (scored 2, 1, 0 – such that higher scores 
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indicate more depressive symptoms. The SMFQ was developed from the highly 
reliable 30-item Mood and Feelings Questionnaire (MFQ) by selecting the 13 items 
that performed well in a variety of psychometric analyses on the MFQ. The selected 
items were predominantly affective and cognitive, which are known to be the best 
predictors of depression. It also included physical symptoms like tiredness. The 
SMFQ correlated well with the Children’s Depression Inventory and discriminated 
well between children diagnosed with depression by clinical interview and those 
without diagnosis. The Internal Consistency of the SMFQ (0.85) reported by the 
developers is almost the same as in the present study (Cronbach Alpha 0.83). The 
questionnaire is usable with children from 6 years. The original study in USA found 
sensitivity of 60% and specificity of 85% with a cut off of 8. A community-based 
twin study in the UK (Thapar and McGuffin 1998) found that twins who met DSM-
III-R diagnosis for depression had a mean score of 8.76(SD = 4.19) compared with 
twins with no diagnosis of depression (mean = 4.46, SD = 5.24). Receiver-Operator-
Curves showed that a cut-off score of 8.0 on the self rated Short MFQ achieved 
optimum sensitivity (0.75) and specificity (0.74) for DSM-III-R depression (Thapar 
and McGuffin 1998). Another UK study involving ethnic minorities in London found 
a mean of 4.4 for boys and 5.7 for girls (Stansfeld et al 2004). Using a cut-off of 8.0, 
this study classified 17.2% of Black boys and 29.5% of Black girls as depression-
positive cases. These figures were also comparable to the proportion of cases among 
White boys and girls in the study (Stansfeld et al 2004).   
 
4.9.6. Self esteem 
Self-esteem was assessed with the Rosenberg Self-Esteem Scale (Rosenberg 1965). 
This is a reliable and widely used Self Esteem Scale. The scale is a summative 10-item 
Likert scale with items answered on a four point scale - from strongly agree to strongly 
disagree (scored 1-4). Higher scores indicate higher self esteem (range 10-40). The 
Internal Consistency in the present study was excellent (Cronbach Alpha 0.86). A 
cross national comparison among students in USA, Canada and New Zealand 
(Rusticus et al 2004) found the following Means (SD) U.S.A = 31.9 (4.97), Canada = 
31.0 (4.82), New Zealand = 29.9 (4.52), which are comparable to the only study I 
found that used the same questionnaire on adolescents with SCD in America (Mean 
31.9 (SD 5.0) (Burlew et al 2000).  
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4.9.7. Family function 
Family function was measured with the 12-item General Functioning (GF) subscale of 
the Family Assessment Device (FAD) (Epstein et al, 1983). This is a self-report 
questionnaire designed to evaluate family functioning according to the McMaster 
Model of Family Functioning (Epstein et al, 1978). The FAD (Epstein et al, 1983) and 
the GF subscale (Byles et al 1988) have good psychometrics. This instrument was 
used in the Survey of Mental Health of Children and Young People in Britain 1999 
(Meltzer et al 2000). It is a Likert scale score 1-4. However, the total score is divided 
by 12 to create a scale range of 1-4. On this scale, scores of 2 or less are considered 
“healthy” family functioning, while scores from 2.01 – 4.0 are considered “unhealthy” 
family functioning. The FAD performed reliably in the present study with Internal 
Consistency (Cronbach Alpha) of 0.86. 
 
4.9.8. Peer network 
Peer social network was measured by asking the young people to identify how many 
friends they have frequent mutual engagement with and whether they had a best 
friend (Fang et al 2003). A composite rating “peer network scale” was developed by 
combining the total number of friends and having a best friend. A weighting of three 
times was given to having a best friend.  
 
4.9.9. Sickle cell severity 
Although various measures and validated scales exist for measuring “illness severity”, 
it is well recognised that intrinsic markers of illness severity can be difficult to 
identify. Thus, so called “severity scales” are often designed to tap into indices of 
impairment (e.g. frequency of hospital admission), which are surrogates of illness 
severity rather than intrinsic measures of severity. One problem with using surrogate 
markers of severity is possible confounding by other factors such as treatment 
adherence or the impact of other unrelated diseases or environmental factors. Despite 
this limitation, surrogate measures of severity can be useful where intrinsic measures 
of severity do not exist or are difficult to obtain. 
 
SCD is one of the few conditions for which there is an intrinsic biologically 
determinable measure of illness severity. It is well recognised that different genotypes 
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in SCD confer different severity profiles to affected persons. For example, the 
genotype HbSS, which results from replacement of glutamic acid by valine in position 
six of the Beta Globin chain confers a more severe illness than HbSC genotype, which 
results from substitution with lysine in the same position (Castro et al 1994, Peak 
2008).  
 
Despite the limitations noted above, surrogate measures of severity were adopted for 
this study. Consideration was given in the study design to obtaining the children’s 
genotype as an intrinsic measure of severity. However, it was felt that children may 
not be reliable informants for such information and that accessing medical records for 
all participants would be the reliable means of obtaining the data. Unfortunately, the 
resources available for the study would not have coped with the logistics of accessing 
medical records for all participants. Also the conditions of the study ethics approval 
allowed only limited access to ten medical records for purposes of checking reliability 
of responses. However, since the conclusion of the study, I have become aware that 
children with SCDs and their parents can be reliable informants about their genotype. 
The absence of genotype information is an important limitation of this study, and 
consideration is being given to seeking further ethics approval to obtain this data. 
However, the additional data if obtained would not form part of this Thesis. 
 
Illness severity measures used in this study were adapted from surrogate measures 
used reliably in a previous study by Hurtig et al (1989) based on: 
1. Frequency of ward admissions (defined as an overnight or longer stay in 
hospital). 
2. Number of Accident and Emergency Department visits not resulting in 
admission. 
3. Frequency, intensity, and duration of painful crises. 
4. Frequency of school absence  
Each of the above measures was presented as incremental ordinal scales and coded 
such that higher scores indicate more severity. A composite rating of illness severity 
was calculated by combining the above measures. However, as frequency of ward 
admissions proved most discriminatory than all the other measures of severity 
including the composite measure, the former was chosen as the measure of severity in 
subsequent analyses.  
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4.9.10. Visible signs of SCDs 
The questionnaire prompted respondents to indicate if they currently had jaundice and 
or leg ulcer. Both variables were coded as 1=Yes/Present, 2=Not present. 
 
4.9.11. Treatment Adherence 
Medications commonly prescribed for people with SCD (penicillin V, hydroxyurea, 
and Folic Acid) were listed in the questionnaire and respondents asked to indicate 
which medication, if any, was prescribed for them and how often they remembered to 
take it. The number of subjects prescribed hydroxyurea was so small (N = 7) that this 
was not included in the adherence scale. The medication adherence scale was 
therefore developed by combining adherence to penicillin and folic acid. Higher score 
on this scale indicates better adherence. Subjects were also asked how often they kept 
out-patient appointments. 
 
4.9.12. Attitude toward illness 
This was measured with an adaptation of the Child Attitude Toward Illness Scale 
(CATIS) (Heimlich et al 2000, Austin and Huberty 1993). CATIS is a 13-item 
summative scale that measures children’s feelings towards having a chronic illness. 
The scale is designed for children from the age of 8 years old. A higher score 
indicates a more favourable attitude towards the illness. Initial psychometric 
assessment of the scale (Austin and Huberty 1993) with children suffering from 
epilepsy or asthma, and further evaluation (Heimlich et al 2000) with children 
suffering from epilepsy found excellent internal consistency, test-retest reliability, and 
construct validity. I found no studies with CATIS in children with SCDs. However, 
the scale performed very well in the current study with a Cronbach Alpha of 0.91. 
 
4.9.13. Receipt of Counselling 
Respondents were asked if they were currently engaged in a regular counselling with 
a therapist. Responses were coded as 1=Yes, 2=No. 
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4.10. Analysis and hypotheses testing 
Data entry and analysis was conducted with SPSS Version 15. The data entry was 
independently checked for accuracy. Frequencies and charts were used to further identify 
inconsistencies, which were checked against the original questionnaire.  Questionnaires 
used were tested for internal consistency using - Cronbach’s alpha. Interval and ordinal 
data which were normally distributed were summarised with means and standard 
deviations, while categorical data were described with Numbers and Percentages. Bi-
variate comparisons to determine group differences were conducted with chi-square, 
Fishers exact, and t-tests.  To test the study hypotheses, independent variables associated 
with the outcome variables for each hypothesis were identified and included as 
predictors in separate multiple regression models with self-perceived stigma, Total 
Difficulties Scale on the SDQ, depressive symptoms, and self esteem as the dependent 
variables. All confidence intervals presented are based on 95%. 
 
All the variables were explored for missing data. On average, most variables had 9% 
missing data (N = 85). The variable with the most missing data (29%) was the “Severity 
rating scale” (N = 66). This is a composite scale which suffered because of cumulative 
effect of missing data in the constituent variables. Incidentally, this “severity scale” was 
not used in the multivariate analyses because frequency of ward admission proved to be 
a better index of severity and was used instead. The pattern of missing data appeared 
random, which means the main consequence is loss of sample size and “Power” in the 
analyses. As recommended by Pallant (2007), subsequent analyses used the SPSS 
Option for “Exclude Cases Pairwise” which excludes cases only if they are missing the 
data required for that particular analysis. This option has a less severe limiting effect on 
the sample size compared with other alternative strategies for handling missing data. 
 
4.11. Difficulties encountered during data collection. 
I encountered major difficulties with recruitment of subjects. Thus, I was only able to 
recruit 93 subjects instead of my target of 133 (i.e. 70% of target) although the study 
remained well powered due to  larger-than predicted group differences. Secondly, the 
period of recruitment lasted almost 2½ years (instead of one year that was set aside for 
recruitment). The main difficulty was that people with SCDs in the UK appear to be 
an over-researched group. Many young people and their families commented that they 
are frequently being approached to take part in research projects, which they found 
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burdensome. Recruitment remained difficult despite having a research nurse on site at 
North Middlesex and St Mary’s Hospitals. Even the offer of £10 shopping voucher 
was not sufficient motivation for some children and their families.  
 
Due to difficulties with the membership database of the Sickle Cell Society, the 
response to the postal questionnaires mailed by the organisation was not optimum. It 
also made it difficult to calculate an accurate response rate from the mail out. The 
difficulties included sending questionnaires to members without SCDs or who had the 
condition but were outside the study age range. The Sickle Cell Society is based in 
Brent and not far from Central Middlesex Hospital. Thus there was an overlap 
between the two catchments and some young people recruited in the hospital 
acknowledged receiving but not responding to the previous mail out by the Sickle 
Cell Society.  
 
The accuracy of the patient database at North Middlesex Hospital was also 
problematic; hence it was not possible to accurately ascertain a response rate from 
that site. St Mary’s Hospital Paddington is a Tertiary referral centre that sees patients 
from a large catchment and sometimes for consultation rather than for ongoing care. 
As a result, it was not feasible or appropriate to calculate response rate from this site. 
Central Middlesex Hospital was therefore the only site with defined catchment and 
sufficiently accurate and accessible database to calculate a response rate (45%).  
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Chapter 5. 
Analysis and results 
This chapter describes the data collected for this thesis. The chapter is divided into four 
Sections: 
• Section 1 provides a description of the variables in the study.  
• Section II explores the bivariate relationship between stigma and other variables.  
• Section III compares the respondents recruited from the Sickle Cell Society and 
those recruited from haematology clinics on variables such as self-perceived stigma 
and measures of psychosocial function 
• Section IV deals with multivariate analyses, which include the testing of the four 
specific hypotheses proposed in the study.  
 
For each Section, the results are presented as tables and or figures with accompanying 
text highlighting the main findings in the relevant table.   
 
Chapter 5, Section 1 
5.1. Descriptive statistics 
This section on Descriptive statistics is presented under the following headings: 
• Statistics related to data collection  
• Sociodemographic variables 
• Physical health variables 
• Mental health and adversity variables 
• Stigma and disclosure variables 
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Statistics related to data collection 
 
Table 5.1. Source of respondents 
 
Variable N (%)  
 
Where questionnaire was completed: 
 
At home 
In clinic 
 
 (n = 88) 
 
52(59.1) 
36 (40.9) 
Source of recruitment 
Central Middlesex Hospital 
North Middlesex Hospital 
St Mary’s Hospital Paddington 
Sickle Cell Society 
Total 
 
 
36 (38.7) 
19 (20.4) 
13 (14.0) 
25 (26.9) 
93 (100) 
 
Some of the young people who took part in the study were sent postal questionnaires 
(see Chapter 4) but others were approached through the haematology clinics. Young 
people approached in the clinics were given the choice of completing the study 
questionnaires in the clinic or taking the questionnaire home for completion and return 
by prepaid post. Table 5.1 shows that more respondents (59.1%) completed the 
questionnaires at home than in the clinics. 
 
Recruitment of subjects took place in the four centres shown in Table 5.1. Most 
respondents (38.7%) were recruited from Brent Sickle Cell and Thalassaemia Service 
(based at Central Middlesex Hospital). Sickle Cell Society was the only centre where 
respondents had only the choice of postal questionnaire. 
 
Section III of this chapter will compare self perceived stigma between respondents who 
completed their questionnaire in the clinic and those who completed theirs at home. 
Comparison will also be made between respondents recruited from Sickle Cell Society 
and the haematology clinics.  
 
Summary of statistics on data collection 
In summary, this section showed that most respondents completed the questionnaire at 
home and of the four study sites, most subjects (38.7%) were recruited from Brent Sickle 
Cell and Thalassaemia Service (based at Central Middlesex Hospital). 
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Sociodemographic variables 
 
Table 5.2. Age and gender 
 
 
Variable 
N (%) or Mean (SD) 
 
Gender: 
 Males 
 Females 
 
 (n= 90) 
46 (51.1) 
44 (48.9) 
 
Age – Mean (SD) 
 
14.2 (2.1) 
Range = 10-19 
 
 
The respondents were almost evenly split in gender with a slight preponderance of males 
(51%) (Table 5.2). An even split is expected given that SCDs are autosomal disorders 
with no genetic gender preponderance. The young people ranged in age from 10-19 
years with a Mean of 14.2 years. The age of the respondents was normally distributed 
(Figure 5.1).  
Figure 5.1. Age distribution of respondents
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Table 5.3. Ethnicity and UK birth. 
 
Variable N (%) 
 
Ethnicity: 
Black British 
Black African 
Black Caribbean 
Mixed ethnicity 
Asian 
 
(n=87) 
43 (49.4) 
31 (35.6) 
9 (10.3) 
1 (1.1) 
3 (3.4) 
Born in UK 
Yes 
No 
(n=91) 
69 (75.8) 
22 (24.2) 
 
 
The vast majority of respondents described themselves either as Black British (49%) or 
Black African (35.6%). Three-quarter of the young people were born in the UK (Table 
5.3). Parts II and III of this chapter will explore associations between non-UK birth and 
stigma and depression respectively.  
 
 
Table 5.4. Family composition and living arrangements 
 
Variable N (%) or Mean (SD) 
 
Who lives with: 
Both biological parents 
Mother only 
Father only 
Others 
(n=91) 
40 (44.0) 
42 (46.2) 
2 (2.2) 
7 (7.7) 
 
Sibling has Sickle cell disease: 
Yes 
No  
 
(n=90) 
26 (28.9) 
64 (71.1) 
Number of biological siblings – Median (Range) 
 
1.5 (0-7) 
 
A high proportion of respondents lived with one parent (48.4%) who was most often a 
mother (46.2%) (Table 5.4). This high proportion of single parent living arrangement is 
consistent with the demographics of many parts of inner London (e.g. 48% lone parent 
families in Lambeth http://www.statistics.gov.uk/CCI/nugget.asp?ID=1166 (accessed 
5/2/10). The median number of siblings is 1.5 (range 0-7); hence if the index child is 
considered, the median number of children per family in my sample (i.e.2.5) is more 
than the mean number of children in UK families (1.8 children per family) 
http://www.statistics.gov.uk/cci/nugget.asp?id=1163 (accessed 5/2/10). About a quarter 
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of the young people had siblings who also have SCD. This figure is consistent with an 
autosomal recessively inherited condition where the natural frequency of occurrence is a 
quarter of all conceptions. 
 
 
Table 5.5. Socio-economic status 
 
Variable N (%) 
 
Socio-economic status (OPCS): 
I = Professional 
II = Managerial-technical 
III = Skilled 
IV = Partly skilled 
V = Unskilled 
VI = Unemployed 
 
(n=80) 
15 (18.8) 
10 (12.5) 
27 (33.8) 
18 (22.5) 
6 (7.5) 
4 (5.0) 
Ownership of car and landline telephone: 
Car 
Landline telephone 
 
72 (80.0) 
83 (91.2) 
 
 
Socio-economic status was assessed in two ways (Table 5.5). First the OPCS 
occupational classification was used. In the OPCS system, most of the respondents lived 
in households headed by someone in a skilled occupation (33.8). In this cohort, the 
proportion of respondents from household headed by someone in professional or 
managerial occupations (31.3%) is comparable to the figure for black Caribbean women 
in professional and managerial occupations (30.2%) in the UK (NOS 2005). However, 
the proportion of heads of household in managerial, professional, and intermediate / 
skilled occupations in this study (65.1%) is considerably higher than the proportion of 
Black people in the UK in the same combined occupation bands (45.1% for Black 
Caribbean and 37.1% for Black Africans) (NOS 2005).  
 
I supplemented the occupation-based OPCS-SES classification with additional 
information on whether respondent’s family owned a car and or a landline telephone. 
The vast majority of respondents lived in families that owned a car (80%) and landline 
telephone (91%).   
 
OPCS-SES category, ownership of a car or landline telephone, and a composite wealth 
scale that combined these two variables did not correlate with many of the measures of 
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psychological wellbeing or adversity (e.g. SDQ, SMFQ) (Figures not shown). This 
observation may be due to low variability resulting from ceiling effect (e.g. nearly all 
families had a land telephone).  
 
In order to explore for associations between extremes of SES and psychological 
difficulty as observed in the National Child Mental Health Survey (Meltzer et al 2000), 
the OPCS-SES categories were further dichotomised into extreme groups by combining 
Classes 1 and 2 into one category and Classes 4, 5, and 6 into another category. Apart 
from Child Attitude Toward Illness Scale, the extreme OPCS-SES categories did not 
correlate with other measures of psychological wellbeing or adversity. 
 
Summary of socio-demographic data 
In summary, the results in this section of the analysis showed that the respondents were 
evenly split in gender. Their age was normally distributed with a mean of 14 years. As 
expected, nearly all were of Black ethnicity (95%). Most were born in the UK, more 
than half lived with a lone parent, and a quarter had another sibling with SCD. More than 
two thirds of the cohort came from households headed by someone in a skilled, 
managerial or professional occupation, which is considerably better than average Black 
families in the UK.  
 
Physical health variables 
 
Table 5.6: Frequency of admissions 
 
Variable N (%) 
 
Frequency of ward admissions in past year: 
None 
Once 
2-4 times 
5-6 times 
7 or more times 
 
(n=88) 
34 (38.6) 
15 (17.0) 
25 (28.4) 
8 (9.1) 
6 (6.8) 
Frequency of A&E attendance in past year: 
None 
Once 
2-4 times 
5-6 times 
7 or more times 
 
(n=87) 
42 (48.3) 
29 (33.3) 
11 (12.6) 
3 (3.4) 
2 (2.3) 
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I obtained data on both admissions to the ward and to Accident and Emergency 
Departments. The ward admissions include patients who had planned admissions, for 
example, for blood transfusion as well as those admitted to the ward after a period in 
A&E. Data on A&E attendance is meant to capture more acute complications. The data 
shows that two-thirds and more than half of the respondents had had at least one ward or 
A&E admission in the past year respectively (Table 5.6). 
 
Table 5.7. Experience of pain 
 
Variable N (%) 
 
Frequency of experience of pain: 
More than once a week 
Once a week 
Twice a month 
Once in 1-5 months 
Twice a year or less frequent 
 
(n=76) 
7 (9.2) 
10 (13.2) 
23 (30.3) 
14 (18.4) 
22 (29.0) 
Intensity of pain: 
Mild or no pain 
Moderate 
Intense 
Very intense 
 
(n=82) 
14 (16.4) 
21 (24.7) 
29 (34.1) 
18 (21.2) 
 
Pain was assessed as an additional measure of severity and disruptiveness in SCD 
among the respondents. More than a fifth of the subjects experienced pain once a week 
or more often (Table 5.7). However about half (47.4%) experienced infrequent pain 
(once a month or less frequently). More than half (55.3%) reported intense or very 
intense pain. 
 
Table 5.8 School absence 
 
Variable N (%) 
 
Number of days absent from school in past year: 
None 
Less than 7 days 
7-14 days 
15-21 days 
22-28 days 
More than 28 days 
 
(n=88) 
8 (9.3) 
26 (30.2) 
21 (24.4) 
11 (12.8) 
4 (4.7) 
16 (18.6) 
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School absence is another index of severity and disruptiveness of SCD.  Like previous 
measures of severity, the school absence data illustrates the high level of variability in 
SCD with some (9.3%) having had no school absence while 18.6% had more than 28 
days (Table 5.8). The school absence rate for the children in this study is worse than the 
average data for secondary school students in England in the year 2007/2008, which 
showed that 6.1% had no absence, while 8.9% had more than 25% days of absence 
http://www.dcsf.gov.uk/rsgateway/DB/SFR/s000832/SFR03_2009NationalTablesv2.xls. 
(accessed 5/2/10) 
 
Table 5.9 Visual signs of SCD (jaundice and leg ulcer) 
 
Variable N (%) 
 
Jaundiced: 
Yes 
No 
 
(n=89) 
41 (46.1) 
48 (53.9) 
Leg ulcer: 
Yes 
No 
 
(n=89) 
5 (5.6) 
84 (94.4) 
Presence of jaundice and or leg ulcer: 
Yes 
No 
 
(n=89) 
41 (46.1) 
48 (53.9) 
 
Jaundice and leg ulcer were used as indices of visual manifestations of SCD. Nearly half 
of the respondents were jaundiced but only 5.6% had leg ulcer (Table 5.9). The 
proportion with either jaundice or leg ulcer was 46.1%. This proportion is the same as 
the proportion with jaundice because all the subjects with leg ulcer were also jaundiced.  
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Table 5.10 Treatment adherence 
 
Variable N (%) 
 
Adherence to folic acid 
Usually remembers 
Sometimes forgets 
Often forgets 
 
(n=69) 
34 (49.3) 
18 (26.1) 
17 (24.6) 
Adherence to penicillin 
Usually remembers 
Sometimes forgets 
Often forgets 
 
(n=81) 
27 (33.3) 
31 (38.3) 
23 (28.4) 
 
Clinic attendance: 
Usually attends 
Sometime or often forgets 
 
(n=91) 
83 (91.2) 
8 (8.8) 
 
In addition to clinic attendance, adherence to two medications commonly prescribed for 
people with SCD were used to assess treatment adherence. Half of the respondents 
prescribed folic acid usually remembered to take the medication (Table 5.10). Adherence 
to penicillin was more limited with only a third of respondents usually remembering to 
take the medication. Unlike medications, most respondents reported they usually 
attended their clinic appointments. The fact that respondents had much better clinic 
attendance than medication adherence may be related to the fact that clinic appointments 
are infrequent but more tangible events; hence easier to remember compared with 
medications which have to be taken daily.  
 
Summary of physical health variables 
In summary, the results in this section of the analysis showed that there was significant 
variability in the physical health of the respondents. Half were jaundiced but only 6% 
had leg ulcer. Two thirds had had at least one ward admission and half had had one or 
more admissions to Accident and Emergency department in the past year. A fifth 
experienced frequent pain (weekly or more often) and 18% had been absent from school 
for month or longer in the previous year. 
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Mental health and adversity variables 
 
 
Table 5.11 Strengths and Difficulties Questionnaire (SDQ) 
 
Table 5.11 displays the Total Difficulties scale of the SDQ and all the five subscales. 
The Total Difficulties Scale is derived from a sum of the subscales (excluding the 
prosocial subscale). Table 5.11 shows the mean scores for subjects in this study and the 
proportion scoring above the cut-off for the Total difficulties scale and the five 
subscales. 
 
Variable Mean (SD) or N (%)   
Total Difficulties score – Mean (SD) (n=78) 
Abnormal (≥ 18) N(%) 
10.8 (5.4) 
12 (15.4) 
Conduct subscale – Mean (SD) (n=88) 
Abnormal ≥ 5 N(%) 
2.2 (1.6) 
10 (11.4) 
Emotional subscale – Mean (SD) (n=86) 
Abnormal ≥ 7 N(%) 
3.6 (2.2) 
9 (10.3) 
Peer problems subscale – Mean (SD) (n=83) 
Abnormal ≥ 6 N(%) 
1.7 (1.9) 
5 (6.0) 
Hyperactivity subscale – Mean (SD) (n=84) 
Abnormal ≥ 7 N(%) 
3.3 (2.0) 
4 (4.7) 
Prosocial subscale – Mean (SD) (n=85) 
Abnormal ≤ 4 N(%) 
7.6 (1.9) 
3 (3.5) 
 
In this study, a cut-off of 18 and above was used for the self report SDQ because this 
cut-off gave prevalence figures in the British Child and Adolescent Mental Health 
Survey (Meltzer et al 2000) that were equivalent to the prevalence found using data 
from multiple sources including parents and teachers (Stansfeld et al 2004). Using this 
cut-off, the percentage of young people classified as SDQ-cases was 15.4%. This 
percentage was higher but not statistically significantly different when compared with 
the percentages of SDQ-caseness among young people in London including Black 
boys (9.2%) or Black girls (10.9%) (Stansfeld et al (2004) (comparison done with the 
StatCalc function of Epi Info statistical package, χ = 3.1, p = 0.078 which is not 
significant). 
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With respect to the subscales, the mean scores for the young people with SCD in this 
study are compared with UK-normative data in Table 5.12 below 
 
Table 5.12 SDQ subscale scores compared with UK norms 
 
SDQ Subscales Young people with SCD 
(this study) 
(Mean SD) 
(see each scale for N) 
 
*UK norms 
(Mean SD) 
 
(n=4228) 
T-Test 
 
Total difficulties scale 
(n=78) 
 
 
Conduct subscale 
(n=88) 
 
 
Emotional Subscale 
(n=87) 
 
 
Peer problems subscale 
(n=84) 
 
 
 
Hyperactivity subscale 
(n=85) 
 
 
 
Prosocial subscale 
(n=86) 
 
 
10.8 (5.4) 
 
 
 
2.2 (1.6) 
 
 
 
3.6 (2.2) 
 
 
 
1.7 (1.9) 
 
 
 
 
3.3 (2.0) 
 
 
 
 
7.6 (1.9) 
 
 
10.3 (5.2) 
 
 
 
2.2 (1.7) 
 
 
 
2.8 (2.1) 
 
 
 
1.5 (1.4) 
 
 
 
 
3.8 (2.2) 
 
 
 
 
8.0 (1.7) 
 
T =0.88 
CI-1.6, 0.6 
P=0.4 
 
equal 
 
 
T=3.47 
CI 0.35, 1.25 
P=0.0008 
 
 
T=1.0 
CI -0.18, 0.59 
P=0.3 
 
 
T=-2.4 
CI -0.91, -0.09 
P=0.019 
 
T=-2.0 
CI -0.79, -0.01 
P=0.047 
*http://www.sdqinfo.com/bba1.pdf  (accessed 2nd October 2009) 
 
The differences in mean scores and standard deviations were compared for statistical 
significance using a free online statistical package available at 
http://www.quantitativeskills.com/sisa/statistics/t-test.htm.(accessed 2/10/09). The 
comparison showed that the young people with SCD score significantly higher than 
the norm on the emotional subscale and significantly less on the hyperactivity and 
Prosocial subscales (Table 5.12).  While these findings are of interest, it is worth 
noting that the differences may not be clinically significant given that in all subscales, 
the Mean scores for children with SCDs are below the cut-off for abnormal scores 
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(See Section 4.9.4) . However, the increase in emotional symptoms over expected 
norm is in line with the literature on paediatric chronic illness. The reduced 
hyperactivity and prosocial scores are of additional interest as this has not been 
examined sufficiently in the literature on chronic illness in children.   
 
Table 5.13. Gender comparison on the SDQ  
 
 
 
Male 
Mean (SD) 
Female 
Mean (SD) 
Test 
 
SDQ Total Difficulties scale (n=77) 
 
 
10.3 (4.6) 
 
11.3 (6.0) 
T = -0.84,  
df =72.2,  
CI -3.4,1.4, 
p=0.4 
 
Conduct subscale (n=87) 2.3 (1.5) 2.0 (1.7) T = 0.98, 
df=81.1,  
CI -0.3,-1.0 
P=0.3 
Emotional subscale (n=86) 3.3 (2.2) 4.2 (2.2) T=-1.9 
df=83.9 
CI-1.8,0.4 
P=0.06 
Peer problem subscale (n=83) 1.5 (1.8) 2.0 (1.8) T=-1.2 
df=81.0 
CI -1.3,0.3 
P=0.2 
Hyperactivity subscale (n=84) 3.3 (1.8) 3.2 (2.0) T=0.3 
Df=81.8 
CI -0.7,1.0 
P=0.8 
Prosocial subscale (n=85) 7.7 (2.0) 7.6 (1.8) T=0.1 
df=82.8 
CI -0.7,0.9 
P=0.9 
 
Unlike previous studies (e.g. Stansfeld et al 2004), which showed gender differences 
in the SDQ, Table 5.13 shows no significant gender differences in Total Difficulties 
scale or any of the five subscales of the SDQ in this study. . 
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Table 5.14 Depressive symptoms 
 
 
Variable 
N (%) or Mean (SD) 
 
 
Short Mood and Feeling Questionnaire (SMFQ) 
score – Mean (SD) (n=88) 
 
 
Depression-positive cases N(%) 
Depression-negative cases N(%) 
 
 
4.5 (4.0) 
 
(n=88) 
16 (18.2) 
72 (81.8) 
 
 
 
The mean score on the SMFQ by respondents in the current study (4.5) is similar to 
scores by non-depressed children in other UK studies (4.6) (Thapar and McGuffin 
1998) and (4.4) (Stansfeld et al 2004). I used a cut off score of 8.0 and above on the 
SMFQ to define caseness for depression. This cut-off was used in the original validation 
study for the self report version of the SMFQ in USA (Angold et al 1995) and in two 
other UK studies (Thapar and McGuffin 1998, Stansfeld et al 2004). In the current 
study, the cut-off ≥ 8.0 identified 18.2% of respondents as depression-positive (Table 
5.14).  
 
Table 5.15 Depression caseness and gender 
 
 
 
Depression  Positive Depressive 
negative  
Gender 
 
Male N(%) 
Female N(%) 
 
 
(n=16) 
4 (9.1) 
12 (27.9) 
 
(n=71) 
40 (90.9) 
31 (72.1) 
Fishers Exact test p = 0.024 
 
The association between depression and gender was explored (Table 5.15). Female 
respondents were statistically significantly more likely than male respondents to be 
classified as depression-positive on the SMFQ. This is consistent with previous studies 
of the SMFQ in the UK including among black children (Stansfeld et al 2004).  
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Table 5.16 Depression and receipt of counselling from a therapist 
  
 
 
Depression  Positive 
(n=16) 
Depressive 
negative  
(n=71) 
 
Receiving Counselling  
 
Yes 
No  
 
N(%) 
 
3 (18.8) 
13 (81.3) 
N(%) 
 
 7 (9.9) 
64 (90.1) 
Fishers Exact test p=0.27  
 
Overall, 11.5% of the young people in the study were receiving counselling at the time 
of completing the questionnaire. Table 5.16 shows that only 18.8% of the children who 
were classified as depression-positive were in receipt of counselling. Also there was no 
statistically significant difference in receipt of counselling between the depression-
positive and depression-negative cases.  
   
 
Table 5.17. Self esteem 
 
 Rosenberg Self Esteem 
Scale – Mean (SD) 
Young people with SCD (this study) (n=80) 
 
USA* (n=543) 
 
Canada* (n=1443) 
 
New Zealand* (n=300) 
 
31.9 (5.0) 
 
31.9 (5.0) 
 
31.0 (4.8) 
 
29.9 (4.5) 
 
* Data from a cross national comparison among students in USA, Canada and New 
Zealand (Rusticus et al 2004). 
 
Table 5.17 shows the mean score (and standard deviation) of the young people with 
SCD on the Rosenberg Self Esteem Scale. The scores are same or better than scores 
from young people in three other developed countries. 
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Table 5.18 Child Attitude to Illness Scale (CATIS) 
 
 CATIS 
Mean (SD) 
T-tests comparing SCD 
separately with diabetes, 
severe, and mild epilepsy 
Young people with SCD (this study) 
(n=88) 
 
 
Children with Type I Diabetes* (n=31) 
 
 
Children with severe epilepsy** (104) 
 
 
 
Children with mild epilepsy** (n=41) 
3.1 (0.8) 
 
 
 
3.6 (0.8) 
 
 
 
3.2 (0.8) 
 
 
 
3.9 (0.6) 
 
 
 
 
 
 
T=-2.99 
CI -0.83, -0.17 
P=0.004 
 
T=-0.86 
CI-0.33, 0.13 
P=0.39 
 
T=-6.3 
CI -1.11, -0.55 
P=0.000 
 
*Data from Amer (2008). **Data from Heimlich et al (2000)  
 
Using the free online statistical package at 
http://www.quantitativeskills.com/sisa/statistics/t-test.htm (accessed 2/10/10), it was 
shown that young people with SCD had significantly worse attitude toward illness 
than children with Type I Diabetes Mellitus and mild epilepsy. Young people with 
SCD scored similar to children with severe epilepsy (Table 5.18). 
 
 
Table 5.19 Family function 
 
Family Assessment Device (FAD): 
 
Raw score – Mean (SD) (n=79) 
 
Standardised Scale – Mean (SD) 
 
Proportion with “healthy” family function N (%) 
 
Proportion with “unhealthy” family function N (%) 
 
 
20.8 (5.1) 
 
1.7 (0.4) 
 
63 (79.7) 
 
16 (20.3) 
 
 
A fifth of the subjects in the study (20.3%) were classified as living in families with 
unhealthy function (Table 5.19). This is comparable to 19% found in the British Child 
and Adolescent Mental Health Survey (Meltzer et al 2000), which used a similar 
definition. Several studies including Meltzer et al (2000) implicate unhealthy family 
 99
function in a range of psychological difficulties. Bearing this in mind, I will use FAD 
as a covariate in Part IV for multivariate analyses and testing of hypotheses. 
 
Summary of mental health and adversity variables 
In summary, the results of this section of the analysis showed that 15.4% of the 
respondents were classified as SDQ-cases. In line with the literature on paediatric 
chronic illness, this cohort scored significantly higher than UK norm on the emotional 
subscale of the SDQ. No differences were observed in other subscales. Also no 
gender differences were seen in any SDQ subscale. In relation to depression, 18.2% of 
respondents were classified as depression-positive cases and female respondents were 
significantly more likely to be so classified than males. However, only 18.8% of the 
children who were classified as depression-positive were in receipt of counselling. The 
young people’s attitude towards SCD was similar to children with severe epilepsy. 
However, they had normative levels of self esteem. The proportion living in families 
with unhealthy function (20%) was comparable to UK norm. 
 
 
Stigma and disclosure questions 
 
Table 5.20. Stigma questions 
Self-perceived stigma was assessed with three questions, which are shown in Table 
5.20 below. These questions were adapted from two previous studies of self-perceived 
stigma among children with epilepsy (Westbrook et al 1992) and stuttering (Blood et 
al 2003). For ease of comparison, data from the latter two studies are displayed in 
Table 5.20 against data from the current study on young people with SCD. 
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Stigma questions: 
 
Sickle cell 
 
N(%) 
Epilepsy 
(Westbrook et 
al 1992) % 
Stuttering 
(Blood et al 
2003)% 
Do you think that having Sickle Cell 
affects whether people want to be 
friends with you? 
Never  
Rarely  
Sometimes  
Often  
 
 
 
 
65 (73.0) 
14 (15.7) 
7 (7.9) 
3 (3.4) 
 
 
 
66 
12 
16 
6 
 
 
 
65 
10 
15 
10 
Do you think that having Sickle Cell 
affects whether people like you or not? 
Never  
Rarely  
Sometimes  
Often  
 
 
 
76 (83.5) 
8 (8.8) 
6 (6.6) 
1 (1.1) 
 
 
60 
14 
20 
6 
 
 
63 
12 
10 
15 
Do you think that having Sickle Cell 
affects whether or not you are invited 
to people’s homes or to parties? 
Never  
Rarely  
Sometimes  
Often  
 
 
 
 
75 (82.4) 
8 (8.8) 
6 (6.6) 
2 (2.2) 
 
 
 
69 
5 
17 
9 
 
 
 
60 
15 
10 
15 
Prevalence of Self-perceived Stigma3  
N (%) 
 
14 (15.1) 
 
  
Stigma scale – Mean (SD) 4.0 (1.8) 
Range 3-10 
 
  
 
A comparison of the proportion of young people answering “Never” to all the three 
stigma questions suggest that young people with SCD experience less self-perceived 
stigma compared with peers with epilepsy and stuttering (Table 5.20).  
 
In order to maximise the analytical power of the stigma questions, responses to the 
three stigma questions were combined into a Stigma Scale (Mean 4.0, Range 3-10) 
(higher scores = more self perceived stigma).  
 
                                                 
3 In this study, I defined respondents as having self–perceived stigma if they endorsed a positive 
answer (i.e. sometimes or often) to at least one of the three stigma questions. Based on this definition, 
the proportion of young people with self-perceived stigma was 15.1%. 
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Direct questions about perceived discrimination may be open to socially desirable 
responding. This is a common liability for questions assessing social attitudes. To 
gain additional insight into self-perceived stigma with less risk of interference from 
socially desirable responding, questions on disclosure were introduced (Table 5.21).  
 
Table 5.21 Disclosure of stigma questions 
Four additional questions on “disclosure of stigma” were used to assess avoidance 
behaviour. These are used as indirect measures of self-perceived stigma that may be 
less vulnerable to socially desirable responding. The questions shown in Table 5.21 
were also adapted from previous studies of epilepsy (Westbrook et al 1992) and 
stuttering (Blood et al 2003). The data from these two studies are displayed for 
comparison against the data from the current study of young people with SCD. 
Disclosure questions: 
 
Sickle Cell   
N (%) 
 
Epilepsy 
(Westbrook et 
al 1992)% 
Stuttering 
(Blood et al 
2003)% 
Do you keep your sickle cell a secret 
from others? 
Often  
Sometimes  
Rarely  
Never  
 
 
 
19 (20.9) 
30 (33.0) 
13 (14.3) 
29 (31.9) 
 
 
 
 
20 
33 
16 
31 
 
 
21 
19 
21 
39 
How often do you talk to people about 
your sickle cell? 
Often  
Sometimes  
Rarely  
Never  
 
 
 
7 (7.7) 
32 (35.2) 
34 (37.4) 
18 (19.8) 
 
 
 
10 
20 
50 
20 
 
 
21 
19 
46 
14 
Do any of your friends know that you 
have sickle cell? 
All  
Some  
Few  
None  
 
 
 
27 (29.7) 
35 (38.5) 
20 (22.0) 
9 (9.9) 
 
 
 
33 
45 
19 
3 
 
 
83 
10 
2 
4 
When people find out you have sickle 
cell, is it usually because: 
You tell them? 
They see you have a sign of sickle cell 
and then you explain? 
Someone else tells them about it?  
 
 
 
62 (68.9) 
 
20 (22.2) 
 
7 (7.8) 
 
 
 
65 
 
19 
 
16 
 
 
15 
 
15 
 
22 
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Unlike the direct questions on self-perceived stigma, more of the respondents with 
SCD positively endorsed the disclosure questions (Table 5.21). For example, 54% 
often or sometimes keep their having SCD secret and 57% rarely or never talk to 
other people about having SCD. This pattern and proportion of responses are also 
evident from the data on children with epilepsy and stuttering. Thus “disclosure 
questions” suggest that the true prevalence of self-perceived stigma could be more 
than indicated by the direct measures.  
 
Summary of stigma and disclosure  
A summary of this section of the analysis showed that 15% of the subjects were 
classified as having self-perceived stigma based on direct questions on stigma.  
However, more respondents positively endorsed indirect questions on stigma based on 
avoidance and disclosure behaviour. The latter suggest that the prevalence of self-
perceived stigma among young people with SCD could be more than indicated by the 
direct questions. Overall, young people in the current study endorsed less self-
perceived stigma compared with peers with epilepsy and stuttering. 
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Chapter 5: Section II 
 
5.2. Unadjusted bivariate associations between stigma and 
other variables 
 
Self-perceived stigma is the main focus of this study. This section will therefore focus 
on exploring the association between stigma and other variables. The analyses shown 
in this section are bivariate (between self perceived stigma and other variables 
individually). The purpose of this Section is to identify variables that have significant 
associations with self-perceived stigma, which would be considered later in Section 
IV for multivariate analyses. The associations explored here in Section II are not 
adjusted for confounding or interactions. Confounding and interactions will be 
considered in Section IV (multivariate analyses). 
 
In order to present comparisons between stigma and other variables as proportions, 
which are more readily appreciated in tables, I used the categorical definition of self-
perceived stigma (i.e. proportion of respondents who endorsed a positive answer to at 
least one of the stigma questions) in this Section. However, where the analysis shows 
no statistically significant association, I conducted a further analysis using the 
dimensional measure of stigma (Stigma Scale) to ensure that no statistically 
significant association was missed by the penalisation of the data that could result 
from using categorical data where a dimensional alternative is available. The result of 
the additional dimensional analysis is shown only in cases where the two analytical 
strategies yield different results. Otherwise, only the categorical result is shown.  
 
5.2.1 Associations between stigma and socio-demographic variables 
The study gathered a considerable amount of socio-demographic data. However, in 
the section that follows, associations are explored only for socio-demographic 
variables with theoretical or putative relationships with self-perceived stigma, 
comparing the 14 participants with perceived stigma according to the above 
categorical definition with the 77 children with no or low perceived stigma.  
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 Table 5.22. Perceived stigma and gender 
.    
 Perceived Stigma 
 
(n=14) 
No or low perceived 
stigma 
(n=76) 
 
Test and p value 
Gender: 
Male N (%) 
Female N (%) 
 
4 (8.7) 
10 (22.7) 
 
42 (91.3) 
34(77.3) 
 
 
Fishers Exact  
p = 0.085     
 
 
Table 5.22 shows that a higher percentage of females than males were classified as 
having self-perceived stigma (22.7% vs. 8.7%) but, the difference was not statistically 
significant.  
 
Table 5.23 Perceived stigma and age 
 
 Perceived 
Stigma 
(n=14) 
No or low 
perceived stigma 
(n=77)   
 
Test 
 
Age - Mean (SD) 
 
 
13.4 (2.5) 
 
 
14.4 (2.1) 
T=-1.5, df 86,  
CI -2.16, 0.29, 
 p = 0.13 
 
 
 
Table 5.23 shows no statistically significant difference in mean age between the 
respondents classified as having self-perceived stigma and those without perceived 
stigma. 
 
 
Table 5.24 Perceived stigma and having a sibling with SCDs 
 
 Perceived Stigma
(n=13) 
No or low 
perceived stigma 
 (n=77) 
Test and 
p value 
Sibling with SCD: 
Yes N (%) 
No N (%) 
 
4 (15.4) 
9 (14.1) 
 
22 (84.6) 
55 (85.9) 
 
Fisher’s 
Exact 
p = 1.0 
 
The above table shows that there was no statistically significant difference in the 
percentage of young people with a sibling with SCD who were classified as having 
self perceived stigma compared with those with no affected sibling Table 5.24). 
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Table 5.25 Perceived stigma and UK birth 
 
 Perceived Stigma
(n=14) 
No or low 
perceived stigma 
 (n=77) 
 
Test and 
p value 
Born in UK: 
Yes - N (%) 
No – N (%) 
 
9 (13.0) 
5 (22.7) 
 
60 (87.0) 
17 (77.3) 
Fishers 
Exact 
p = 0.31 
 
The above table shows that there was no statistically significant difference in the 
percentage of children with SCD born in the UK who were classified as having self-
perceived stigma compared with those born outside the UK (Table 5.25). 
 
 
Table 5.26 Self-perceived stigma and Socio-economic status 
 
To reduce the number of cells with small numbers, the six OPCS-SES categories were 
collapsed into three groups by combining Groups 1 and 2, 3 and 4, and 5 and 6 as 
shown in Table 5.26. 
 
 Perceived 
Stigma 
 
(n=12) 
No or low 
perceived stigma 
 (n=68) 
Test and 
p value 
OPCS-SES category: 
 
1 & 2 - N (%) 
3 & 4 - N (%) 
5 & 6 – N (%) 
 
 
 
5 (20.0) 
4 (8.9) 
3 (30) 
 
 
20 (80.0) 
41 (91.1) 
7 (70.0) 
 
 
χ = 3.4 
df = 2 
p = 0.17 
 
Table 5.26 shows no statistically significant association between OPCS-SES category 
and classification as having self-perceived stigma. The analysis was repeated with other 
measures of socio-economic status (ownership of a car and land telephone line) which 
also showed no statistically significant association (Figures not shown). 
 
Summary of stigma and Sociodemographic variables 
In summary, the results of this section of the analysis shows that no socio-
demographic variable (gender, age, whether or not born in the UK, having a sibling 
with SCD, and SES) was statistically significantly associated with self-perceived 
stigma.  
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5.2.2. Associations between stigma and illness variables 
 
 
Table 5.27 Self perceived stigma and presence of jaundice 
 
 Perceived Stigma
(n=14) 
No or low 
perceived stigma 
(n=75) 
Test and 
p value 
Jaundice: 
Yes N(%) 
No N(%) 
 
6  (14.6) 
8  (16.7) 
 
35 (85.4) 
40 (83.3) 
 
χ = 0.07 
df = 1 
p = 0.8 
 
Jaundice is one of the physical manifestations of SCD. Stigma theory predicts that 
physical signs that increase visibility increase the stigmatising potential of a 
condition. However, Table 5.27 shows no significant association between stigma and 
presence of jaundice. 
 
 
Table 5.28 Self-perceived stigma and leg ulcer 
 
 Perceived Stigma
(n=14) 
No or low 
perceived stigma 
 (n=75) 
Test and 
p value 
Leg ulcer: 
Yes N(%) 
No N(%) 
 
3 (60.0) 
11 (13.1) 
 
2 (40.0) 
73 (86.9) 
Fishers Exact 
test 
p = 0.03 
 
 
The presence of leg ulcer is another physical feature seen in SCD. It is a less common 
feature than jaundice (5.6% vs. 46.1% in this study). However, unlike jaundice, Table 
5.28 shows that the presence of leg ulcer is statistically significantly associated with 
self-perceived stigma. This therefore provides preliminary support for the application 
of stigma theory to SCD, which suggests that having a visible sign increases the 
stigmatising potential of a condition. This association is preliminary because it has not 
been subjected to multivariate analysis to partial out the effect of other variables that 
may be potential confounders. This will be addressed in Section IV of this chapter. 
 
 
 
 
 107
Self-perceived stigma and measures of severity of SCD 
Five surrogate variables were used to assess severity in SCD: frequency of ward 
admissions, frequency of admissions to Accident and Emergency department, 
frequency of school absence, frequency of experience of pain, and intensity of pain. 
These measures of severity were included as indices of disruptiveness because stigma 
theory proposes that disruptiveness increases the stigmatising potential of a condition. 
Given that the above measures of severity were determined in categories with up to 
five or more options, I decided that for purposes of bivariate and multivariate 
analyses, it would not be appropriate to assess their relationships with self-perceived 
stigma with cross-tabulation as the loss of power would increase the risk of Type II 
errors. Instead, I treated the categories in the measures of severity as ordinal scales 
and calculated correlation coefficients (Spearman rho) between them and the 
dimensional measure of stigma (Table 5.29). 
 
 
Table 5.29 Correlation coefficients between self-perceived stigma and measures 
of severity 
 
   
Stigma 
(dimensional) 
School absence R .09
  N 86
Pain frequency R .04
  N 74
Pain intensity R .30**
  N 83
Frequency of ward 
admissions 
R .34**
  N 86
Frequency of A&E 
admissions 
R .31**
  N 85
r = Spearman rho correlation 
**  Correlation is significant at the 0.01 level (2-tailed). 
 
 
Table 5.29 shows that self-perceived stigma had statistically significant correlation 
with only three of the five measures of severity (pain intensity, frequency of ward 
admissions and frequency of Accident and Emergency admissions). Based on the 
coding scheme of the data, the direction of the correlations indicates that young 
people who experienced more of these three measures of severity had more self-
perceived stigma. This finding provides further preliminary support for the 
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application of stigma theory to SCD, which predicts that the more disruptive a 
condition is the more stigmatising it is likely to be. The independence of this 
association will be explored further with multivariate analysis in Section IV of this 
chapter. 
 
Table 5.30 Self-perceived stigma and clinic attendance: 
 
 Perceived 
Stigma 
 
(n=14) 
No or low 
perceived stigma 
(n=77)  
Test and 
p value 
 
Clinic attendance: 
Usually remembers to attend.  
N(%) 
 
Sometimes or often forgets to attend. 
N(%) 
 
 
12 (14.5) 
 
 
2 (25.0) 
 
 
 
71 (85.5) 
 
 
6 (75.0) 
 
Fisher’s 
Exact 
p = 0.6 
  
 
The association in Table 5.30 was explored because of the possibility that young 
people who perceive stigma may be less likely to associate with activities that 
highlight the saliency of SCD such as attending appointments at sickle cell clinics. 
The Table shows no significant association between self-perceived stigma and clinic 
attendance.  
 
Tables 5.31 (a,b,c) Self-perceived stigma and medication adherence: 
As with clinic attendance, the association between self-perceived stigma and 
medication adherence was explored on the basis that young people with increased 
self-perceived stigma may be less likely to adhere to their SCD medication because 
the latter makes the disorder more salient for them. More data was available on 
adherence to two medications commonly prescribed for people with SCD (folic acid 
and penicillin). The analysis was based on adherence to penicillin as this had more 
complete data compared with folic acid. One-way ANOVA was used to compare the 
Mean scores on the dimensional stigma scale among the three categories of adherence 
to penicillin. The outputs are shown in Tables 5.31 a-c below. 
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Table 5.31a. Descriptive statistics for self-perceived stigma at different three 
levels of adherence to penicillin 
Dependent variable = Self-perceived stigma 
Adherence 
to penicillin  N Mean 
Std. 
Deviation
Std. 
Error 
95% Confidence 
Interval for Mean 
Lower               Upper 
Often 
forgot 21 4.80 2.18 0.47 3.81 5.80 
Sometimes 
forgot 31 3.90 1.83 0.32 3.23 4.57 
Usually 
remembers 27 3.62 1.49 0.28 3.03 4.22 
Total 79 4.05 1.86 .021 3.63 4.46 
 
  
 
Table 5.31b. Test of Homogeneity of Variances 
 
Dependent variable = Self-perceived stigma 
Levene 
Statistic Df1 df2 Sig. 
2.42 2 76 .096
 
 
 
Table 5.31c. ANOVA 
 
Dependent variable = Self-perceived stigma 
 
Sum of 
Squares Df Mean Square F Sig. 
Between 
Groups 17.55 2 8.77 2.62 .08 
Within Groups 254.24 76 3.34    
Total 271.79 78     
 
 
The ANOVA showed that young people who often forgot to take their penicillin 
scored higher on the stigma scale than those who sometimes forgot. The latter group 
also scored higher than those who usually remember to take their penicillin. However 
the differences in mean did not reach statistical significance.  
 
Summary of associations between stigma and illness variables 
In summary, the results of this section of the analysis show that there are statistically 
significant associations between self-perceived stigma and presence of leg ulcer, and 
three indices of severity (pain intensity, frequency of ward admissions and frequency 
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of A&E attendance). No significant associations were found with keeping of clinic 
appointments or medication adherence. 
 
5.2.3. Associations between stigma and emotional and behavioural 
adjustment 
 
Table 5.32. Self perceived stigma and scores on the Strengths and Difficulties 
Questionnaire 
 
 Perceived Stigma
 
 
No or low 
perceived stigma 
 
Test and 
p value 
 
Total Difficulties Score 
(Mean, SD) 
 
(n=13) 
16.1 (6.5) 
 
(n=65) 
9.7 (4.5) 
 
t = 4.3, df = 76 
p = 0.0001  
 
Conduct subscale 
 
(n=14) 
2.4 (2.0) 
 
(n=74) 
2.1 (1.5) 
 
t=0.4, df = 86 
p = 0.7 
 
Emotional subscale (n=14) 
5.6 (2.2) 
 
(n=73) 
3.4 (2.1) 
 
t=3.5, df=85 
p=0.003 
 
Peer problems subscale (n=13) 
4.0 (2.2) 
 
(n=71) 
1.3 (1.5) 
 
t=5.6, df=85 
p=0.0001 
Hyperactivity subscale 
 
(n=14) 
3.7 (2.2) 
 
(n=71) 
3.2 (1.9) 
 
t=0.9, df=83 
p=0.3 
 
Prosocial subscale 
 
(n=13) 
7.9 (2.1) 
(n=73) 
7.6 (1.9) 
t=0.6, df=84 
p=0.6 
 
 
Compared with those with no or low self-perceived stigma, young people classified as 
having self-perceived stigma had statistically significantly higher Total Difficulties 
scores as well as higher scores on the emotional and peer problems subscales (Table 
5.32). The group means for each of these three subscales of the SDQ differed by more 
than one standard deviation. 
 
 
Table 5.33 Self-perceived stigma and depression scores 
 
 Perceived Stigma 
 
(n = 13) 
No or low 
perceived stigma 
(n = 75) 
Test and 
p value 
 
Short MFQ score  
(Mean, SD) 
 
7.6 (4.7) 
 
3.9 (3.6) 
t = 3.3 
df=86 
p = 0.001   
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Table 5.33 shows that young people classified as having perceived stigma had 
statistically significant more depressive symptoms than those with no or low self-
perceived stigma. In fact, the mean depressive symptoms for two groups differed by 
almost one standard deviation. 
 
Table 5.34 Self-perceived stigma and self esteem 
 
 Perceived Stigma 
 
(n = 11) 
No or low 
perceived stigma 
 (n = 69) 
Test and 
p value 
 
Rosenberg Self Esteem Rating 
Scale (Mean, SD) 
 
 
29.4 (5.6) 
 
32.3 (4.8) 
t = 4.3 
df=78 
p = 0.07 
 
Table 5.34 shows that young people with self perceived stigma had lower self esteem 
than those with no or low stigma. However, the mean difference between the two groups 
was not statistically significant. On the other hand, when the dimensional measure of 
self-perceived stigma was correlated with self esteem scores (data not shown), the 
coefficient of correlation was statistically significant (r = -0.29, p = 0.01) showing that 
young people with self-perceived stigma scored less on the self esteem scale. The fact 
that the T-test in Table 5.34 was not statistically significant (but the correlation 
coefficient was significant) demonstrates the loss of statistical power associated with 
categorisation of continuous dimensional measures. 
 
Table 5.35 Self-perceived stigma and family function 
 
 Perceived Stigma 
 
(n = 12) 
No or low 
perceived stigma 
 (n = 67) 
Test and 
p value 
 
Family Assessment Device 
(raw scores) Mean (SD) 
 
 
21.4 (5.9) 
 
20.6 (4.9) 
t=0.5 
df=77 
p=0.6 
 
 
Young people with self-perceived stigma did not differ significantly in their family 
function compared with those without perceived stigma (Table 5.35). 
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Table 5.36 Self –perceived stigma and attitude toward illness 
 
 Perceived Stigma 
 
(n = 13) 
No or low 
perceived stigma 
 (n = 75) 
Test and 
p value 
 
Child Attitude toward Illness 
Scale (raw scores) Mean (SD) 
 
35.1 (10.6) 
 
41.3 (10.3) 
t=-2.0 
df=86 
p=0.049 
 
 
Young people with self-perceived stigma had statistically significant poorer attitude 
towards SCD than peers without self-perceived stigma (Table 5.36).  
 
Summary of associations between stigma and emotional and behavioural 
adjustment 
In summary, the results of this section of the analysis show that in unadjusted bivariate 
comparisons, young people classified as having self-perceived stigma had significantly 
worse scores than those not so classified on most of the measures of emotional and 
behavioural adjustment. In some cases, the two groups differed by more than one 
standard deviation. The group with self-perceived stigma had statistically significantly 
higher Total Difficulties scores as well as higher scores on the emotional and peer 
problems subscales of the SDQ. Also, they had significantly more depressive symptoms, 
lower self esteem, and poorer attitude towards SCD. The only measure with no 
significant difference between the two groups was family function. Multivariate 
analysis will be employed later to explore if these significant associations between 
stigma and emotional and behavioural variables remain after controlling for 
confounding variables. 
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Chapter 5: Section III 
 
5.3. Unadjusted bivariate comparisons between respondents 
recruited from Sickle cell society and those recruited from 
haematology clinics 
 
 
Table 5.37. Age of respondents recruited from Sickle Cell Society compared with 
those recruited from haematology clinics 
 
 
 
Sickle cell society 
(n=24) 
Haematology 
clinics 
(n=64) 
 
Test 
 
Age.  Mean (SD) 
 
 
14.2 (2.4) 
 
14.2 (2.1) 
 
t=0.13 
df-86 
p=0.90 
 
 
Table 5.37 shows no difference in mean age between subjects recruited from the Sickle 
Cell Society or haematology clinics. 
 
 
Table 5.38. Gender of respondents recruited from Sickle Cell Society compared 
with those recruited from haematology clinics 
 
 
 
Sickle cell society 
(n=24) 
Haematology 
clinics 
(n=66) 
Test 
Gender 
Male N(%) 
Female N(%) 
 
9 (19.6) 
15 (34.1) 
 
37 (80.4) 
29 (65.9) 
 
χ=2.4 
df=1 
p=0.15 
 
 
Table 5.38 shows more males were recruited from clinics and more girls from the Sickle 
Cell Society but the percentage differences are not statistically significant. 
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Table 5.39. Association between Socioeconomic status (OPCS) and whether 
respondents were recruited through a haematology clinic or Sickle Cell Society 
 
To test this association, the six categories of the OPCS were collapsed into three 
categories by combining categories 1 and 2, 3 and 4, 5 and 6 in order to reduce the 
number of cells with small or no numbers. As shown in Table 5.39 below, there was no 
statistically significant association between these OPCS-SES categories and source of 
recruitment.  
 
 
OPCS-SES categories 
Sickle cell society 
(n=20) 
N(%) 
Haematology 
clinics 
(n=60) 
N(%) 
Test 
1&2 3 (15) 
 
22 (36.7) 
3&4 13 (65) 32 (53.3) 
 
5&6 4 (20) 
 
6 (10) 
χ = 3.8 
df=2 
p=0.15 
 
However, given that the six OPCS-SES categories represent an ordinal scale, the 
association was also tested by calculating the Spearman rho correlation coefficient 
between the full six-category OPCS-SES (coded as in Table 5.5) and the two categories 
of source of recruitment (coded as haematology clinics = 1, Sickle Cell Society = 2). The 
Spearman rho correlation coefficient (n=80, r = 0.3) was statistically significant 
(p=0.006). The coding frame indicates that respondents recruited from haematology 
clinics were more likely to come from households headed by someone in a higher 
professional status compared with the children recruited from Sickle Cell Society. 
 
 
Table 5.40 Comparison between respondents recruited from Sickle Cell Society 
and those recruited from haematology clinics on whether or not they were born 
in the UK 
 
 
Sickle cell society 
(n=24) 
Haematology 
clinics 
(n=67) 
Test 
Born in the UK 
Yes N(%) 
No N(%) 
 
15 (21.7) 
9 (40.9) 
 
54 (78.3) 
13 (59.1) 
 
χ=3.1 
df=1 
p=0.10 
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Table 5.40 shows that a higher percentage of the subjects born in the UK were recruited 
from the haematology clinics compared with respondents who were not born in the UK. 
However, the difference was not significant. 
 
Table 5.41. Self-perceived stigma among respondents recruited through 
haematology clinics or Sickle Cell Society 
 
Given that the Sickle Cell Society is an advocacy organisation, people with SCD who 
are members could be a self select group that have a more positive attitude toward 
SCD and be less likely to perceive stigmatisation. This premise justifies exploring 
whether fewer children from among those recruited through the Sickle Cell Society 
were classified as having self perceived stigma compared with those recruited from 
haematology clinics. 
 
 
 
Sickle cell society 
(n=24) 
Haematology 
clinics 
(n=67) 
Test 
Self perceived stigma 
Yes N(%) 
No N(%) 
 
3 (21.4) 
21 (27.3) 
 
11 (78.6) 
56 (72.7) 
 
Fisher’s Exact 
p=0.75 
 
 
 
Table 5.41 above shows that there is no significant association between source of 
recruitment and classification as having self-perceived stigma. 
 
Table 5.42. Association between stigma and whether respondents completed 
questionnaire in clinic or at home 
 
Theoretically, young people completing questionnaires in clinic may be more likely to 
report self-perceived stigma as their attendance to the clinic while their peers are at 
school or engaging in other activities could become a symbolic reminder of the 
disruptive effect of having SCD.  
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Perceived 
Stigma 
 
(n=13) 
No or low 
perceived  
stigma 
(n=74) 
Test 
Where questionnaire was 
completed 
 
Homes N (%) 
Clinic N (%) 
 
 
 
 
6 (11.8) 
7 (19.4) 
 
 
 
 45 (88.2) 
29 (80.6) 
 
 
χ = 1.0 
df=1 
p=0.4 
 
Table 5.42 shows no significant association between stigma and whether respondents 
completed questionnaires in haematology clinics or at home. 
 
 
Table 5.43. Comparison of depressive symptoms between respondents from 
Sickle Cell Society and haematology clinics 
 
 
 
Sickle cell society 
 
(n=23) 
Haematology 
clinics 
 
(n=65) 
Test 
Depressive symptoms (SMFQ) 
Mean (SD) 
 
 
3.4 (2.8) 
 
4.8 (4.2) 
 
t=1.5 
df=86 
p=0.08 
 
 
Table 5.43 shows that the children recruited from haematology clinics scored higher on 
the SMFQ than those recruited from Sickle Cell Society but the difference was not 
statistically significant.  
 
Table 5.44. Comparison of Total Difficulties Scale of the SDQ between 
respondents from Sickle Cell Society and haematology clinics 
 
 
 
Sickle cell society 
(n=23) 
Haematology 
clinics 
(n=55) 
Test 
Total Difficulties Scale of the SDQ. 
Mean (SD) 
 
 
11.0 (5.1) 
 
10.6 (5.5) 
 
t=-0.26 
df=76 
p=0.79 
 
 
Table 5.44 shows that the children recruited from haematology clinics did not differ in 
their score on the Total Difficulties scale of the SDQ compared with those recruited from 
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Sickle Cell Society. Also they did not differ significantly on any of the five SDQ 
subscales (data not shown). 
 
Table 5.45. Comparison of self esteem between respondents from Sickle Cell 
Society and haematology clinics 
 
 
 
Sickle cell society 
(n=23) 
Haematology 
clinics 
(n=57) 
 
Test 
Rosenberg Self Esteem Scale Mean 
(SD) 
 
 
33.7 (3.7) 
 
31.2 (5.3) 
 
t=-2.1 
df=78 
p=0.04 
 
 
Table 5.45 shows that the children recruited from haematology clinics scored lower on 
the Rosenberg Self Esteem scale compared with those recruited from Sickle Cell Society 
and the difference is statistically significant (p=0.04). 
 
 Table 5.46. Comparison of Attitude towards illness between respondents from 
Sickle Cell Society and haematology clinics 
 
 
 
Sickle cell society 
(n=23) 
Haematology 
clinics 
(n=65) 
 
Test 
 
Attitude toward illness (CATIS 
score) Mean (SD) 
 
 
40.6 (11.5) 
 
40.3 (10.3) 
 
t=-0.12 
df=86 
p=0.91 
 
 
Table 5.46 shows that the children recruited from haematology clinics did not differ in 
their attitude towards SCD compared with those recruited from Sickle Cell Society.  
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Table 5.47. Receipt of counselling among respondents recruited from Sickle Cell 
Society compared with those recruited from haematology clinics 
 
 
 
Sickle cell society 
(n=24) 
Haematology 
clinics 
(n=76) 
 
Test 
Counselling 
Yes N(%) 
No N(%) 
 
2 (20.0) 
22 (27.5) 
 
8 (80.0) 
58 (72.5) 
 
Fisher’s Exact 
p=1.0 
 
 
Table 5.47 shows no significant difference in the percentage of respondents recruited 
from Sickle Cell Society who were receiving counselling compared with those recruited 
from haematology clinics. 
 
 
Table 5.48. Comparison of family function between respondents from Sickle Cell 
Society and haematology clinics 
 
 
 
Sickle cell society 
(n=22) 
Haematology 
clinics 
(n=57) 
Test 
Family Assessment Device (FAD) – 
General Function Scale (raw score) 
Mean (SD) 
 
 
20.5 (4.5) 
 
20.9 (5.3) 
 
t=0.28 
df=77 
p=0.78 
 
 
Table 5.48 shows that the children recruited from haematology clinics did not differ in 
family function compared with those recruited from Sickle Cell Society.   
 
Table 5.49. Association between frequency of admission and whether respondents 
were recruited through a clinic or Sickle Cell Society 
 
 
Frequency of ward admission in 
past year 
Sickle cell society 
(n=23) 
N(%) 
Haematology 
clinics 
(n=65) 
N(%) 
 
Test 
No admission 11 (47.8) 23 (35.4) 
Once 3 (13.0) 12 (18.5) 
2-4 times 4 (17.4) 21 (32.3) 
5-6 times 3 (13.0) 5 (7.7) 
7-10 0 2 (3.1) 
>10 times 2 (8.7) 2 (3.1) 
χ = 4.7 
df=5 
p=0.5 
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Table 5.49 shows no statistically significant association in frequency of ward 
admission (a measure of severity) between respondents recruited through Sickle Cell 
Society and those recruited from haematology clinics. 
 
Summary of unadjusted bivariate comparisons between respondents recruited 
from Sickle cell society and those recruited from haematology clinics 
In summary, the results of the analysis for this section show that the subjects recruited 
from the Sickle Cell Society differed only on two items (OPCS-SES status and Self-
esteem) from those recruited from haematology clinics. Respondents recruited from 
the Sickle Cell Society were more likely to come from families with lower SES. 
However, they were more likely to have higher self-esteem. The two groups did not 
differ significantly on age, gender, whether or not born in the UK, levels of self-
perceived stigma, whether they completed the questionnaire at home or in the clinic, 
depressive symptoms, Total Difficulties scale or subscales of the SDQ, receipt of 
counselling, family function, or frequency of ward admissions (measure of severity). 
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Chapter 5. Section IV. 
 
5.4. Multivariate analysis and hypotheses testing 
 
This section describes the procedure and outcome of the tests of the four hypotheses 
proposed for this thesis. The analytical strategies employed are multivariate, which 
allow for confounders to be controlled and for interactions to be explored.  
 
The study hypotheses to be tested are: 
1. Measures of disruptiveness (e.g. frequency of admissions) and visibility (e.g. 
presence of leg ulcer) will significantly and independently predict levels of 
self perceived stigma.  
 
2. Self perceived stigma will significantly and independently predict scores on 
the Total difficulties scale of the SDQ. 
 
3. Self perceived stigma will significantly and independently predict Depressive 
symptoms measured by SMFQ 
 
4. Self perceived stigma will significantly and independently predict Self Esteem 
measured by Rosenberg Scale  
 
Incidentally, the process of exploring the above primary hypotheses gave 
opportunities to explore additional associations between each dependent variable and 
other psychological, illness, and social predictor variables over and above self-
perceived stigma.  
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First hypothesis 
Measures of disruptiveness (e.g. frequency of admissions) and visibility (e.g. 
presence of leg ulcer) will significantly and independently predict levels of self 
perceived stigma.  
 
This hypothesis is based on stigma theory, which suggests that certain attributes of a 
condition (referred to as stigma dimensions) predict whether the condition is likely to 
be stigmatising. The common dimensions described in the literature are; Visibility, 
Threat or Peril, Chronicity, Responsibility, and Disruptiveness (Katz 1981, Jones et al 
1984). Stigma dimensions were explored in detail in Chapter 2. The stigma 
dimensions considered measurable for this study on SCD are visibility and 
disruptiveness. The hypothesis is that if stigma theory is applicable to SCD, then 
measures of visibility and disruptiveness would predict self-perceived stigma.  
 
The first step in exploring this hypothesis is to establish if measures of visibility and 
disruptiveness have statistically significant associations with self-perceived stigma. 
 
Measures of visibility 
In this study, Visibility was measured with presence of jaundice and presence of leg 
ulcer. As shown in Table 5.27, jaundice was not significantly associated with self 
perceived stigma. Thus this measure of visibility was not considered further in the 
analysis. However presence of leg ulcer had a statistically significant association with 
self-perceived stigma (Table 5.28) in bivariate analysis. The latter therefore shows 
preliminary support for this hypothesis. However, multivariate analysis will be used 
next to ascertain if this association is independent of other explanatory variables.  
 
Measures of disruptiveness 
Disruptiveness was assessed in this study with five variables: frequency of ward 
admissions, frequency of admissions to Accident and Emergency department, 
frequency of school absence, frequency of experience of pain, and intensity of pain. A 
composite measure “severity” was also created. As shown in Table 5.50 below, only 
the combined scale “severity”, pain intensity, frequency of ward admission and 
frequency of A&E admissions correlated significantly with stigma. It was not 
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appropriate to consider including all the three measures of disruptiveness in 
multivariate analysis for several reasons (Field 2005). First is to avoid problems of 
multicollinearity. Secondly, to avoid having redundant independent variables, as each 
extra covariate reduces the degree of freedom for error by one (the goal being to 
obtain maximum adjustment for the dependent variable with minimum loss of degrees 
of freedom for the error term) 
http://www.psych.umn.edu/courses/spring05/federicoc/psy8815/lectures/stats_lecture
9.pdf .(accessed 03/01/2010). Third reason is to reduce the total number of predictors. 
Although many authors suggest that a ratio of 10 subjects per predictor in a regression 
model is adequate (Pallant 2007), Field (2005) recommends a more stringent ratio. He 
suggests a ratio based on the formula 50 + 8K, where K is the number of variables. 
Given that the sample size of this study is 93, this more stringent ratio will allow the 
inclusion of a maximum of five predictor variables (50 + 8x5) = 90. Taking account 
of missing data, four variables per model would be the most stringent. However, I 
took a pragmatic approach in the following multivariate analyses by using varying 
stringency of number of variables while keeping to a total of 4 -7 predictors per 
model. 
 
Bearing the above considerations in mind, I decided to choose one of the three 
measures of disruptiveness for the multivariate analysis. Of the four variables that 
correlated significantly with self-perceived stigma, frequency of ward admissions was 
chosen as the best measure of disruptiveness as it correlated strongest with self-
perceived stigma and also with other measures of disruptiveness (Table 5.50).  
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Table 5.50. Bivariate correlations between measures of severity 
  
   
School 
absence 
Pain 
frequency
Pain 
Intensity 
Frequency 
of ward 
admissions 
Frequency 
of A&E 
admissions Stigma  
Pain frequency r .14  
  N 72  
Pain intensity r .18 .09  
  N 80 74  
Frequency of 
ward 
admissions 
r 
.27* .28* .37**  
  N 83 73 82  
Frequency of 
A&E 
admissions 
r 
.16 .18 .38** .54**  
  N 83 73 81 85  
Stigma 
(dimensional) 
r .09 .04 .30** .34** .31** 
  N 86 74 83 86 85 
Severity scale r .17 .44** .56** .66** .63** .29*
  N 66 69 69 69 69 67
r = Spearman rho 
**  Correlation is significant at the 0.01 level (2-tailed). 
*  Correlation is significant at the 0.05 level (2-tailed). 
 
Thus, this hypothesis will be tested using presence of leg ulcer as the measure of 
visibility and frequency of ward admissions as the measure of disruptiveness. The 
Hypothesis can therefore be re-stated as “Presence of leg ulcer (visibility) and 
frequency of ward admissions (disruptiveness) will significantly and independently 
predict levels of self perceived stigma”. 
 
Using the dimensional measure of stigma as the dependent variable, this 
hypothesis could be tested with one of three multivariate techniques: hierarchical 
linear regression, standard linear regression, or Analysis of Covariance. 
 
In practice I availed the data the opportunity to be explored with all three techniques, 
which gave similar results. I have presented the analysis using hierarchical linear 
regression as I considered it theoretically more appropriate for this hypothesis. 
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Hierarchical linear regression is appropriate where there is a theoretically valid reason 
for deliberately entering predictor variables in separate blocks in the regression 
model. As a general rule, known predictors or confounders are entered first, and the 
new predictors entered last.  
 
Thus hierarchical multiple regression was used to test the ability of two stigma 
dimensions (presence of leg ulcer and frequency of admissions to predict) to predict 
levels of self-perceived stigma (dimensional stigma scale) after controlling for 
potential confounders (Age and Gender).  
 
Age and Gender were entered together in Step 1, and they explained 6% of the 
variance in self-perceived stigma. Presence of leg ulcer was entered alone in Step 2 
because visibility has more saliency, proximity, and immediacy in eliciting or 
inducing self-perceived stigma than disruptiveness. The entry of Leg ulcer alone in 
Step 2 increased the total variance explained by the model to 15% F(3, 81) =  4.7, p = 
004. Thus leg ulcer alone explained an additional 8.4% of the variance in self-
perceived stigma after controlling for Age and Gender, R squared change = 0.085, F 
change (1, 81) = 8.1, p = 0.006. Frequency of ward admission was entered alone in 
Step 3. The total variance explained by the model as a whole was 19% with 
Frequency of admission alone explaining an additional 4.3% of the variance in self-
perceived stigma after controlling for Age, Gender, and leg ulcer, R squared change = 
0.43, F change (1, 80) = 4.3 , p = 0.42. In the final model, only the two stigma 
dimensions (leg ulcer and admissions) were statistically significant, with leg ulcer 
recording a slightly higher beta value (beta = - 0.23, p = 0.031) than frequency of 
admissions (beta = 0.22, p = 0.042). The regression outputs are shown in Tables 5.51 
(a,b,c) below. Thus these findings provide support for the hypothesis “Presence of leg 
ulcer (visibility) and frequency of ward admissions (disruptiveness)) will 
significantly and independently predict levels of self perceived stigma)”. 
 
The analysis was checked to ensure that the assumptions for multiple regression: 
normality, linearity, multicollinearity and homoscedasticity (Field 2005) 
were met. For example, the Durbin-Watson statistic of 1.9 in Table 5.51a indicates no 
autocorrelation in the residuals (values close to 2.0 are considered normal). Tolerance 
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is the percentage of the variance in a given predictor that cannot be explained by the 
other predictors. The Tolerance values between 0.8-0.99 in Table 5.51c are 
considered very good (meaning that less than 20% of the variance in the predictors are 
explained by other predictors. Tolerance of less than 0.1 suggests multicollinearity). 
The Variance Inflation Factors (VIF) in the range of 1.0-1.1 in Table 5.51c are also 
good because only values greater than 2 are considered abnormal. Finally, the Normal 
P-P plot of residuals (Figure 5.2) follow a 45º angle indicating that the assumption of 
normality was not violated. 
 
 
 
 
Table 5.51a. Model Summary 
 
Mode
l     Change Statistics 
Durbin-
Watson
  R  
R 
Square  
Adjusted 
R Square 
Std. Error 
of the 
Estimate 
R Square 
Change 
F 
Change df1 df2 
Sig. F 
Change  
1 .25(a) .06 .04 1.74 .06 2.81 2 82 .066  
2 .38(b) .15 .11 1.67 .08 8.06 1 81 .006  
3 .43(c) .19 .15 1.64 .04 4.26 1 80 .042 1.90
a  Predictors: (Constant), Gender, Age 
b  Predictors: (Constant),Gender, Age, Ulcer 
c  Predictors: (Constant), Gender, Age, Ulcer, Frequency of ward admissions 
d  Dependent Variable: Self-perceived stigma (dimensional measure) 
 
 
 
 
Table 5.51b. Model Summary 
 
Model   
Sum of 
Squares Df Mean Square F Sig. 
1 Regression 17.15 2 8.57 2.81 .066(a) 
  Residual 249.94 82 3.04    
  Total 267.10 84     
2 Regression 39.79 3 13.26 4.72 .004(b) 
  Residual 227.30 81 2.80    
  Total 267.10 84     
3 Regression 51.30 4 12.82 4.75 .002(c) 
  Residual 215.79 80 2.69    
  Total 267.10 84     
a  Predictors: (Constant), Gender, Age 
b  Predictors: (Constant),Gender, Age, Ulcer 
c  Predictors: (Constant), Gender, Age, Ulcer, Frequency of ward admissions 
d  Dependent Variable: Self-perceived stigma (dimensional measure) 
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Table 5.51c. Model Summary 
 
Model   
Unstandardised 
Coefficients 
Standardised 
Coefficients   
Collinearity 
statistics 
    B Std. Error Beta t  Sig Tolerance VIF 
1 (Constant) 4.28 1.32  3.22 .002 
  Age -.11 .09 -.13 -1.23 .219 0.96 1.03
  Gender .85 .38 .24 2.21 .029 0.96 1.03
2 (Constant) 8.58 1.97  4.33 .000 
  Age -.11 .08 -.13 -1.30 .195 0.96 1.03
  Gender .90 .37 .25 2.44 .017 0.96 1.03
  Ulcer -2.24 .79 -.29 -2.84 .006 0.99 1.00
3 (Constant) 6.99 2.08  3.35 .001 
  Age -.09 .08 -.11 -1.09 .275 0.95 1.04
  Gender .72 .37 .20 1.93 .056 0.91 1.09
  Ulcer -1.77 .80 -.23 -2.19 .031 0.91 1.08
  Frequency of 
admission .28 .14 .22 2.06 .042 0.87 1.14
a  Dependent Variable: Self-perceived stigma (dimensional measure) 
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Figure 5.2 
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Second hypothesis 
Self perceived stigma will significantly and independently predict Total difficulties 
score on the Strengths and Difficulties Questionnaire (SDQ) 
 
This hypothesis explores whether self-perceived stigma contributes uniquely to 
psychological difficulty (assessed with The Total Difficulties Scale of the SDQ) in 
young people with SCD. The Total Difficulties Scale of the SDQ is the sum of four of 
the five subscales of the SDQ (emotional, conduct, peer problems, and hyperactivity 
subscales).  
 
In the ensuing analysis the Total Difficulties subscale of the SDQ is considered the 
dependent variable. The first step in exploring this hypothesis is to establish if The 
Total Difficulties subscales of the SDQ is significantly associated with self-perceived 
stigma. This association was established in Section II (Table 5.32) and in Table 5.52 
below. The next step is to identify other independent variables significantly associated 
with Total Difficulties Scale of the SDQ that could confound the relationship with 
self-perceived stigma. Table 5.52 shows a correlation matrix of the Total Difficulties 
scale of the SDQ and potential independent variables. Self-perceived stigma was 
included in the correlation matrix (Table 5.52) to ease the identification of potential 
confounders, which are variables that correlate with both Total Difficulties Scale of 
SDQ and self-perceived stigma. Table 5.52 shows that Frequency of ward admissions 
and attitude towards SCD meet this criterion for confounding; hence they will be 
included as covariates in the multivariate analysis. Given that leg ulcer had shown 
significant association with stigma in bivariate analysis (Table 5.28), and that 
previous studies have shown associations between, age, gender, family function and 
psychological difficulty in children, these variables were also included as covariates. 
Although depressive symptoms and self esteem correlated strongly with SDQ (data 
not shown), the former two variables were not considered for inclusion because they 
measure overlapping aspects of psychological function or wellbeing. Overall, the 
number of predictor variables included in this regression analysis (i.e. 7) is within the 
range of stringency described earlier for the sample size of this study. 
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Table 5.52. Bivariate correlation coefficients between SDQ and potential 
predictor variables. 
 
    SDQ 
Stigma 
(dimensional) 
SDQ R .52(**)
  N 76
Stigma (dimensional) R .51**
  N 76
Age R -.15 -.09
  N 76 86
Gender r* .04 .18
  N 77 88
OPCS r* .21 .07
  N 70 78
Born in UK r* .05 .20
  N 78 89
Frequency of ward 
admissions 
r* .30** .34**
  N 76 85
Ulcer r* -.14 -.19
  N 76 87
Receipt of counselling r* -.14 -.17
  N 78 88
Family Function R .341(**) .205
  N 70 77
Attitude towards Illness R -.542(**) -.329(**)
  N 75 86
r = Pearson correlation coefficients, r* = Spearman rho correlation coefficients 
**  Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
Coding: Gender- male = 1, female = 2; Born in UK – yes = 1, no = 2, leg ulcer – yes = 1, no = 
2 
 
 
This hypothesis could be tested with either multiple regression or ANCOVA. The 
data was explored with both methods and similar results were obtained. The 
ANCOVA showed no significant interactions; hence the output from multiple 
regression is presented here. Standard “simultaneous” regression method was used as 
there was no theoretical justification to adopt either a hierarchical or a stepwise 
method. The results are shown in Tables 5.53(a,b,c). 
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Table 5.53a. Model Summary 
 
Model R R Square 
Adjusted 
R Square 
Std. Error of 
the Estimate 
Durbin-
Watson 
1 .69(a) .48 .42 4.07 2.23 
a  Predictors: (Constant), Family function, Age, Leg ulcer, Frequency of ward admissions, 
Gender, Stigma, Attitude toward illness 
b  Dependent Variable: SDQ 
 
 
Table 5.53b. ANOVA 
 
Model   
Sum of 
Squares Df Mean Square F Sig. 
1 Regression 947.06 7 135.29 8.15 .000(a) 
  Residual 1028.58 62 16.59    
  Total 1975.65 69     
a  Predictors: (Constant), Family function, Age, Leg ulcer, Frequency of ward admissions, 
Gender, Stigma, Attitude toward illness 
b  Dependent Variable: SDQ 
 
 
Table 5.53c. Coefficients 
 
Mode
l   
Unstandardised 
Coefficients 
Standardised 
Coefficients   
Collinearity 
Statistics 
    B Std. Error Beta t  Sig. Tolerance VIF 
1 (Constant) 14.02 6.91  2.028 .047   
  Stigma .99 .31 .33 3.179 .002 .77 1.29
  Frequency 
of ward 
admission 
.47 .40 .12 1.165 .249 .76 1.30
  Leg ulcer -.22 2.29 -.01 -.098 .922 .85 1.17
  Attitude 
towards 
Illness 
-.17 .05 -.33 -3.214 .002 .76 1.30
  Age -.28 .23 -.11 -1.188 .239 .93 1.06
  Gender -.87 1.08 -.08 -.811 .420 .81 1.23
  Family 
Function .21 .10 .19 1.973 .053 .83 1.20
a  Dependent Variable: SDQ 
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Figure 5.3.  
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In summary, a standard simultaneous multiple regression was used to test the ability 
of self-perceived stigma to predict scores on the Total Difficulties Scale of the SDQ 
independent of other potential confounding variables (Age, Gender, leg ulcer, 
frequency of admissions, family function, and attitude towards SCD).  
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The model as a whole explained 48% of the variance in the Total Difficulties Scale of 
the SDQ F(7, 62) =  8.2, p < 0001. Only self-perceived stigma and attitude towards 
SCD were statistically significant and independent predictors of Total Difficulties 
Scale of the SDQ. Attitude towards SCD recorded a slightly higher beta value (beta = 
- 0.34, p = 0.02) than self-perceived stigma (beta = 0.33, p = 0.02). Thus these 
findings provide support for the hypothesis “Self perceived stigma will significantly 
and independently predict Total difficulties score on the Strengths and Difficulties 
Questionnaire (SDQ)”. 
 
The analysis was checked to ensure that the assumptions for multiple regression 
(Field 2005) such as Durbin-Watson statistic of 2.2 in Table 5.53a, which indicates no 
autocorrelation in the residuals, Tolerance values between 0.77-0.94 in Table 5.53c 
and Variance Inflation Factors (VIF) in the range of 1.2-1.3 in Table 5.53c. Also, the 
Normal P-P plot of residuals (Figure 5.3) follow a 45º angle indicating that the 
assumption of normality was not violated. 
 
Third hypothesis 
Self perceived stigma will significantly and independently predict Depressive 
symptoms as measured by SMFQ 
 
In addition to psychological difficulty, which was assessed with the SDQ, the study 
also obtained data on a specific psychopathology (depression). This hypothesis 
therefore explores whether self-perceived stigma contributes uniquely to depressive 
symptoms (assessed with the Short Mood and Feelings Questionnaire – SMFQ).  
 
This hypothesis was assessed with a standard multiple regression with the Short 
Mood and Feelings Questionnaire score as the dependent variable. The first step 
in the analysis is to establish if SMFQ is significantly associated with self-perceived 
stigma. This association was established in Section II (Table 5.33) and in Table 5.54 
below. The next step is to identify other independent variables significantly associated 
with SMFQ that could confound the relationship with self-perceived stigma. Table 
5.54 shows a correlation matrix of SMFQ and potential independent variables. 
Potential confounders are variables that correlate significantly with both SMFQ and 
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self-perceived stigma. Table 5.54 shows that attitude towards SCD, and frequency of 
ward admission met this criterion to be included as covariates in the regression 
analysis. However, given that gender, birth in UK, and family function correlated 
significantly with SMFQ (Table 5.54) and leg ulcer showed statistical significance in 
bivariate comparison with depressive symptoms (data not shown), these four variables 
were included as additional covariates. Also as previous studies have shown 
association between age and depression, age was also included as a covariate.   
 
The analysis presented here is standard multiple regression. However, the analysis 
was repeated with ANCOVA to explore for interactions. No significant interactions 
were seen and the ANCOVA model was similar to the regression model; hence only 
outputs from the latter are presented (Tables 5.54a,b,c). 
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Table 5.54. Correlation matrix between depression, self-perceived stigma and 
other predictor variables 
 
    Depression (SMFQ) Stigma (dimensional) 
Depression (SMFQ) R .39** 
  N 86 
Stigma (dimensional) R .39**  
  N 86  
Age R .05 -.09 
  N 85 86 
Gender R* .32** .18 
  N 87 88 
OPCS-SES R* .13 .07 
  N 77 78 
Sibling has SCD R* .003 -.04 
  N 87 88 
Born in UK R* .23* .20 
  N 88 89 
Leg ulcer R* -.19 -.19 
  N 86 87 
Family function  R .43** .21 
  N 78 77 
Attitude towards Illness R -.52** -.33** 
  N 85 86 
Frequency of ward admissions R* .42** .33** 
  N 85 86 
r * = Spearman rho correlation coefficient. r = Pearson correlation coefficient 
**  Correlation is significant at the 0.01 level (2-tailed). 
*  Correlation is significant at the 0.05 level (2-tailed). 
Coding: Gender- male = 1, female = 2; sibling has SCD – yes = 1, no = 2; Born in UK – yes = 1, no = 2; leg ulcer 
– yes = 1, no = 2 
 
 
Table 5.55a. Model Summary 
 
Model R R Square 
Adjusted 
R Square 
Std. Error of 
the Estimate 
Durbin-
Watson 
1 .69(a) .47 .41 3.04 2.00 
a  Predictors: (Constant), Frequency of admission, Age, Family function, Born in UK, Leg 
ulcer, Gender, Stigma, Attitude towards illness,  
b  Dependent Variable: Depression 
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Table 5.55b. ANOVA 
 
Model   
Sum of 
Squares df Mean Square F Sig. 
1 Regression 559.42 8 69.93 7.54 .000(a) 
  Residual 621.46 67 9.28    
  Total 1180.88 75     
a  Predictors: (Constant), Frequency of admission, Age, Family function, Born in UK, Leg 
ulcer, Gender, Stigma, Attitude towards illness,  
b  Dependent Variable: Depression 
 
 
 
 
 
 
 
Table 5.55c. Coefficients 
 
Model   
Unstandardised 
Coefficients 
Standardised 
Coefficients   
Collinearity 
Statistics 
    B 
Std. 
Error Beta T Sig. Tolerance  VIF  
1 (Constant) 1.40 5.03  .28 .78    
  Gender .98 .79 .12 1.24 .22 .78 1.28
  Leg ulcer -.81 1.64 -.05 -.49 .62 .85 1.17
  Attitude 
towards 
illness 
-.11 .04 -.29 -2.86 .006 .73 1.37
  Age .07 .17 .04 .39 .69 .91 1.09
  Born in 
UK .03 .89 .003 .03 .98 .83 1.21
  Family 
Function .19 .08 .24 2.44 .02 .82 1.21
  Stigma .28 .22 .13 1.26 .21 .76 1.31
  Frequency 
of 
admission 
.71 .29 .24 2.40 .02 .76 1.31
a  Dependent Variable: Depression  
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Figure 5.4 
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In summary, a standard simultaneous multiple regression was used to test the ability 
of self-perceived stigma to predict depressive symptoms (scores on SMFQ) 
independent of other potential confounding variables (Age, Gender, leg ulcer, 
frequency of admissions, family function, birth in or outside UK, and attitude towards 
SCD).  
 
The model as a whole explained 47% of the variance in SMFQ scores F(8, 67) =  7.5, 
p < 0001. The statistically significant and independent predictors of SMFQ scores 
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were; attitude towards SCD (beta = -0.30, p = 0.006), family function (beta = 0.24, p 
= 0.017, and frequency of ward admissions (beta = 0.24, p = 0.019. 
 
Thus these findings DO NOT provide support for the hypothesis “Self perceived 
stigma will significantly and independently predict Depressive symptoms as 
measured by SMFQ”. 
 
The analysis met the assumptions for multiple regression (Field 2005) such as Durbin-
Watson statistic of 2.0 in Table 5.55a, which indicates no autocorrelation in the 
residuals, tolerance values between 0.73-0.92 in Table 5.55c and Variance Inflation 
Factors (VIF) in the range of 1.1-1.4 in Table 5.55c. Also, the Normal P-P plot of 
residuals (Figure 5.4) follow a 45º angle indicating that the assumption of normality 
was not violated. 
 
 
Fourth hypothesis 
Self perceived stigma will significantly and independently predict Self Esteem 
measured by Rosenberg Scale  
 
This hypothesis explores whether self-perceived stigma contributes uniquely to self 
esteem (assessed with Rosenberg Scale).  
 
This hypothesis was assessed with a standard multiple regression with Self esteem as 
the dependent variable. Section II (Table 5.34) and Table 5.56 below show 
statistically significant association between self esteem and self-perceived stigma. The 
next step is to identify other independent variables significantly associated with Self 
esteem that could confound the relationship with self-perceived stigma. Table 5.56 
shows a correlation matrix of Self-esteem and potential independent variables. As 
previously explained, potential confounders are variables that correlate significantly 
with both Self esteem and self-perceived stigma. Table 5.56 shows that frequency of 
ward admissions and attitude towards SCD met this criterion to be included as 
covariates. Gender, family function, receipt of counselling and source of recruitment 
were included as additional covariates as they correlated significantly with self 
esteem.  
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The analysis presented here is standard multiple regression. When the analysis was 
repeated with ANCOVA, no significant interactions were seen and the ANCOVA 
model was similar to the regression model; hence only outputs from the latter are 
presented (Tables 5.57a,b,c). 
 
Table 5.56. Bivariate Correlations between self esteem and potential predictors 
 
    Self esteem 
Stigma 
(dimensional) 
Self esteem  R -.29** 
  N 78 
Stigma (dimensional) R -.29**  
  N 78  
Gender R* -.33** .18 
  N 79 88 
OPCS R* -.12 .07 
  N 72 78 
Age R .02 -.09 
  N 77 86 
Sib has SCD R* -.11 -.04 
  N 79 88 
Born in UK R* -.12 .20 
  N 80 89 
Frequency of admission R* -.35** .33** 
  N 77 86 
Leg ulcer R* .04 -.19 
  N 78 87 
Family function R -.48** .21 
  N 72 77 
Attitude towards SCD R .48** -.33** 
  N 79 86 
Receipt of counselling R* .24* -.17 
  N 79 88 
Source of recruitment R* .22* .02 
  N 80 89 
r* = Spearman rho correlation coefficient. r = Pearson correlation coefficient 
**  Correlation is significant at the 0.01 level (2-tailed). 
*  Correlation is significant at the 0.05 level (2-tailed). 
Coding: Gender- male = 1, female = 2; sibling has SCD – yes = 1, no = 2; Born in UK – yes = 
1, no = 2; leg ulcer – yes = 1, no = 2; receipt of counselling – yes = 1, no = 2; source of 
recruitment – haematology clinic = 1, Sickle Cell Society = 2 
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Table 5.57a. Regression Model Summary 
 
Model R R Square 
Adjusted 
R Square 
Std. Error of 
the Estimate 
Durbin-
Watson 
1 .69(a) .48 .42 3.80 1.7 
a  Predictors: (Constant), Stigma, Source of recruitment, Family function, Receipt of 
counselling, Frequency of admission, Gender, Attitude towards illness. 
b  Dependent Variable: Self esteem 
 
 
 
Table 5.57b. ANOVA 
 
Model   
Sum of 
Squares df Mean Square F Sig. 
1 Regression 859.11 7 122.73 8.47 .000(a) 
  Residual 926.45 64 14.47    
  Total 1785.56 71     
a  Predictors: (Constant), Stigma, Source of recruitment, Family function, Receipt of 
counselling, Frequency of admission, Gender, Attitude towards illness. 
b  Dependent Variable: Self esteem 
 
 
 
Table 5.57c. Regression Coefficients 
 
Model   
Unstandardised 
Coefficients 
Standardised 
Coefficients   
Collinearity 
Statistics 
    B 
Std. 
Error Beta T Sig. B VIF  
1 (Constant) 29.57 4.51  6.55 .000    
  Source of 
recruitment 2.75 1.03 .24 2.66 .010 .96 1.04
  Gender -2.32 .98 -.23 -2.36 .021 .84 1.19
  Frequency of 
admissions -.32 .37 -.09 -.86 .391 .79 1.26
  Family 
function -.29 .09 -.29 -2.99 .004 .83 1.19
  Attitude 
towards SCD .14 .05 .29 2.78 .007 .75 1.33
  Receipt of 
counselling 2.06 1.49 .13 1.38 .172 .92 1.09
  Stigma -.09 .28 -.03 -.32 .747 .79 1.27
a  Dependent Variable: Self esteem  
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Figure 5.5 
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In summary, a standard simultaneous multiple regression was used to test the ability 
of self-perceived stigma to predict self esteem independent of other potential 
confounding variables (Source of recruitment, Gender, frequency of admissions, 
family function, attitude towards SCD, and receipt of counselling).  
 
The model as a whole explained 48% of the variance in Self esteem scores F(7, 64) =  
8.5, p < 0001. The statistically significant and independent predictors of self esteem 
scores were; source of recruitment (beta = 2.8, p = 0.01), gender (beta = -2.3, p = 
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0.02), family function (beta = -0.29, p = 0.004, and attitude towards SCD (beta = 0.14, 
p = 0.007). 
 
Thus these findings DO NOT provide support for the hypothesis “Self perceived 
stigma will significantly and independently predict Self Esteem measured by 
Rosenberg Scale”. 
 
Depression and self esteem are closely related and low self esteem is a criterion 
diagnostic symptom for depressive disorder (WHO 1992). Bearing this in mind, the 
above regression analysis on self-esteem was repeated with depressive symptoms 
(SMFQ) included as a covariate (in place of stigma). Stigma was removed from the 
model when SMFQ was added in order to limit the number of covariates to a 
maximum of seven as previously explained. The inclusion of depression in the model 
is meant to explore if the independent predictors of self esteem identified earlier 
remained predictors even after taking depressive symptoms into account. The 
inclusion of SMFQ in the model made some difference in that gender and attitude 
towards SCD ceased to be significant predictors. The new model explained 56% of 
the variance in self esteem scores F(7, 64) =  11.7 p < 0001. The new statistically 
significant and independent predictors of self esteem scores were; depression (beta = -
0.51, p = 0.001, source of recruitment (beta = 2.0, p = 0.047), and family function 
(beta = -0.20, p = 0.038. 
 
The above finding suggests that exploring self-esteem in its own right rather than just 
as a symptom of depression is worthwhile. This significance is demonstrated by the 
fact that recruitment from Sickle Cell Society and healthy family function predicted 
self-esteem over and above the presence of depressive symptoms. 
 
The finding that attitude towards SCD ceased to predict self-esteem when depression 
was included in the model suggest that negative attitudes towards SCD may be more 
relevant as a contributor to active psychological and emotional difficulties (e.g. as 
measured by SDQ and SMFQ) rather than to self-esteem (which is a background 
psychological state or trait).  
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Also, nullification of the predictive ability of attitude towards SCD on self-esteem in 
the presence of depression is not entirely surprising given that, intuitively, young 
people with SCD who have depressive symptoms are more likely to have a negative 
attitude towards the disorder they see as being responsible for their depression. This 
view is supported by a large correlation between depressive symptoms (SMFQ) and 
attitude towards SCD (CATIS), (r = -0.52, p = 0.001). 
 
Summary of multivariate analyses 
The multivariate analyses found support for two of the four study hypothesis. 
Hierarchical regression provided support for the first hypothesis that presence of leg 
ulcer (visibility) and frequency of ward admissions (disruptiveness)) will predict 
levels of self perceived stigma. Regression analysis also provided support for the 
second study hypothesis that self perceived stigma will predict SDQ Total difficulties 
score. The hypotheses that self perceived stigma will predict depressive symptoms 
was not supported. Instead, more depressive symptoms were predicted by poorer 
attitude towards SCD, unhealthy family function, and frequent ward admissions. 
Similarly, the hypothesis that self perceived stigma will predict self esteem was not 
supported by multivariate analysis. Instead, higher self esteem was predicted by 
recruitment from Sickle Cell Society, male gender, healthy family function and 
positive attitude towards SCD. Recruitment from Sickle Cell Society and healthy 
family function remained significant predictors of better self-esteem even when 
depressive symptoms were included as a covariate. 
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Chapter 6 
 
Discussion 
 
This chapter is discussed under the following subheadings: 
6.1.   Introduction and summary of main findings 
6.2.   Stigma: prevalence and correlates in SCD 
6.2.1. Stigma prevalence 
6.2.2. Application of study findings to stigma theory 
6.2.3. Significance of leg ulcer in SCD 
6.3.   Prevalence and predictors of psychological difficulties (SDQ) in SCD 
6.3.1. Prevalence of psychological difficulty 
6.3.2. Association between stigma and psychological difficulty 
6.3.3. Relationship between attitude to illness and psychological difficulty 
6.4. Prevalence and predictors of depressive symptoms 
6.4.1. Prevalence of depressive symptoms 
6.4.2. Family function and depression 
6.4.3. Illness severity and depression 
6.4.4. Attitude to SCD and depression 
6.4.5. Depression and stigma 
6.4.6. Depression and receipt of counselling 
6.5. Level and predictors of self esteem in SCD 
6.5.1. Level of self esteem in SCD 
6.5.2. Association between source of recruitment and stigma 
6.5.3. Gender and self esteem 
6.5.4. Family function and self esteem  
6.5.5. Attitude to illness and self esteem 
6.5.6. Stigma and self esteem 
6.6. Methodological issues and limitations 
6.6.1. Reliability 
6.6.2. External validity  
6.6.3. Limitations 
6.7. Summary 
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6.1 Introduction and summary of main findings. 
The aims of this study were to estimate the prevalence of self-perceived stigma in 
young people with SCD and to explore associations between self-perceived stigma 
and illness, psychosocial, and socio-demographic variables. These aims were achieved 
with a cross-sectional questionnaire survey of 93 young people with SCD aged 10-19 
years. To my knowledge some of the findings of this study are unique and have not been 
previously reported among people with SCD. The main findings are summarised next. 
 
• Only 15% of the respondents met the study criteria for directly measured self-
perceived stigma. However, indirect assessment of self perceived stigma based on 
disclosure practices (e.g. keeping SCD secret) suggests a much higher level of 
perceived stigma (57%) in the current study. 
 
• Consistent with stigma theory, the study found that high self-perceived stigma was 
independently and significantly predicted by presence of leg ulcer (measure of 
visibility), and increased frequency of ward admissions (measure of 
disruptiveness). As far as I am aware, this is the first time stigma theory has been 
successfully applied to SCD. 
 
• Compared with SDQ UK norms, young people with SCD in this study scored 
significantly higher on the emotional subscale of the SDQ (p=0.0008). The 
prevalence of SDQ-caseness (caseness for psychological difficulty) among young 
people with SCD (15.4%) is slightly higher compared with young black boys and 
girls in London (9.2% and 10.9% respectively) but the difference was not 
statistically significant (p=0.078). 
 
• More psychological difficulty was independently and significantly predicted by 
high self-perceived stigma and negative attitude to illness. The independent 
contribution of self-perceived stigma to psychological difficulty in SCD is another 
unique finding of the study. 
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• The prevalence of depressive symptoms and caseness for depression (depression-
positive) in the young people with SCD were similar or lower compared with 
young black people in London  
 
• Contrary to my hypothesis, depressive symptoms were not predicted by self-
perceived stigma. However, increased depressive symptoms were independently 
and significantly predicted by unhealthy family function, increased frequency of 
ward admissions (index of severity), and negative attitude towards SCD.  
 
• Only 18.8% of the children who were classified as depression-positive were in 
receipt of counselling. Also there was no statistically significant difference in receipt 
of counselling between the depression-positive and depression-negative cases.  
   
• The young people with SCD achieved self esteem scores that were similar to 
young people without SCD in three other developed countries 
 
• Contrary to my hypothesis, self-perceived stigma was not an independent 
predictor of self-esteem among young people with SCD. However higher self-
esteem was significantly predicted by source of recruitment (respondents from 
Sickle Cell Society had higher self esteem than those from haematology clinics, 
gender (males higher than females), healthy family function, and positive attitude 
towards SCD. The predictive ability of gender and attitude towards SCD was 
nullified when depression was included in the regression model for self-esteem. 
However, source of recruitment and family function remained predictors of self-
esteem independent of depressive symptoms.  
 
• Given that the Sickle Cell Society is an advocacy organisation, the children 
recruited through the organisation were compared with those recruited from 
haematology clinics on self-perceived stigma and all psychological measures to 
see if they had different responses. Apart from self-esteem, there were no 
statistically significant differences between the two groups on psychological 
measures. 
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6.2. Stigma: prevalence and correlates in SCD 
6.2.1. Stigma prevalence 
Only 15% of the young people with SCD were classified as having self-perceived 
stigma in this study. These were the respondents who gave positive endorsement to 
one or more of the three direct stigma questions. To put this in perspective, the 
responses of the young people with SCD in this study were compared with those of 
young people with epilepsy (Westbrook et al 1992) and stuttering (Blood et al 2003), 
which used similar methodology (Table 5.20). 
 
In response to the question “Do you think that having Sickle Cell affects whether 
people want to be friends with you?” 73% of the children with SCD in this study 
stated that this was “never” the case. The proportions of children with epilepsy and 
stuttering who gave the same answer are 66% (Westbrook et al 1992) and 65% (Blood 
et al 2003) respectively. Similarly, in response to the question, “Do you think that 
having Sickle Cell affects whether people like you or not?” 84% of the children with 
SCD stated that this was “never” the case. The proportions for children with epilepsy 
and stuttering are 60% and 63% respectively. These comparisons show that children 
with SCD in this study consistently endorsed less direct perception of stigma 
compared with children with epilepsy or stuttering.  
 
Several reasons can account for the differential responding to these direct questions 
assessing the prevalence of self-perceived stigma (with respect to being liked by other 
children or not) by children with SCD in this study compared with children with 
epilepsy and stuttering  
 
The first possibility is that children with SCD may genuinely not perceive stigma as 
much as children with epilepsy or stuttering. This possibility has some support from 
stigma theory. As outlined in Chapter 2, conditions that are more visible tend to be 
more stigmatising than those with less visible features. Although SCD, epilepsy and 
stuttering all have visible features, it could be argued that for most affected persons in 
developed countries like the UK (with access to advanced medical care), SCD may be 
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less visible than epilepsy and stuttering. While some children with epilepsy may have 
infrequent seizures, each fit; especially grand mal seizures can be very dramatic and 
highly visible. Similarly, children with stuttering demonstrate evidence of their 
difficulty with almost every verbal communication. 
 
Another possible explanation for the different prevalence is socially desirable 
responding by the children with SCD. However, there is no good evidence that 
children with SCD are more prone to socially desirable responding than children with 
epilepsy or stuttering. Neither this study nor the studies by Westbrook and colleagues 
or Blood and colleagues incorporated measures of socially desirable responding. So 
this hypothesis cannot be tested directly at present.  
 
Differences in context could be another reason for the observed differences in 
prevalence of self-perceived stigma between children with SCD and those with 
epilepsy or stuttering. The latter two studies were conducted in the United States 
among predominantly white children, whereas this study was conducted in the UK 
among predominantly black children. I am not aware of any data on the differential 
perception of stigma among different ethnic groups or countries, but such a difference 
is possible. However, given the possible association between stigma and racism 
(Scambler 2004), a higher prevalence of self-perceived stigma among black children 
and young people could be expected. Instead, I found the opposite. 
 
We also used questions on disclosure behaviour as indirect measures of self-perceived 
stigma. Unlike the direct questions on self-perceived stigma, more of the children and 
young people with SCD in this study positively endorsed the disclosure questions. For 
example, 54% reported that they keep their SCD secret “sometimes” or “often”. This 
compares with 53% for children with epilepsy (Westbrook et al 1992) and 40% for 
children with stuttering (Blood et al 2003). Also 57% of children with SCD in this 
study reported that they “rarely” or “never” talk to other people about having SCD. 
This figure compares with 70% of children with epilepsy and 60% of children with 
stuttering. Thus, although the prevalence of directly measured self-perceived stigma 
(with regards to being liked by other children) was lower among children with SCD, 
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indirect evidence from “disclosure questions” suggests that the prevalence of self-
perceived stigma is closer to children with epilepsy or stuttering.   
 
In summary, when self-perceived stigma is assessed directly by measures of being 
liked by other children, fewer children with SCD appear to perceive stigma compared 
with children with epilepsy or stuttering. However, when measured indirectly, similar 
proportions of children in all three disorder groups appear to perceive stigma. This 
observation provides some indirect support for the suggestion in an earlier paragraph 
(above) that socially desirable responding by children with SCD may account for their 
lower endorsement of direct questions on perceived stigma compared with the other 
two groups. One way to explore this further is a head-to-head study of self-perceived 
stigma among children with SCD and the other disorders with an instrument that 
incorporates a measure of socially desirable responding. 
 
6.2.2. Application of study findings to stigma theory 
The findings of this study provide support for the application of stigma theory to 
SCD. As outlined in Chapter 2, stigma dimensions are the characteristics that 
determine the stigma potential of conditions like SCD (Katz 1981, Jones et al 1984). 
The stigma dimensions that are relevant here are “visibility” and “disruptiveness”.  
 
Visibility refers to the extent that SCD has attributes that are obvious, not 
concealable, or aesthetically challenging to others. In general, stigma theory predicts 
that the more visible and disfiguring an attribute the more stigmatising it is likely to 
be. Some people with SCD have easily recognisable physical manifestations such as 
jaundice, leg ulcers, and delayed physical development (Dick 2008). Severe cases, 
especially in developing countries where effective treatments are not widely available, 
may be associated with gross physical signs such as gnathopathy (Wessberg et al. 
1980), and bossing of the forehead (Acquaye et al. 1985). While widespread access to 
advanced medical treatment in the UK makes such gross physical signs unlikely, 
many affected persons in the UK still have obvious signs of the disease. In this study, 
almost half of the subjects (46.1%) were jaundiced but very few (5.6%) had leg ulcer.   
Jaundice was not associated with self-perceived stigma in bivariate analysis but leg 
 149
ulcer was; hence the latter was used as the measure of visibility in multivariate 
analysis. 
 
The stigma dimension of “Disruptiveness” describes the extent to which having SCD 
interferes with personal functioning and interpersonal relationships of affected 
persons. The findings of this study support the well recognised fact that the natural 
course of SCDs is variable such that while many affected persons live relatively 
healthy undisrupted lives, others require frequent hospitalisation as a result of 
different acute illness episodes particularly pain (Wethers 2000). For example, 38.6% 
of the respondents in this study had had no ward admissions in the past year while 
16% had five or more admissions. In addition, some affected persons may experience 
even more frequent but less severe episodes of pain not requiring hospital admission 
but nonetheless necessitating rest at home. The limitations imposed by these illness 
episodes could be disruptive to schooling, employment, and social encounters (Atkins 
and Ahmad 2001). For example, 23.3% of the respondents in this study had had four 
weeks or more of school absence in the previous year. The disruptiveness engendered 
by these frequent admissions, pain and school absence make concealment of having 
SCD difficult and increase the threat of unwanted disclosure. 
 
In this study, visibility was assessed with presence of leg ulcer, while disruptiveness 
was assessed with frequency of ward admissions. As predicted by stigma theory, both 
measures were independent and significant predictors of self-perceived stigma. This is 
the first study that I am aware of to show a direct application of stigma theory to SCD. 
 
6.2.3. Significance of leg ulcer in SCD 
As already highlighted above, this study found that leg ulcer independently predicted 
self perceived stigma. Leg ulceration is a severely disabling complication of SCD 
associated with the most severe forms of the disease (Halabi et al 2008). The ulcers 
are chronic with up to 40% having open wounds for over a year (Briggs and 
Flemming 2007) and a median duration of 29 months even in developed countries 
(Halabi et al 2008). In a study of risk factors for leg ulcers in people with SCD in 
Jamaica, Cumming and colleagues found the predictors of ulceration to include low 
socio-economic status and biological variables such as high lactate dehydrogenase 
and venous incompetence (Cumming et al 2008). The prevalence of leg ulcer in that 
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study was 29%, which is considerably higher than the 6% found in the current study. 
This difference may reflect access to advanced treatment for SCD in the UK 
compared with Jamaica. 
 
In addition to being a marker for severity, leg ulceration has been directly associated 
with social difficulties in SCD in other studies. For example, in an early study in 
Jamaica, Alleyne and colleagues found that compared with a control group with no 
leg ulceration, the ulcer-affected group experienced wide ranging adverse 
psychosocial effects on education, employment, and marriage (Alleyne et al. 1976).  
 
Given the specific association shown in this study between leg ulcer and self 
perceived stigma, leg ulceration could be seen as a specific physical indicator of 
increased psychosocial vulnerability. Incidentally, in the current study, leg ulcer had 
statistically significant bivariate associations with the emotional subscale of the SDQ, 
depressive symptoms, and poor attitude towards SCD. These findings would suggest 
that more effective treatment of leg ulcer could contribute to improved psychological 
well-being in SCD. There is in fact evidence that intensive combination of several 
treatment modalities can achieve rapid healing of chronic leg ulcer in people with 
SCD (Schleucher et al 2007). 
 
6.3.   Prevalence and predictors of psychological difficulty (SDQ)  
6.3.1. Prevalence of psychological difficulty 
In this study, psychological difficulty was assessed with the self-report version of the 
Strengths and Difficulties Questionnaire (SDQ). The SDQ produces a Total Difficulties 
Scale in addition to five other subscales (Emotional, Hyperactivity, Conduct, Peer 
problems, and Prosocial). I used the cut-off of ≥ 18 on the Total Difficulties Scale to 
define SDQ-caseness as this cut-off gave prevalence figures in the British Child and 
Adolescent Mental Health Survey (Meltzer et al 2000) that were equivalent to the 
prevalence found using data from multiple sources including parents and teachers. 
The same cut-off was also used in a more recent UK epidemiological study (Stansfeld 
et al 2004). Based on this cut-off, the proportion of young people with SCD classified 
as SDQ-cases (15.4%) was higher compared with black boys or girls in East London 
schools (9.2% and 10.9% respectively) (Stansfeld et al 2004). However, the 
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difference was not statistically significant (p=0.078). I am not aware of any other 
SCD-related study that has used the SDQ as a measure of psychological difficulty. 
 
In relation to the SDQ subscales, a comparison of the mean scores by young people with 
SCD in this study and the UK norms showed statistically significant differences in three 
subscales (emotional, hyperactivity and prosocial scales). Conduct and peer problems 
subscales were not significantly different. 
 
For the three subscales with significant differences, young people with SCD scored 
higher on the emotional subscale and lower on both the hyperactivity and prosocial 
subscales.  
 
Large epidemiological studies of childhood mental disorders (e.g. Meltzer et al 2000) 
consistently find increased risk of psychopathology among children with chronic 
physical. Children with disorders that involve the brain (like SCD) are particularly at 
higher risk. For example, Pegelow and colleagues found that up to 20% of people 
with SCD have evidence of ischaemic brain damage on MRI by the age of 20 years 
(Pegelow et al 2002). Thus, compared with UK norms, the higher score on the SDQ-
emotional subscale by young people with SCD may be partly related to overt or 
covert ischaemic brain damage. In additional to bio-medical causes, other 
psychosocial factors (e.g. cognitive and educational, family and wider interpersonal 
relationships) may be contributing to the observed difference.  
 
As discussed in Chapter 2, studies of psychopathology in SCD tend to give different 
results depending on whether the samples are from developed or developing 
countries. In general, the trend suggests that more recent studies in developed 
countries find no increased rates of psychopathology while studies in developing 
countries continue to show higher rates compared with unaffected control groups. 
Helps and colleagues suggest that this differential trend might be due to easy access to 
advanced physical care for people with SCDs in developed countries (Helps et al 
2003). Bearing this in mind, the prevalence of psychopathology in this study will only 
be compared with previous studies in developed countries.  
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Thus, on the whole, recent studies in developed countries show closer to normative 
levels of psychopathology in SCDs. For example, a study of affected children in USA 
(Noll et al 2007) found no differences in measures of emotional wellbeing compared 
with their unaffected peers. In this study, teachers described the children with SCDs 
as more prosocial and less aggressive. These results are similar to what the authors 
found 10 years earlier (Noll et al 1996).  
 
Another study of adolescents with SCDs in USA (McElligott 2006) found that 
affected young people did not score higher than the norms in different measures of 
self esteem, anxiety, depression and behavioural difficulties. Further, a longitudinal 
study, which followed children with SCDs in USA for up to 10 years found no 
differences in measures of depression, self worth and internalising symptoms 
compared with healthy peers either cross-sectionally or longitudinally (Getzoff 2005). 
In an earlier study in the UK involving 39 children with SCD and 24 controls, 
Midcence and colleagues (Midence et al 1996) found no significant differences 
between the two groups on depression and self esteem.  
 
Thus, the finding in this study of a statistically significant difference in the SDQ-
emotional subscale compared with UK norms is not in keeping with the trend of less 
psychopathology in recent studies in developed countries. There are six possible 
explanations for this difference. First, it is possible that the emotional subscale of the 
SDQ used in this study is a more sensitive measure compared with the questionnaires 
and methods of assessment used in the previous studies. Secondly, there could be 
relevant differences in the sampling of the young people with SCD and their reference 
groups. For example, this study compared the young people with SCD against UK 
national norms and reference groups, which were established 6-10 years earlier. This 
is different from the other studies in which the young people with SCD were 
compared with contemporary control or reference groups. Third, there could be 
cultural differences given that the three most recent comparison studies (Noll et al 
2007, McElligot 2006, and Getzoff 2005) were conducted among American children, 
while this study is on UK children. Fourth, my study has both community and clinic 
samples compared with two of the other studies (Noll et al 2007, Getzoff 2005) which 
were community samples. Although the two samples in my study did not differ 
significantly in stigma or psychopathology, the trend was for more depressive 
 153
symptoms in the clinic sample and the clinic sample in my study had significantly 
lower self esteem. Fifth, whereas my sample did not exclude children with overt brain 
involvement, at least one of the comparison studies (Noll et al 2007) included only 
children with SCDs who had not had an overt stroke. Finally, this could be a false 
positive finding which has arisen by chance due to the multiple statistical tests in the 
Thesis. It is recognised that if multiple statistical tests are conducted at 5% level of 
significance, there is a 1 in 20 chance of a false positive finding.  
 
 
6.3.2 Association between stigma and psychological difficulty 
Consistent with my hypothesis, regression analysis (Table 5.53c) showed that self-
perceived stigma independently and significantly predicted scores on the Total 
Difficulties scale of the SDQ. To my knowledge, this is the first study to demonstrate 
this association between stigma and psychological difficulty in SCD. 
 
This finding is consistent with previous studies of self-perceived stigma and other 
physical disorders with recognised stigma potential. For example, several studies have 
shown associations between self-perceived stigma and higher levels of psychological 
and emotional distress in psoriasis (Richards et al 2001, Leary et al 1998), vitiligo 
(Kent 2000), and epilepsy (Westbrook et al 1992; Austin et al 2004; Adewuya et al 
2006). 
 
Several mechanisms can explain the association between self-perceived stigma and 
psychological difficulty in SCD. First, self-perceived stigma has been shown to 
increase a sense of demoralisation and alienation (Link and Phelan 2001). Applying 
this to SCD, it is possible that young people with SCD who perceive stigma may feel 
different from others, which further increases what Link and Phelan referred to as the 
“us and them” gap (Link and Phelan 2001), which in turn could lead to even more 
sense of alienation and a vicious negative cycle. For a young person who already has 
a serious, potentially life threatening illness, this sequence of events could lead to 
sustained psychological difficulty.  
 
Another mechanism associating self-perceived stigma and psychological difficulty is 
pervasive fear of unwanted disclosure of their SCD status. The fear of disclosure 
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could lead to avoidance behaviour such as social withdrawal and self isolation. 
Consistent with the cognitive behavioural theory, this sequence of events could set up 
a vicious cycle resulting in progressive increase in self-perceived stigma and 
worsening distress and self isolation. Link and colleagues have shown that self 
isolation is a common stigma management strategy for people with stigmatising 
conditions (Link et al 1991). Unfortunately, this is a maladaptive coping strategy with 
costly penalties in terms of peer relationships. This study provides support for this 
proposition. For example, the study showed that of the four subscales of the SDQ, the 
peer problems scale recorded the most difference between the young people with SCD 
who perceived stigma and those that did not perceive stigma (Table 5.32). An even 
greater support for this hypothesis is provided by the observation that peer problem 
does not appear to be a pervasive problem for all young people with SCD but rather a 
specific difficult for those who have self-perceived stigma. For example, Table 5.12 
shows that compared with UK norms, as a group, the young people with SCD did not 
differ from their peers on the peer problems scale of the SDQ. In fact, of the five SDQ 
subscales, the peer problem scale was one of the only two scales that did not differ 
between the young people with SCD and UK norms. Thus peer problems appear to be 
a specific difficulty only for the young people with SCD who perceive stigma. 
 
The significance of the finding in this study that self-perceived stigma predicts 
psychological difficulty in SCD is the possibility that intervening directly against self-
perceived stigma could reduce the risk of psychological difficulty in SCD. 
 
6.3.3 Relationship between attitude to illness and psychological difficulty 
Attitude towards SCD (measured by CATIS) was a statistically significant 
independent predictor of Total Difficulties Scale of the SDQ. This is another unique 
finding, which has not been shown previously among children with SCD. 
 
This finding shows that young people’s attitude towards having SCD can influence 
their psychological adjustment or vice versa. This is consistent with studies of young 
people with other chronic physical conditions like epilepsy, asthma, and diabetes 
mellitus, which show association between negative attitude towards illness and a 
range of adverse psychological outcomes including depression, behaviour problems 
and low self esteem (Austin and Huberty 1993, Amer 2008).  
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It is possible that young people with negative attitude toward SCD could see the 
disorder and associated disruptions as frequent intrusions on daily life. This view of 
their circumstance could result in a perpetual sense of distress and inability to take up 
and maximise their periods of adequate health. On the other hand, a positive attitude 
toward SCD could help bolster young people’s resistance to risk factors for poor 
adaptation. For example, if a young person sees the limitations associated with having 
SCD as challenges that can be overcome, they would be more likely to actively seek 
and use opportunities to optimise their function and reduce impairment.  
 
 
6.4. Prevalence and predictors of depressive symptoms 
 
6.4.1. Prevalence of depressive symptoms 
Depressive symptoms were assessed with the Short MFQ. Caseness for depression 
(depression-positive) was determined by converting the Short MFQ scores into 
categorical classification using a cut-off score of ≥ 8.0. This cut-off was chosen 
because a previous UK study (Thapar and McGuffin 1998) found 8.0 to have 
optimum sensitivity and specificity for the self report version of the Short MFQ. Also 
the original psychometric study on the Short MFQ in USA found optimum sensitivity 
and specificity with a cut-off of 8.0 (Angold et al 1995). 
 
In this study, the whole sample of children with SCD had a Mean score on the Short 
MFQ of 4.5 with a standard deviation of 4.0. These figures are comparable to the 
mean Short MFQ scores of healthy UK twins (Mean (SD) 4.5 (5.2). Incidentally, the 
mean score for the whole sample of children with SCD in this study was much lower 
compared with the scores of UK twins clinically diagnosed with a depressive disorder 
(Mean (SD) 4.5(4.0) Vs 8.8(4.2).  
 
In this study, a cut-off of ≥ 8.0 on the Short MFQ identified 18% of the children with 
SCD as depression-positive cases. However, given the evidence that questions about 
somatic symptoms in screening questionnaires like the Children Depression Inventory 
(which is similar to the Short MFQ) lead to overestimation of depression in SCD 
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(Yang et al 1994), the actual proportion of children identified in this study as 
depression-positive cases may be lower than 18%.  
 
However, to put the prevalence of depression caseness in this study into perspective, I 
compared it with the prevalence of depression caseness reported in a community-
based survey involving Black adolescent children in London using the same cut-off of 
≥ 8.0 on the Short MFQ (Stansfeld et al 2004). These researchers reported a 
depression caseness of 17.2% for Black boys and 29.5% for Black girls (Stansfeld 
2004). Thus the prevalence among young people with SCD in this study is 
comparable to the reported prevalence for Black boys but much lower than the 
prevalence for Black girls in the community. However, this comparison should be 
taken with caution because the young people in my study appeared to be 
socioeconomically more advantaged than the Black children in the Stansfeld et al 
(2004) study (e.g. unemployed head of household 5% vs. 25% and car ownership 80% 
vs 70%). Also my sample had a wider age range (10-19 years) compared with the 
sample in Stansfeld et al (2004) 11-14 years.  I have focused the comparison with 
Black children because SCD affects predominantly people of African and Caribbean 
origin but the prevalence of depression caseness for White children in the same study 
was similar to Black children (Stansfeld et al 2004).  
 
The finding of no increased rates of depression in this study is consistent with the 
trend since the late 1990s whereby people with SCDs in developed countries have less 
psychopathology compared with previous decades and compared with affected 
persons in developing countries (see chapter 3). 
 
In summary, the findings from this study and the comparison with Black children in 
the UK suggest that with specific reference to depressive symptoms, children with 
SCD do not appear to have increased rates of depression caseness. However, as 
already discussed, unlike depression (measured by SMFQ), the young people with 
SCD in this study scored higher on the emotional subscale of the SDQ compared with 
UK population norms (Goodman et al 1998). These different findings indicate mixed 
results suggesting that the prevalence of some specific psychopathologies (e.g. 
depression) is not increased while the prevalence of more general emotional difficulty 
is increased in SCD. The difference in the findings could also be due to the different 
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symptoms targeted by the SDQ and SMFQ. For example, of the five items in the 
emotional subscale of the SDQ, four items are explicit measures of anxiety rather than 
depression. Thus, it is possible that anxiety related measures are more sensitive in 
SCD. In this study the emotional subscale of the SDQ proved more sensitive than the 
Total Difficulties scale and the other four subscales. 
 
This study found that female children had a statistically significantly higher score on 
the Short MFQ compared with males. This finding is consistent with other studies of 
depression in adolescence (e.g. Stansfeld et al 2004).  
 
Even though rates of depression were not increased against expected norms we found 
associations between depression and illness features which indicate that when 
depression is present in young people with SCD, it is shaped by the illness; hence 
depression may affect the management of SCD and its management is likely to 
require an understanding of the vicissitudes of SCD.  In the following paragraphs I 
discuss the psychosocial and illness associations of depression in our sample with 
SCD.  
 
6.4.2. Family function and depression 
Family function was one of the three statistically significant and independent 
predictors of high SMFQ scores. The other predictors were negative attitude towards 
SCD and severity (increased frequency of ward admissions). 
 
The association between family function and depression can be easily understood 
from an ecological perspective (Brofenbrenner 1979). Families can have a powerful 
influence on the well-being of their members, especially those already vulnerable 
from physical and mental disorders. For example, Silk and colleagues have recently 
shown that compared with a low risk control group, children with a current or 
previous episode of major depressive disorder had mothers with higher expressed 
emotion, especially criticism (Silk et al 2009). 
 
With reference to SCD, other studies have shown a powerful influence of families on 
the adjustment of affected members. For example, in a study of 182 young people 
with SCD, Barbarin and colleagues found that the best predictors of the affected 
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child’s psychological adjustment included relationships with their parents and siblings 
(Barbarin et al 1999). Similarly, Burlew et al (2000) found that ecological factors 
such as family relationships were better predictors of adjustment than biomedical 
factors in SCD. 
 
Thus, the finding in this study that family function predicts depressive symptoms is in 
keeping with theoretical models of adjustment and previous studies of children with 
SCDs.  
 
Living with a child affected by SCDs could be challenging especially for more severe 
cases with frequent complications. Parents may have to make allowances for and give 
more attention to the affected child. In particular, parents’ capacity to set and enforce 
appropriate boundaries for their child with SCD may be compromised by this 
perceived need to make allowances for the child. This could lead to resentment by 
siblings and disagreements and feeling of alienation in the spouse or partner. Parents 
may have to give up work to provide more care for the affected child resulting in lost 
economic and social opportunities. Parents may be blamed by others or may blame 
themselves for having an affected child (Burnes et al 2008). Parents and siblings 
could be at risk of courtesy stigma (Hinshaw 2005).  
 
Given the importance of family in the psychosocial adjustment of children with SCD 
as shown in this and other studies, it is important that families are assessed and 
supported as part of caring for the child affected by SCDs. 
 
6.4.3. Illness severity and depression 
Consistent with the bio-psycho-social model of adjustment in chronic physical 
disorders, this study found that a surrogate index of severity of SCD (frequency of 
ward admissions) was one of the independent predictors of depressive symptoms.  
 
This finding is in keeping with the general evidence that people with more severe 
forms of SCDs are at more risk of depression. For example, Segbena and Sangare 
(1994) used the Hamilton Depression Rating Scale to assess 30 patients with SCDs 
and 31 heterozygous carriers of the sickle gene. Although no subject in either group 
scored above the threshold for moderate depression, the level of anaemia and the 
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number of sickle-cell crises per year was associated with depressive symptoms in the 
SCDs group. Similarly, Hasan and colleagues showed that SCD patients who make 
more frequent use of accident and emergency department and had more frequent 
blood transfusions (both good markers of severity) were more likely to be depressed 
(Hasan et al 2003).  
 
Thus, although disease severity alone is not a sole determinant of mood or function in 
SCD (Grant et al 2000), evidence from this and other studies suggest that young 
people with more severe forms of SCD (e.g. frequent in-patient admissions) should be 
targeted for screening for depression.  
 
6.4.4. Attitude to SCD and depression 
Negative attitude to SCD was the third statistically significant independent predictor 
of depression in young people with SCD in this study. This is consistent with previous 
studies of young people with other chronic physical conditions like epilepsy, asthma, 
and diabetes mellitus, which all show association between negative attitude towards 
illness and psychological adversities such as depression, behaviour problems and low 
self esteem (Austin and Huberty 1993, Amer 2008). The mechanisms and 
implications explained in Section 6.3.3 will also be applicable to depression; hence 
will not be repeated.  
 
6.4.5. Depression and self-perceived stigma 
My hypothesis that self-perceived stigma would be an independent predictor of risk of 
depression in young people with SCD was not supported by the data. Although risk of 
depression and self perceived stigma were strongly associated in bivariate analysis, the 
relationship was not sustained in multivariate analysis. Once other relevant variables 
such as age, gender, leg ulcer, frequency of admissions, family function, birth in or 
outside UK and attitude towards SCD were controlled for, the apparent association 
between self-perceived stigma and depression ceased.  
 
This finding that self-perceived stigma did not predict depression was surprising given 
that self-perceived stigma did predict SDQ, which is a measure of psychological 
difficulty. The difference may lie in the nature of the constructs measured by the two 
instruments used to assess depression (SMFQ) and psychological difficulty (SDQ). On 
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closer examination, two SDQ subscales (emotional and peer problems) had the strongest 
association with self-perceived stigma. The differences between these two subscales and 
the SMFQ may hold the key to why this difference occurred. Unlike the SMFQ which 
maps only onto depression, the emotional subscale of the SDQ maps mostly onto 
anxiety. It is therefore possible that measures of anxiety are more sensitive to self-
perceived stigma than measures of depression. Also, in keeping with stigma theory, the 
peer problem scale of the SDQ is likely to be sensitive to self-perceived stigma 
compared with the SMFQ. In fact, the SMFQ has no question that directly taps into peer 
problems. 
 
6.4.6. Depression and receipt of counselling 
Although 18% of the children with SCD in the study were classified as depression-
positive cases on the Short MFQ and 15.4% scored in the abnormal range on the Total 
Difficulties Scale of the SDQ, only 11% of the whole sample was receiving 
counselling from a therapist. More importantly, only 18.8% of the children who were 
classified as depression-positive were in receipt of counselling. Also there was no 
statistically significant difference in receipt of counselling between the depression-
positive and depression-negative cases.  
 
This finding suggests possible problems with identifying children with SCD who have 
significant psychological and emotional difficulty and targeting psychological therapy 
towards them. This mismatch could be due to patchy availability of assessment and 
counselling opportunities for children with SCD or lack of information to enable 
precision in targeting resources to those in greatest need. Thus the findings of this 
study could contribute towards targeting. For example, although the prevalence of 
depression is not increased in young people with SCD as a group, the following three 
subgroups; those with unhealthy family function, more severe forms of SCD, and 
more negative attitude toward SCD, should be targeted for screening for depression. 
The study also showed that the Short MFQ could be a useful screening instrument for 
depression in SCD although the overlap of physical symptoms between the 
questionnaire and SCD could lead to high false positive rates. It is important to 
resource local SCD services with paediatric liaison Child and Adolescent Mental 
Health staff to ensure that those identified have ready access to psychological 
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treatment as appropriate. Alternatively, cases identified could be referred to local 
Child and Adolescent Mental Health Services (CAMHS). 
 
6.5. Level and predictors of self esteem in SCD 
6.5.1. Level of self esteem in SCD 
This study measured self esteem with the Rosenberg scale. Therefore in order to assess 
whether or not the self esteem of the young people in this study is normative, their scores 
have to be compared with a similar sample where the same instrument was used as a 
measure of self esteem. I found only one previous study of children with SCD where the 
Rosenberg scale was used to measure self esteem (Burlew et al 2000). The mean score 
on the Rosenberg Self Esteem scale by young people in my study was 31.9 (SD 5.0). 
These figures are almost the same as the mean score in the study by Burlew and 
colleagues (Mean = 31.2, SD = 5.5) (Burlew et al 2000). As there were no other studies 
of children with SCD in which Rosenberg self esteem scales was used, I compared my 
sample with other groups. I was unable to find a UK norm for the Rosenberg scale but I 
located a multinational study of self esteem among students in USA, Canada and New 
Zealand, which used the Rosenberg Self esteem scale (Rusticus et al 2004). Compared 
with the mean score of young people in my study (Mean, 31.9, SD 5.0), the American 
students scored exactly the same (Mean, 31.9, SD 5.0), the Canadian students score 
slightly less (Mean, 31.0, SD 4.8), while the New Zealand students scored the lowest 
(Mean 29.9, SD 4.5). 
 
In general, the results of studies of self esteem in children with SCD are inconsistent 
just as the studies of psychopathology in children with SCD. As such, some studies 
show reduced self esteem (e.g. Brown et al 1993), while others (like my study) 
indicate normal self esteem (e.g. Midence et al 1996, Cepeda et al 2000). It is possible 
that this variation is due to use of different measurements for self-esteem in the 
studies (e.g. Brown et al 1993 used Harter’s scale, Cepeda et al 2000 used Peirs-
Harris scale, while my study used the Rosenberg scale). 
 
In this study, self-esteem was strongly correlated with depression, Total Difficulties 
scale and emotional and peer problems subscales of the SDQ, and attitude towards SCD. 
Good self esteem is thus a desirable characteristic especially in children with a chronic 
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disorder and is regarded as a protective factor in relation to the development of some 
psychological disorders (Kliewer and Sandler 1992). I will therefore consider here the 
specific associations with young people with SCD.  
 
6.5.2. Association between source of recruitment and self esteem 
An interesting finding of the study was that Self esteem was independently and 
significantly predicted by whether subjects were recruited from Sickle Cell Society or 
haematology clinics. Young people recruited from Sickle Cell Society scored higher on 
the self esteem scale than those recruited from haematology clinics. This finding 
remained even after controlling for depressive symptoms. 
 
Consistent with this finding, several other studies have linked membership or 
participation in self help or support groups with improved self-esteem in a wide 
variety of disorders and settings (Yahne and Long 1988; Folgheraiter and Annalisa 
2009; Castelein et al 2008).  
 
Whilst it is not possible to rule out the possibility that better self-esteem and possibly 
confidence made membership of Sickle Cell Society more likely, it is also worth 
considering how the latter in turn could help improve self-esteem. 
 
Crocker and Major (1989) have outlined possible mechanisms which could help 
vulnerable people to preserve their self esteem despite experiencing stigma. Some of 
these strategies could explain how membership or participation in self-help could 
improve self esteem in SCD. One protective mechanism is the availability of 
alternative positive attitudes from significant others. Sickle Cell Society is an 
advocacy organisation. They employ volunteers who provide active support and 
encouragement to people with SCD, which is likely to improve their self esteem. In 
fact, the Organisation runs a befriending service for young people with SCD with one 
of the stated aims being “to boost their confidence and self esteem.” 
http://www.sicklecellsociety.org/pdf/befriendFlyer.pdf (accessed 27/01/2010).  
 
Another mechanism is what Crocker and Major (1989) referred to as “in-group 
comparison”. This strategy suggests that membership of an organisation like Sickle 
Cell Society provides the young people opportunities to compare themselves with 
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other young people with similar difficulties. They argue that this comparison is less 
exacting on self esteem than comparisons with other people with perceived 
advantages.  
 
6.5.3. Gender and self esteem 
Gender was one of the independent significant predictors of self esteem in this study. 
Male respondents scored higher than females on the self esteem scale. However, the 
robustness of this association is in question as it was nullified when depressive 
symptoms were included in the model. 
 
Other studies have shown higher self esteem in males than females. For example, Kling 
and colleagues conducted a meta-analysis of studies involving over 90,000 respondents 
to examine this phenomenon (Kling et al 1999). They found a small overall effect size of 
0.21 in favour of males. Incidentally, the authors found that the greatest difference 
between the genders emerged in adolescence, which is the age group of the respondents 
in my study. Kling and colleagues also analysed three large data sets of 48,000 young 
Americans and found that male students scored higher than females in measures of self 
esteem (Kling et al 1999). These authors offered several potential explanations. For 
example, they highlight that traditional male gender roles tend to be associated with 
better self esteem. Another factor they suggested is physical appearance, especially in 
adolescence. Whereas the masculine physique developed by males in adolescence is 
associated with improved self esteem, the weight gain associated with menarche in 
females results in body image dissatisfaction and low self esteem in some girls.  
 
6.5.4. Family function and self esteem  
Family function is one of the four statistically significant independent predictors of 
self esteem scores by young people with SCD in this study. Young people from 
families with “unhealthy function” scored lower on the Rosenberg self esteem scale 
compared with those from healthy functioning families. This finding remained even 
after controlling for depressive symptom. It is also consistent with other studies on the 
development of self esteem in children, which emphasise the importance of the family 
(Gecas and Schwalbe, 1986).  
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The family is one of the most important environmental influences on the development of 
children’s self esteem. This is not surprising given the critical role of the family in 
children’s early socialisation and identity formation. In the context of a child with SCD, 
certain aspects of family function could have potential adverse consequences on the 
children’s self esteem. Examples include inappropriate comparisons with non-affected 
siblings, and overprotection resulting in less than optimum challenging of the affected 
child’s abilities (e.g. inappropriate exclusion from all sporting activities). On the other 
hand, adequate parental warmth, support and encouragement that are frequently and 
positively communicated to the child could benefit the self esteem of children affected 
by SCDs (Gecas and Seff 1990). 
 
6.5.5. Attitude toward illness and self esteem 
Attitude to illness was a statistically significant predictor of self esteem in this study. 
Young people with negative attitude toward SCD had lower self esteem compared with 
those with positive attitude. Although this finding was not sustained when depression 
was included in the regression model, it is nonetheless illustrative of the importance of 
attitude towards illness in the adjustment of young people with chronic physical 
disorders. Other studies of young people with diabetes (Ho et al 2008, Amer 2008) and 
epilepsy (Heimlich et al 2000) have shown associations between attitude towards illness 
and self esteem.  
 
The finding that attitude towards SCD ceased to predict self-esteem when depression 
was included in the model is not surprising. For example young people with SCD who 
have more depressive symptoms are likely to have a negative attitude towards the 
disorder they see as being responsible for their depression. This observation also 
suggests that negative attitudes towards SCD may be more relevant as a contributor to 
active psychological and emotional difficulties than to self-esteem, which is a 
background psychological trait. 
 
6.5.6. Stigma and self esteem 
Contrary to my hypothesis, in this study, self-perceived stigma was not an independent 
statistically significant predictor of self esteem among young people with SCD. This was 
a surprise and ran contrary to studies of other chronic physical conditions in children and 
young people, particularly epilepsy, which have shown significant associations between 
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self perceived stigma and self esteem (Westbrook et al 1992). However, the lack of 
association between self-perceived stigma and self esteem in this study could be because 
the measure (Rosenberg scale) was not sensitive enough. It is possible that a longer, 
multi-domain and child-specific measure (e.g. Pier-Harris or Harter scales) might have 
demonstrated a significant association (Piers and Harris 1969, Harter 1985).  
 
Although my study did not find independent association between stigma and self esteem, 
it is worth exploring the possible mechanisms since these could explain the alternative 
findings in other studies (e.g. Westbrook et al 1992). 
 
Crocker and Major have reviewed mechanisms by which stigma could lead to low self 
esteem (Crocker and Major 1989). Two examples are readily applicable to the 
association between self esteem and self-perceived stigma found in some studies. One 
example is the so called “reflected appraisals” theory. This theory proposes that an 
individual could develop low self esteem if he believes that other people have a low or 
negative evaluation of him and goes on to adopt the negative views he perceives are held 
about him. The second mechanism is called “efficacy-based” theory. According to this 
theory, self esteem is improved by someone’s ability to control and master their 
environment (Crocker and Major 1989). Thus, conditions like SCD, which could 
interfere with or limit a person’s ability to demonstrate some types of competence, 
ability or achievement, could interfere with self esteem. A third mechanism is the 
“discounting” theory (Crocker and Major 1989). This theory suggests that people with 
stigmatising conditions may attempt to protect their self esteem by diminishing the 
importance or significance of abilities they are unable to acquire. While this may help 
them cope in the short term, in the long term, they may become even more sensitive to 
differences between them and their peers resulting in a greater threat to their self-esteem 
(Yovetich et al 2000).  
 
While the theoretical and empirical details outlined above provide a clear association 
between low self esteem and self-perceived stigma, this association is also not 
inevitable for every person with a stigmatising condition (Crocker and Major 1989). 
Some individuals protect their self esteem despite experiencing or perceiving stigma. 
As already pointed out, one protective mechanism is the availability of alternative 
positive attitudes from significant others such as family members, teachers, and 
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counsellors and the ability of the young person to accept and assimilate the positive 
views.  
 
6.6. Methodological issues and limitations  
The study has many strengths which include the sample being reasonably 
representative (e.g. even gender split and normally distributed age), the sample size 
which was large enough to examine the issues under study, the reliability of the 
instruments used and the acceptable response rate. Nevertheless it also has limitations. 
The strengths and limitations are discussed in detail next. 
 
6.6.1. Reliability 
Reliability refers to the level of consistency shown by a measuring instrument. There are 
five reasons to support the reliability of the measurements used in this study. 
 
• First, measurements were selected only if they had shown good reliability in their 
development and previous publications.  
 
• Second, the measurements all showed good to excellent internal consistencies 
(Cronbach’s Alpha) in this study.  
 
• Third, the measurements correlated in a sensible and predictable manner with each 
other. 
 
• Fourth, the data demonstrated the types of associations predicted by stigma theory. 
 
• Fifth, there was a complete agreement when some responses by ten of the children 
were checked against their medical records. 
 
6.6.2. External validity 
This refers to how generalisable the findings could be to a wider population (Ebrahim 
and Sullivan 1995). The following considerations support the external validity of the 
findings. 
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• First, the response rate of 45% is respectable given that the target sample is an over 
researched and hard to reach group 
 
• Second, there were no major differences between respondents and non respondents 
in the demographic measures we had access to. 
 
• Third, the gender ratio of the respondents in the study is about equal and so reflective 
of the general population 
 
• Fourth, about a quarter (29%) of the children had a sibling with SCD. This 
proportion is consistent with the expectation for a recessively inherited autosomal 
condition where a quarter of conceptions are likely to be homozygous. 
 
• Fifth, the findings that females had more depressive symptoms and more self-
perceived stigma than males are consistent with other studies.  
 
• Sixth, of the several socio-demographic and psychosocial variables compared 
between the children recruited from sickle cell society and those recruited from 
haematology clinics, only two statistically significant differences were identified 
between the two groups (socioeconomic status and self esteem). The two groups did 
not differ significantly on age, gender, whether or not born in the UK, levels of 
self-perceived stigma, whether they completed the questionnaire at home or in the 
clinic, depressive symptoms, Total Difficulties scale or subscales of the SDQ, 
receipt of counselling, family function, or frequency of ward admissions (measure 
of severity). 
 
6.6.3. Limitations 
There are several limitations to this study.  
• The first and important limitation of the study is the absence of data on the 
genotype of the young people who took part in the study. It is well recognised that 
different genotypes in SCD confer different severity profiles to affected persons. 
For example, people with HbSS genotype tend to have a more severe illness 
compared with those with HbSC genotype (Peak 2008). The study used surrogate 
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markers of severity such as frequency of admissions, whereas genotype would 
have been a more direct and valid biological measure of severity. Surrogate 
markers of severity are at risk of confounding by other factors such as treatment 
adherence or the impact of other unrelated diseases or environmental factors. Also 
the inclusion of all forms of SCDs in the study was likely to have introduced some 
variability which is difficult to quantify because of the absence of information on the 
young people’s genotype. Consideration was given to obtaining the children’s 
genotype in this study. However, it was felt that children may not be reliable 
informants for such information and that accessing medical records for all 
participants would be the reliable means of obtaining the data. Unfortunately, the 
study did not have the capacity to cope with the logistics of accessing medical 
records for all participants. Also the conditions of the study ethics approval 
allowed only limited access to ten medical records to assess reliability of 
responses. However, since the conclusion of the study, I have become aware that 
children with SCDs and their parents can be reliable informants about their 
genotype. Consideration is now being given to seeking further ethics approval to 
obtain this data. However, the additional data if obtained would not form part of 
this Thesis. 
 
• The second limitation is that the respondents were volunteers who were willing to 
participate in research and thus might constitute an altruistic group who may have 
come to terms with SCD in a way that those who did not volunteer to take part 
might not have. This potential selection bias might account for the less than 
hypothesised prevalence of stigma and normative levels of depressive symptoms 
and self esteem. 
 
• Third, socially desirable responding was not assessed in the study. This may have 
contributed to lower than hypothesised prevalence of self-perceived stigma. 
 
• The study adopted a cross-sectional design. This was logistically more feasible to 
execute and methodologically adequate to test the study hypotheses. However, it has 
the limitation of ascertainment of risk factors at the same time as the outcome 
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measures (e.g. stigma). This makes temporal relationships and causal interpretations 
difficult.  
 
• Despite the cross-sectional data collection, the interpretation of the study hypotheses 
was strengthened by the use of robust multivariate data analysis such as standard and 
hierarchical regression modelling. While not able to resolve the dilemma of 
temporality, the regression techniques produced more robust associations by 
controlling for known and measured confounders  
 
• Another limitation is the sample size.  Although the sample was sufficient to support 
adequate exploration of key associations and hypothesis, missing data meant it was 
probably insufficient for a few associations that approached but did not reach 
statistical significance (probable Type II errors). 
 
• As the study was conducted in the UK, the external validity may not apply to 
developing countries, where the vast majority of children with SCD live. Even 
within the UK, the external validity has to be considered with some caution. For 
example, the proportion of heads of household in managerial, professional, and 
intermediate occupations in this study (65.1%) is much higher than the proportion of 
Black people in the UK in the same occupation bands (45.1% for Black Caribbean 
and 37.1% for Black Africans) (NOS 2005). This suggests the respondents came 
from families that were more economically advantaged than average back families in 
the UK.  
 
• Another threat to the external validity is the observation in Table 4.2 that the 
respondents experienced three times more admissions in the past year compared with 
non respondents. This suggests that the respondents may have been more unwell 
than typical children with SCD in the community. 
 
• Lack of a control group for the psychological measures was a limitation but this 
was mitigated by good use of epidemiological and other comparative data, which 
allowed a meaningful comparison to be made. 
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• The use of questionnaires to assess psychological status is a limitation as they do not 
assess psychopathology but are very useful as screening instruments. Also the 
reliance on young people’s self report and lack of data triangulation from parents and 
teachers is a limitation. There was data triangulation with hospital records but this 
was limited. 
 
Summary 
Despite the limitations noted above, this study achieved its objectives and two of the 
four hypotheses were supported by the data. The findings provide robust evidence to 
support the application of stigma theory to SCD. The study showed that when asked 
directly, young people with SCD do not appear to perceive stigma as much as would 
be predicted but indirect questioning indicates higher levels of perceived stigma. The 
finding that self-perceived stigma predicts psychological difficulty in SCD is 
important as this has not been shown previously in SCD. On the whole, young people 
with SCD in the sample did not experience depressive symptoms more than peers in 
the community. However, children with SCD appear to be at risk of anxiety 
symptoms (emotional subscale of SDQ has mainly anxiety symptoms) when 
compared with general population norms and there appears to be a subgroup of young 
people with SCD who are at increased risk of depression. The latter include those 
with more severe disease, who easily perceive stigma, come from families with 
unhealthy function, and those with negative attitude towards SCD. Children with SCD 
who have these risk factors should be targeted for screening for psychological and 
emotional difficulties. Most children with SCD who were depression-positive were 
not receiving counselling. This suggests a need for an effective system to target 
psychological intervention towards children with SCD most in need. The 
characteristics outlined earlier could form the basis for targeting such services. 
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Chapter 7 
 
Conclusions, clinical and research implications 
 
The bio-medical, psychosocial, and economic burden of SCD on some affected 
persons and their families is already very high. This study has contributed to a better 
understanding of how self-perceived stigma could be adding to this burden. 
 
This study set out to explore the extent to which young people with SCD perceive 
being stigmatised and the associations between this perception and psychosocial 
outcomes. The methodology proved successful in answering the research objectives. 
The measurements demonstrated good evidence of reliability in data collection. Also 
the evidence supports some external validity for the findings. The study supported 
two of the four hypotheses including a demonstration that the theoretical constructs in 
stigma theory are applicable to SCD. Some of the findings are unique as they have not 
been shown previously in SCD. The conclusions from the study are outlined below. 
These are followed by clinical and research recommendations. 
 
7.1. Conclusions. 
The following hypotheses were supported by the data from this study: 
1. Measures of disruptiveness (e.g. frequency of admissions) and visibility (e.g. 
presence of leg ulcer) will significantly and independently predict levels of 
self perceived stigma. This is the first time stigma theory has been 
successfully applied to SCD. 
 
2. Self perceived stigma will significantly and independently predict Total 
difficulties score on the Strengths and Difficulties Questionnaire (SDQ) 
 
Two hypotheses were not supported by the data: 
1. Self perceived stigma will significantly and independently predict Depressive 
symptoms as measured by SMFQ 
 
 172
2. Self perceived stigma will significantly and independently predict Self Esteem 
measured by Rosenberg Scale  
 
Other important findings include: 
• Only 15% of the respondents met the study criteria for directly measured self-
perceived stigma. However, indirect assessment of self perceived stigma based on 
disclosure practices (e.g. keeping SCD secret) suggests a much higher level of 
perceived stigma (57%) in the current study. 
• When directly measured, fewer young people with SCD in this study appeared to 
perceive stigma compared with young people with epilepsy and stuttering. 
However, when indirectly measured, a similar proportion of young people in all 
three groups appear to perceive stigma 
• Compared with SDQ UK norms, young people with SCD in this study scored 
significantly higher on the emotional subscale of the SDQ. The prevalence of 
SDQ-caseness (caseness for psychological difficulty) among the group (15.4%) is 
slightly higher compared with young black boys and girls in London (9.2% and 
10.9% respectively) but the difference was not statistically significant (p=0.078). 
• Compared with Black children in London, the children with SCD in this study did 
not have increased risk of depressive disorder. However, based on regression 
analysis, a subgroup of children with SCD (e.g. those with unhealthy family 
function, increased frequency of ward admissions (surrogate index of severity), 
and who have negative attitude towards SCD) were found to be more vulnerable 
to risk of depression and need to be targeted for screening and interventions. 
• The young people with SCD in the study had normal levels of self esteem but low 
self-esteem was associated with female gender, having a negative attitude to SCD, 
and coming from a family with unhealthy function. Association with Sickle Cell 
Society was linked with higher self esteem. Self esteem and depression were 
strongly associated and the inclusion of depression in the model nullified the 
predictive ability of gender and negative attitude towards SCD. 
• The children with SCD had limited access to counselling as only 11.5% of the 
sample was in receipt of counselling. Also the availability of counselling did not 
reflect need. For example, only 18.8% of the children who were classified as 
depression-positive were in receipt of counselling. Also there was no statistically 
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significant difference in receipt of counselling between the depression-positive and 
depression-negative cases.   
• The presence of leg ulcer appears to be a useful marker for both illness severity 
and increased risk of psychosocial distress.  
• Negative attitude toward illness predicted all the three psychosocial outcomes 
variables (i.e. psychological difficulty (SDQ), depression, and to a less extent, self 
esteem). Unhealthy family function, predicted both depression and self esteem. 
 
7.2 Recommendations. 
I have made two sets of recommendations. First for clinical interventions, and secondly 
for further research needs. 
 
7.2.1. Clinical 
SCD is a chronic and potentially challenging illness; hence affected children require 
optimum support to adjust to living with the disorder. In developed countries, advances 
in physical care have led to tremendous improvement in life expectancy, quality of life, 
and to some extent improvement in psychosocial adjustment.  
 
However, there appear to be sub-groups of children with SCD who are still at increased 
risk of psychological and emotional difficulties. These include young people who 
perceive SCD-related stigma, females, those with leg ulcer and more severe illness, who 
have negative attitude to having SCD, and or come from families with unhealthy 
function. Young people with these features need to be targeted for mental health 
screening and intervention. 
 
There is need to resource more psychological services to support children with SCD. 
However, such services need to use the markers of increased risk of psychological and 
emotional difficulties identified in this study to screen children at risk and target their 
interventions more effectively and efficiently. 
 
The evidence-base for the types of psychological interventions that are effective in SCD 
is still limited (Anie and Green 2002). Pending the availability of better evidence, it 
would be pragmatic and appropriate to consider interventions that first target those at 
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risk of psychiatric disorder (e.g. abnormal SDQ or SMFQ scores) who may be at more 
immediate need and may be keener for help. Secondly, it may be helpful to specifically 
address or incorporate the psychosocial risk variables identified in this study (e.g. self-
perceived stigma, negative attitude towards SCD, and family dysfunction) as targets for 
intervention. For example, in relation to family dysfunction, it is likely that the benefit of 
a psychological intervention for a young person with SCD would be enhanced if his or 
her family were to be supported simultaneously.  
 
In relation to self-perceived stigma, this study shows that not every young person with 
SCD experience self-perceived stigma. However, for those who do, it is associated with 
significant psychological difficulty.  It is recognised that while some aspects of self-
perceived stigma could originate from actual experience of discrimination, other 
components could be based on unfounded or exaggerated fears of discrimination. Indeed 
self-perceived stigma in SCD has the potential to become a self-fulfilling prophesy 
whereby the fear of discrimination leads the young person to avoid peers thereby 
missing opportunities to test out whether in fact their fears of discrimination would have 
happened. For this reason, it is possible for self perceived stigma to be modified with a 
cognitive behavioural intervention (CBT). CBT is an effective therapy where beliefs 
driving a particular distress are not founded on fact or reality. The technique could 
involve the use of behavioural experiments to disconfirm the fears driving self-perceived 
stigma. This type of intervention can help affected young people to develop resilience. 
 
In addition, given that some self-perceived stigma may be driven by actual experience of 
enacted stigma caused by discriminatory or prejudicial behaviour by other people, the 
case is made for a public education and anti-stigma campaign to improve public 
understanding and attitude towards SCD. The campaign could initially be targeted at 
communities or places with many young people with SCD. Greater understanding of 
SCD by the public could lead to greater sensitivity in interactions with people with 
SCD, which could improve their psychosocial outcomes. 
 
The finding that respondents recruited from the Sickle Cell Society had higher self 
esteem than those recruited from haematology clinics provides impetus for the 
advocacy and psychosocial support provided by the organisation to people with SCD. 
While bearing in mind the caveat of reverse causality, this finding could be seen as 
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providing some evidence that the organisation’s stated goal of improving the self-
esteem of affected young people is being achieved. It may therefore be appropriate to 
young people with SCD to be encouraged to avail themselves of the opportunities 
provided by the Sickle Cell Society. 
 
7.2.2. Research 
This study has pioneered the exploration of stigma and related concepts and experiences 
in children with SCD. While the study has answered some important research questions 
with clinical and policy implications, it has also generated new questions worth further 
exploration. 
 
This study found low endorsement of self perceived stigma by young people with SCD 
when asked directly and more admission to the phenomenon when asked indirectly 
(through disclosure practices). This suggests that the findings may have been 
confounded by socially desirable responding, which is a recognised limitation of 
attitudinal surveys. It would therefore be helpful to extend this study and incorporate 
measures of socially desirable responding and compare children with SCD with children 
with other conditions known to be potentially stigmatising (e.g. epilepsy).  
 
Future studies of this nature would be strengthened if the assessment of psychopathology 
is based on standardised psychiatric interview rather than questionnaires. It would be 
further enhanced if in addition to self report; information on psychopathology is sourced 
from teachers and parents to allow triangulation. 
 
This study found for the first time that self-perceived stigma independently predicted 
psychological difficulty in SCD. It is likely that this association operates through 
intermediate factors such as self-isolation by people with high perceived stigma. In order 
to understand this association fully and to exploit the potential therapeutic gains 
embedded in it, further studies are required to identify the intermediate factors linking 
self-perceived stigma and psychological difficulty in SCD. 
 
Negative attitude towards SCD was a consistent predictor of psychological and 
emotional outcomes in this study. However, there is limited understanding of the 
determinants of attitude towards having SCD. This warrants further exploration to 
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understand how negative attitude towards illness is generated and maintained. Such 
studies could unlock hitherto unknown therapeutic strategies for young people with 
SCD. 
 
7.3. Concluding remark 
The physical and psychosocial outcomes for children with SCD in developed countries 
have improved significantly. However, the outlook in poor developing countries remains 
desperate as highlighted by a recent study from Kenya. Williams and colleagues showed 
that most of the 90% of children with SCD who die even before diagnosis could be 
saved if diagnosed early and given existing vaccines against the common bacterial 
infections responsible for their mortality (Williams et al 2009). Thus there is an urgent 
need for more investment in the care of children with SCD in poorer countries to reduce 
this avoidable waste of human life. However, more resources may not be the solution if 
the additional resources are not equitably and efficiently utilised. The situation of 
children with SCD in Cuba illustrates this. Despite limited resources, the organisation of 
health care in Cuba has enabled people with SCDs to achieve good outcomes compared 
with other poor countries (Aguila et al 2008). Finally, this study has shown that despite 
access to advanced medical treatment and better psychosocial support, a minority of 
young people with SCD in developed countries may still be at risk of psychological and 
emotional difficulties. It is therefore important to have systems for identifying and 
providing appropriate psychological interventions for this subgroup.  
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(Date: 10/05/2007       Version 003) 
 
Invitation letter for parents/guardians to be sent with questionnaire  
 
Dear Sir/Madam, 
 
Invitation to take part in a research project to examine whether young people with sickle cell 
disease feel they are treated differently by other people as a result of their health problems. 
 
The Sickle Cell Society or your Sickle Cell Clinic sent this letter to you on our behalf.  
 
We would like to invite your child to take part in a research project. The purpose of the 
research is to see whether young people with sickle cell disease feel stigmatised (treated 
differently by other people) and whether this affects how they feel about themselves. The 
information we gather from the research could help improve the support we provide young 
people with sickle cell disease. Those who agree to take part will be asked to complete a 
questionnaire, which will take about 20 minutes. 
 
Before you decide for your child to take part, it is important for you to understand why the 
research is being done and what it will involve.  This is all explained in the enclosed 
information leaflets for you and your child. Please take time to read the information carefully 
and discuss it with other people if you wish.  Also ask us if there is anything that is not clear 
or if you would like more information. Take time to decide whether or not you wish for your 
child to take part. Please ask you child to read his or her own Information leaflet and to 
discuss it with you and other people if they wish to.  
 
If having read the information leaflet and you and your child are happy to take part, please do 
the following: 
1. Sign both copies of the Consent Form 
2. You and your child should sign both Copies of the Assent Form. 
3. Ask your child to complete the Questionnaire 
4. Keep one copy each of the signed Consent Form and Assent Form for your records. 
5. Put all the other signed Forms and the Questionnaire in the stamped and addressed 
envelope we provided (you do not need to put any more stamp) 
6. Put the envelope in a Post Box 
 
We appreciate the time involved in completing the questionnaire and we will offer £10 worth 
of shopping vouchers to every young person who completes one. 
 
If you do not wish for your child to take part in the research, please do not complete the 
Forms and Questionnaire. Instead, return them (uncompleted) to us in the envelope we 
provided. We will not send you any reminders once we receive the uncompleted Forms and 
Questionnaires. Your decision not to take part will not affect the standard of care your child 
will receive.  
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The Organisation that sent you this letter on our behalf has not given us your name, address 
or clinical details. We will only know the name of people who return completed 
questionnaires to us. 
 
Thank you for reading this. 
 
Yours sincerely 
 
 
 
 
 
Dr Cornelius Ani 
Honorary Lecturer and Specialist Registrar in Child and Adolescent Psychiatry 
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(Date: 10/05/2007)       Version 003) 
 
Information Sheet for Parents/Guardians 
 
Research project to examine whether young people with sickle cell disease feel they are 
treated differently by other people as a result of their health problems. 
 
What is this about? 
Your child is being invited to take part in a research project. Before you decide it is important 
for you to understand why the research is being done and what it will involve. 
 
Before you decide for your child to take part, it is important for you to understand why the 
project is being done and what it will involve.  Please take time to read the following 
information carefully and discuss it with other people if you wish.  Also ask us if there is 
anything that is not clear or if you would like more information. Take time to decide whether 
or not you wish your child to take part. This research is being done for an educational project 
and will involve completing a questionnaire. 
 
 
What is the purpose of the project? 
Some people do not understand sickle cell disease and how it affects people who have it. It is 
possible that such people may treat people with sickle cell disease differently for having 
the disease. This is what we refer to as someone feeling stigmatised. The purpose of this 
research is to see whether young people with sickle cell disease feel stigmatised by other 
people and whether this affects how they feel about themselves. 
 
Why have my child been chosen? 
All young people with sickle cell disease aged between 11 and 18 years and who live in 
London are being invited to participate. We hope that about 133 young people will take part. 
 
Does my child have to take part? 
No, it is up to you and your child to decide whether or not to take part.  You are both free to 
decide whether or not to take part. You are both free to decide to withdraw from the research 
at any time and without giving a reason. Your decisions about this will not affect the standard 
of care your child will receive.  
 
What will happen to my child if we agree to take part? 
If you are happy to for your child to take part, and are satisfied with our explanations, you 
will be asked to sign a consent form. If your child is able to understand the research and is 
happy to take part and can write their name, they will be asked to sign an “assent” form with 
you, if they want to. You will be given a copy of the signed information sheet and 
consent/assent forms to keep for your records. 
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What does my child have to do if we agree to take part? 
Your child will be given a questionnaire to complete. The questionnaire will take about 20 
minutes to complete. They can complete it on their own and return it to us in a stamped 
envelope, which we will give you. Alternatively, they can complete it in the clinic, where Dr 
Cornelius Ani will be available to help if he or she wants. Finally, he or she can choose for 
one of us to telephone him/her and complete the questionnaire for them over the phone. Dr 
Ani will also go through the medical records of 20 persons who take part to compare some of 
their responses to the information in their medical records. We appreciate the time involved in 
completing the questionnaire and we will offer £10 worth of shopping vouchers to every 
young person who completes one. Twenty participants will be asked to complete a second 
copy of the same questionnaire 2 weeks after completing the initial questionnaire. The second 
questionnaire will also take about 20 minutes to complete. A second offer of £10 worth of 
shopping vouchers will be made to the 20 participants who complete the second 
questionnaire. We expect that your child will complete the questionnaire himself/herself 
although he/she could ask you for help in remembering factual information to help them 
answer the questions. If your child prefers to complete the questionnaire over the phone, 
please return the enclosed Slip indicating a preferred phone number and time when we could 
contact you. 
 
What are the possible disadvantages and risks of taking part? 
Apart from the 20 minutes or so it will take to complete the questionnaire; we do not envisage 
any risks or disadvantages to your child. 
 
What are the possible benefits of taking part? 
The information we get might help improve our understanding of whether young people with 
sickle cell disease feel stigmatised and how this might be affecting them. This could help 
improve the support we provide young people with sickle cell disease.  
 
What if something goes wrong? 
If you are not happy and wish to complain about any aspect of the way you or your child have 
been approached or treated during the course of this research, the normal National Health 
Service complaints procedure should be available to you. It is unlikely, but if your child is 
harmed by taking part in this project, you may be entitled to compensation. 
 
Will my child’s taking part in this study be kept confidential? 
If you agree for your child to take part, his/her records may be inspected as part of the 
research. Your child’s name, however, will not be disclosed outside the hospital.  All 
information, which is collected, about your child during the course of the research will be 
kept strictly confidential.  The information will be kept securely at the Academic Unit of 
Child and Adolescent Psychiatry, Imperial College London for 15 years. Any such 
information, which leaves the hospital, will have your child’s name and address removed so 
that they cannot be recognised from it. 
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What will happen to the results of the research study? 
We hope to complete the study within the next 2 years after which you will be informed about 
the results. The results will be published in a medical journal so that other professionals 
working with young people with sickle cell disease can learn from our research. The 
individuals who took part in the study will NOT be identified in any report/publication about 
the project.  
 
Who is organising the research? 
The research is organised by a team of doctors from Imperial College and Central and North 
West London Mental Health NHS Trust. None of the doctors involved in the research will 
benefit financially from your participation. 
 
Who has reviewed the study? 
This research study has been reviewed and approved the South West Multicentre Research 
Ethics Committee. 
 
Contact for Further Information 
If you would like any further information about the research, please contact Dr Cornelius Ani 
or Dr Matthew Hodes at Academic Unit of Child and Adolescent Psychiatry, Imperial College 
London, St Mary's Campus, Norfolk Place, London W2 1PG, Tel: 02078861145   Fax: 
0207886 6299, e-mail: c.ani@imperial.ac.uk 
 
Thank you for reading this and considering taking part in this study. You will be given a copy 
of this information sheet and a signed consent form to keep for your records. 
 SDS0210M   P.I.S. (February 2001) 
 
 
 
 
 
 
 
 
 
(Version 003)                               Date: 10/05/2007 
 
Patient Identification Number: 
 
CONSENT FORM (for parents/guardians) 
 
 
Title of Project:  
Research project to examine whether young people with sickle cell disease feel they are treated 
differently by other people as a result of their health problems. 
 
Name of Researcher: 
 
 
       Please initial box 
 
1. I confirm that I have read and understand the information sheet dated ............................  F
 (version ............) for the above study and have had the opportunity to ask questions. 
 
2. I understand that my child’s participation is voluntary and that we are free to withdraw 
      at any time, without giving any reason, without my child’s medical care or legal  
     rights being affected.                                                                                                                 F  
 
3. I understand that sections of any of my child’s medical notes may be looked at by Dr  
     Cornelius Ani or responsible individuals from regulatory authorities where it is relevant          F 
      to my child taking part in research.  I give permission for these individuals to have access to my  
 child’s records. 
 
4. I agree that my child may take part in the above study.  F 
 
 
________________________ ________________ ____________________ 
Name of Parent/ guardian Date Signature 
 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date  Signature 
(if different from researcher) 
 
 
_________________________ ________________ ____________________ 
Researcher   Date  Signature 
 
 
 
 1 for patient;  1 for researcher;  1 to be kept with clinical notes 
 
(Version 003)                               Date: 10/05/2007 
                                                                                                     
ASSENT FORM FOR CHILDREN 
(to be completed by the child and their parent/guardian) 
 
Title of Project:  
Research project to examine whether young people with sickle cell disease feel they are treated 
differently by other people as a result of their health problems. 
 
Child (or if unable, parent on their behalf) /young person to circle all they agree with please: 
Have you read (or had read to you) the Information Sheet about this project?     Yes/No 
Do you understand what this project is about?                Yes/No 
Have you asked all the questions you want?       Yes/No 
Have you had your questions answered in a way you understand? Yes/No 
Do you understand it’s OK to stop taking part at any time without giving reason? Yes/No 
Are you happy to take part?                Yes/No 
If any answers are ‘no’ or you don’t want to take part, don’t sign your name! 
If you do want to take part, please write your name and today’s date  
 
Your name       ___________________________ 
   
      Sign                      ___________________________ 
 
Date                       ___________________________ 
 
 
Your parent or guardian must write their name here too if they are happy for you to do the project 
 
Print Name  ___________________________ 
 
Sign               ___________________________ 
 
Date              ___________________________ 
 
 
The doctor who explained this project to you needs to sign too: 
 
Print Name    ___________________________ 
 
Sign               ___________________________ 
 
Date              ___________________________ 
 
Thank you for your help. 
 
 1 copy for patient; 1 for researcher; 1 copy to be kept with clinical notes 
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(Date: 10/05/2007)       Version 002) 
 
Slip to be completed and returned by participants who prefer to be interviewed over the 
phone 
 
Title: 
Research project to examine whether young people with sickle cell disease feel they are 
treated differently by other people as a result of their health problems. 
 
 
Dear Participant, 
 
 
If you would prefer for Dr Ani to contact you and arrange for you to complete the research 
questionnaire over the phone, please provide the information requested below and return this 
slip in the stamped envelope provided. 
 
I would like to complete the Questionnaire over the phone (tick)    
 
 
My name is _____________________________________________________________ 
 
 
My preferred telephone number to be contacted on is ___________________________ 
 
 
My preferred day of the week to be contacted is _________________________________ 
 
 
My preferred time to be contacted is _________________________________________ 
 
 
Thank you. 
 
Please put this Slip in the envelope provided and place it in a Post Box. Dr Ani will then 
contact you on the number and at the preferred day and time you indicated. 
 
S/N: 
Version 004        Date 10/05/2007      
 
Research project to examine whether young people with sickle cell disease feel 
they are treated differently by other people as a result of their health 
problems. 
 
Thank you for your help in completing this questionnaire. The questions measure 
a variety of attitudes, feelings, and behaviours about yourself and other people. 
There are no right or wrong answers so we would be grateful if you could answer 
as honestly as you can. The answers are completely confidential. Please contact 
Dr Ani or Dr Hodes on 02078861145 if you are unsure about how to complete 
the questionnaire. We will call you back and explain. It would help us a lot if you 
answered all questions even if you are not absolutely certain or the question 
seems daft! 
 
Once again, thank you for your help.  
 
 
 
Please tell us your name and address below. This will enable us to contact 
you to let you know the results of the research study. This first page, 
which identifies you, will be removed from the rest of the Questionnaire 
and kept secure in a safe place. 
 
Name:________________________________________ 
 
Address (including post code): _________________________________ 
 
 
 
 
 
QUESTIONNAIRE     S/N: ___________                      
 
Date of completing questionnaire:  ___________________ 
 
Where was the questionnaire completed?   At Home   
       In Clinic (name)   
Over the telephone   
What is your Date of Birth? ______________________________ 
 
Are you a boy or a girl?    Boy    Girl    
 
Which of your parents live at home? Both natural parents   
      Mother only     
      Father only     
      Mother + stepfather   
      Father + stepmother   
      None (I live on my own)   
 
What work do your parents’ do?   
 Father  _______________ 
 Mother  _______________ 
 Stepfather _______________ 
 Stepmother _______________ 
 
How many brothers and sisters do you have?  
Natural brothers and sisters________ 
Half brothers and sisters __________ 
 
 
 
Do any of your brothers or sisters also suffer from Sickle Cell Disease?  
 Yes          
 No   
 
How many people live in your house or flat?   _________________  
 
How many bedrooms does your house or flat have? _________________ 
 
Does your family own a car?   
Yes      
No   
 
Does your family have a BT or Cable telephone line (not mobile phone)? 
Yes    
No   
   
How would you describe your Ethnic Group?   
Black British           
 Black African           
 Black Caribbean           
 Mixed Race   
Black other    
Mediterranean   
Asian   
 
Were you born in the UK?    
Yes    
 No    
 
If you were not born in the UK, how long have you lived in the UK?  
_______________ 
 
 
Are you still in school? 
 Yes    
 No    
 
If you are in school, how many days have you had off school in the past school 
year? 
None     
Less than 7 days   
7-14 days      
15-21     
22-28 days      
More than 28 days    
 
Do you have a best friend?   
Yes    
 No    
 
How many other friends do you have that are so close to you that you sleep over 
at each other’s house? _________________________________ 
 
How many other friends do you have that are so close to you that you can 
confide in him/her? _________________________________ 
 
Do you think that having Sickle Cell affects whether people want to be friends 
with you? 
Never   
Rarely   
Sometimes   
Often   
 
 
Do you think that having Sickle Cell affects whether people like you or not? 
Never   
Rarely   
Sometimes   
Often   
 
Do you think that having Sickle Cell affects whether or not you are invited to 
people’s homes or to parties? 
Never   
Rarely   
Sometimes   
Often   
 
Do you keep your sickle cell a secret from others? 
Often    
Sometimes   
Rarely   
Never   
 
 
How often do you talk to people about your sickle cell? 
Often    
Sometimes   
Rarely   
Never   
 
Do any of your friends know that you have sickle cell? 
All    
Some   
Few   
None   
 
When people find out you have sickle cell, is it usually because: 
You tell them?   
They see you have a sign of sickle cell and then you explain?   
Someone else tells them about it?   
 
 
 
 
 
 
 
 
  
 
The following questions are to help us understand you and your family. By “Family” we mean those 
individuals with whom you usually live and have the strongest emotional ties. For each of the 
following statements, please tick the box that most applies to you and your family. 
 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
Planning family activities is difficult 
because we misunderstand each other 
    
In times of crises we can turn to each 
other for support 
    
We cannot talk to each other about the 
sadness we feel 
    
Individuals are accepted for what they are     
We avoid discussing our fears and 
concerns 
    
We can express feelings to each other     
There is lots of bad feelings in the family     
We feel accepted for what we are     
Making decisions is a problem for our 
family 
    
We are able to make decisions on how to 
solve problems 
    
We don’t get along well together     
We confide in each other     
 
 
 
 
 
 
Thank you for getting this far in completing the questionnaire. Please remember 
that there are no right or wrong answers and all answers are completely 
confidential to the researchers. Your answers will not affect you in any way 
whatsoever.  
 
Over the past year, how often have you had sickle cell pain? 
  More than once a week   
Once a week   
Two times a month   
Once a month   
Once every 2-4 months    
Two times in the year    
Once in the year    
No pain in the past year   
 
If you had sickle cell pain in the past year, how would you describe the average 
intensity of the painful episodes? 
  Mild   
Moderate   
Intense   
Very intense   
I did not have pain in the last year   
 
 
 
 
 
 
 
 
 
 
 
Over the past year, how many times have you been admitted for one night or 
more in a hospital ward due to problem of sickle cell? 
  No admission in the past year 
Once   
2-4 times   
5-6 times   
7-10 times   
More than 10 times    
 
Over the past year, how many times have you been to Accident and Emergency 
(A & E) Department due to problem of sickle cell but not admitted to a hospital 
ward? 
  No visit to A & E in the past year 
Once   
2-4 times   
5-6 times   
7-10 times   
More than 10 times    
 
Which of the following signs of sickle cell do you have at present?   
Jaundice (yellow eyes)   
Leg ulcer   
 
Are you prescribed Penicillin Tablets?  
Yes    
  No    
 
If you answered “Yes”, how often do you forget to take Penicillin Tablets? 
I often forget to take the tablet   
I sometimes forget to take the tablet   
I usually remember to take the tablet   
 
 
 
 
Are you prescribed Folic Acid Tablets?   
Yes    
  No    
 
If you answered “Yes”, how often do you forget to take Folic Acid Tablets? 
I often forget to take the tablet   
I sometimes forget to take the tablet   
I usually remember to take the tablet   
 
Are you prescribed Hydroxyurea Tablets?   
Yes    
  No    
 
If you answered “Yes”, how often do you forget to take Hydroxyurea Tablets? 
I often forget to take the tablet   
I sometimes forget to take the tablet   
I usually remember to take the tablet   
 
How often do you remember to attend your appointments at the Sickle Cell 
Clinic? 
I usually remember to attend   
I sometimes forget to attend   
I often forget to attend   
 
Are you receiving any regular counselling from a therapist?  
Yes    
  No    
 
 
 
 
 
 
For each item, please mark an ‘2’ in the box for Not True, Somewhat True or 
Certainly True. Please give your answer on the basis of how things have been for 
you over the last 6 months. 
 
 Not 
True 
Somewhat 
True 
Certainly 
True 
I try to be nice to other people. I care    
about their feelings 
I am restless, I cannot stay still for long    
I get a lot of headaches, stomach-aches or 
sickness 
   
I usually share with others (food, games, 
pens etc) 
   
I get very angry and often lose my temper    
I am usually on my own. I generally play 
alone or keep to myself 
   
I usually do as I am told    
I worry a lot    
I am helpful if someone is hurt, upset or 
feeling ill 
   
I am constantly fidgeting or squirming    
I have one good friend or more    
 
 
 
 
 
 
 Not 
True 
Somewhat 
True 
Certainly 
True 
I fight a lot. I can make other people do what I 
want 
   
I am often unhappy, down-hearted or tearful    
Other people my age generally like me    
I am easily distracted, I find it difficult to 
concentrate 
   
I am nervous in new situations. I easily lose 
confidence 
   
I am kind to younger children    
I am often accused of lying or cheating    
Other children or young people pick on me or 
bully me 
   
I often volunteer to help others (parents, 
teachers, children) 
   
I think before I do things    
I take things that are not mine from home, 
school, or elsewhere 
   
I get on better with adults than with people my 
own age 
   
I have many fears, I am easily scared    
I finish the work I’m doing. My attention is 
good 
   
 
 
 
 
 
 
Please place an ‘2’ in the column, which you think most nearly applies to you. 
 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
On the whole, I am satisfied with myself     
At times I think that I am no good at all     
I feel that I have a number of good 
qualities 
    
I am able to do things as well as most 
people 
    
I feel I do not have much to be proud of     
I feel useless at times     
I feel that I am a person of worth, at 
least on an equal plane with others 
    
I wish I could have more respect for 
myself 
    
All in all I am inclined to feel that I am a 
failure 
    
I take a positive attitude towards myself     
 
 
 
 
 
 
 
Please place an ‘2’ in the box, which you think most nearly applies to you. 
 
1. How good or bad do you feel it is that you have sickle cell disease? 
Very good    
A little good    
Not sure    
A little bad    
Very bad   
 
2. How fair is it that you have sickle cell disease? 
Very fair    
A little fair    
Not sure    
A little unfair    
Very unfair   
 
3. How happy or sad is it for you to have sickle cell disease? 
Very sad    
A little sad    
Not sure    
A little happy    
Very happy   
 
4. How bad or good do you feel it is to have sickle cell disease? 
Very good    
A little good    
Not sure    
A little bad    
Very bad   
 
 
 
 
 
 
 
 
 
5. How often do you feel that your sickle cell disease is your fault? 
Never     
Not often    
Sometimes   
Often      
Very often   
 
6. How often do you feel that your sickle cell disease keeps you from doing 
things you like to do? 
Very often   
Often     
Sometimes   
Not often    
Never    
 
7. How often do you feel you will always be sick? 
Never     
Not often    
Sometimes    
Often      
Very often   
 
8. How often do you feel that your sickle cell disease keeps you from starting 
new things? 
Very often   
Often      
Sometimes   
Not often    
Never    
 
 
 
 
 
 
 
 
 
9. How often do you feel different from others because of your sickle cell 
disease? 
Never     
Not often    
Sometimes    
Often      
Very often   
 
10. How often do you feel bad because you have sickle cell disease? 
Very often   
Often      
Sometimes    
Not often    
Never    
 
11. How often do you feel sad about being sick? 
Never     
Not often    
Sometimes    
Often      
Very often   
 
12. How often do you feel happy even though you have sickle cell disease? 
Never     
Not often    
Sometimes    
Often      
Very often   
 
 
 
 
 
13. How often do you feel just as good as other kids your age even though you 
have sickle cell disease? 
Very often   
Often      
Sometimes    
Not often    
Never    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This form is about how you might have been feeling or acting recently. For each 
item, please tick how much you have felt or acted this way in the past two 
weeks. 
 
If a sentence was true about you most of the time, tick true. If it was only 
sometimes true, tick sometimes. If a sentence was not true about you, tick not 
true. 
 
 True Sometimes Not 
True 
1. I felt miserable or unhappy    
2. I didn’t enjoy anything at all    
3. I felt so tired I just sat around and did nothing    
4. I was very restless    
5. I felt I was no good any more    
6. I cried a lot    
7. I found it hard to think properly or 
concentrate 
   
8. I hated myself    
9. I was a bad person    
10. I felt lonely    
11. I thought nobody really loved me    
12. I thought I could never be as good as other 
kids 
   
13. I did everything wrong    
 
 
 
 
 
 
Please read each of the following statements carefully and indicate in the 
appropriate box how much this is like you. 
 
I worry about what other people will think of me even when I know it doesn’t 
make any difference  
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
I am unconcerned even if I know people are forming an unfavourable impression 
of me  
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
I am frequently afraid of other people noticing my shortcomings  
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
I rarely worry about what kind of impression I am making on someone  
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
 
 
 
 
 
 
 
I am afraid that others will not approve of me 
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
I am afraid that others will not approve of me 
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
I am afraid that people will find fault with me 
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
 
 
 
 
 
 
Other people’s opinions of me do not bother me  
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
When I am talking to someone, I worry about what they may be thinking about 
me 
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
I am usually worried about what kind of impression I make 
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
If I know someone is judging me, it has little effect on me 
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
Sometimes I think I am too concerned with what other people think of me 
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
I often worry that I will say or do the wrong things 
Not at all like me   
Slightly like me   
Moderately like me   
Very much like me   
Extremely like me   
 
In the last 12 months, have you been attacked for reasons to do with your race 
or colour?       
Yes    
 No    
 
If yes, was this verbal abuse  
 Yes    
 No    
 
Have you experienced a direct physical attack? 
 Yes    
 No    
 
Have you experienced destruction or vandalism of your property? 
 Yes    
 No    
 
Do you think there are employers in Britain who would refuse a job to a person 
because of his or her race, or colour, religion or cultural background 
 Yes    
 No    
 
If so, do you think this is true of            
Most employers   
Half of employers                   
Fewer than half of employers                 
Hardly any employers   
 
THE END 
 
 
 
THANK YOU VERY MUCH FOR YOUR TIME.  
THIS IS THE END OF THE QUESTIONNAIRE 
 
Now, please return the completed questionnaire to the person who gave it 
to you or in the return envelope provided. Your £10 shopping voucher will 
be posted to you once we receive your completed questionnaire. 
 
If you found answering parts of the questionnaire made you feel worried or 
upset, you can discuss this with your parents, or arrange to discuss it with your 
Sickle Cell Counsellor or GP. You can also phone NHS Direct (08454647) or 
ChildLine (08001111) for advice. 
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                No          
 
If yes, please refer to relevant sections of the REC application in the “summary of 
changes” below. 
 
(b) Amendment to the protocol 
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If yes, please submit either the revised protocol with a new version number and 
date, highlighting changes in bold, or a document listing the changes and giving 
both the previous and revised text. 
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Is this a modified version of an amendment previously notified to the REC and given 
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Notice of amendment (non-CTIMP), version 3.1, November 2005 
Summary of changes 
 
Briefly summarise the main changes proposed in this amendment using language comprehensible to 
a lay person.  Explain the purpose of the changes and their significance for the study.  In the case of 
a modified amendment, highlight the modifications that have been made. 
 
If the amendment significantly alters the research design or methodology, or could otherwise affect 
the scientific value of the study, supporting scientific information should be given (or enclosed 
separately).  Indicate whether or not additional scientific critique has been obtained. 
 
In the course of recruitment, we have received feedback to suggest that the project title 
“Research project to examine whether young people with sickle cell disease feel shame and 
embarrassment as a result of their health problems”, which is on our recruitment documents 
were found to be “too negative” by some users because of the phrase “shame and 
embarrassment”. This may have contributed to our low response rate.  
 
In order to address this, we propose to amend the project title by replacing the phrase 
“made to feel shame and embarrassment” with “treated differently by other people”. The 
new title will then read “Research project to examine whether young people with sickle cell 
disease feel they are treated differently by other people as a result of their health problems” 
 
We believe the amended title would be more acceptable to the young people and their 
families while still accurately conveying the essence of the project.  
 
We do not believe that this amendment significantly alters the research design or methodology, or 
has the potential to affect the validity of  our study, 
 
 
 
 
Any other relevant information 
 
Applicants may indicate any specific ethical issues relating to the amendment, on which the opinion 
of the REC is sought. 
 
We do not believe that this amendment raises any specific ethical issues. 
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(Date: 03/03/06)       Version 002) 
 
Information Sheet for Parents/Guardians 
 
Research project to examine whether young people with sickle cell disease feel shame 
and embarrassment as a result of their health problems. 
 
What is this about? 
Your child is being invited to take part in a research project. Before you decide it is important 
for you to understand why the research is being done and what it will involve. 
 
Before you decide for your child to take part, it is important for you to understand why the 
project is being done and what it will involve.  Please take time to read the following 
information carefully and discuss it with other people if you wish.  Also ask us if there is 
anything that is not clear or if you would like more information. Take time to decide whether 
or not you wish your child to take part. This research is being done for an educational project 
and will involve completing a questionnaire. 
 
 
What is the purpose of the project? 
Some people do not understand sickle cell disease and how it affects people who have it. It is 
possible that such people may behave in ways that make people with sickle cell disease fell 
shame for having the disease. This is what we refer to as someone feeling stigmatised. The 
purpose of this research is to see whether young people with sickle cell disease feel 
stigmatised by other people and whether this affects how they feel about themselves. 
 
Why have my child been chosen? 
All young people with sickle cell disease aged between 11 and 18 years and who live in 
London are being invited to participate. We hope that about 133 young people will take part. 
 
Does my child have to take part? 
No, it is up to you and your child to decide whether or not to take part.  You are both free to 
decide whether or not to take part. You are both free to decide to withdraw from the research 
at any time and without giving a reason. Your decisions about this will not affect the standard 
of care your child will receive.  
 
What will happen to my child if we agree to take part? 
If you are happy to for your child to take part, and are satisfied with our explanations, you 
will be asked to sign a consent form. If your child is able to understand the research and is 
happy to take part and can write their name, they will be asked to sign an “assent” form with 
you, if they want to. You will be given a copy of the signed information sheet and 
consent/assent forms to keep for your records. 
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What does my child have to do if we agree to take part? 
Your child will be given a questionnaire to complete. The questionnaire will take about 20 
minutes to complete. They can complete it on their own and return it to us in a stamped 
envelope, which we will give you. Alternatively, they can complete it in the clinic, where Dr 
Cornelius Ani will be available to help if he or she wants. Finally, he or she can choose for 
one of us to telephone him/her and complete the questionnaire for them over the phone. Dr 
Ani will also go through the medical records of 20 persons who take part to compare some of 
their responses to the information in their medical records. We appreciate the time involved in 
completing the questionnaire and we will offer £10 worth of shopping vouchers to every 
young person who completes one. Twenty participants will be asked to complete a second 
copy of the same questionnaire 2 weeks after completing the initial questionnaire. The second 
questionnaire will also take about 20 minutes to complete. A second offer of £10 worth of 
shopping vouchers will be made to the 20 participants who complete the second 
questionnaire. We expect that your child will complete the questionnaire himself/herself 
although he/she could ask you for help in remembering factual information to help them 
answer the questions. If your child prefers to complete the questionnaire over the phone, 
please return the enclosed Slip indicating a preferred phone number and time when we could 
contact you. 
 
What are the possible disadvantages and risks of taking part? 
Apart from the 20 minutes or so it will take to complete the questionnaire; we do not envisage 
any risks or disadvantages to your child. 
 
What are the possible benefits of taking part? 
The information we get might help improve our understanding of whether young people with 
sickle cell disease feel stigmatised and how this might be affecting them. This could help 
improve the support we provide young people with sickle cell disease.  
 
What if something goes wrong? 
If you are not happy and wish to complain about any aspect of the way you or your child have 
been approached or treated during the course of this research, the normal National Health 
Service complaints procedure should be available to you. It is unlikely, but if your child is 
harmed by taking part in this project, you may be entitled to compensation. 
 
Will my child’s taking part in this study be kept confidential? 
If you agree for your child to take part, his/her records may be inspected as part of the 
research. Your child’s name, however, will not be disclosed outside the hospital.  All 
information, which is collected, about your child during the course of the research will be 
kept strictly confidential.  The information will be kept securely at the Academic Unit of 
Child and Adolescent Psychiatry, Imperial College London for 15 years. Any such 
information, which leaves the hospital, will have your child’s name and address removed so 
that they cannot be recognised from it. 
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What will happen to the results of the research study? 
We hope to complete the study within the next 2 years after which you will be informed about 
the results. The results will be published in a medical journal so that other professionals 
working with young people with sickle cell disease can learn from our research. The 
individuals who took part in the study will NOT be identified in any report/publication about 
the project.  
 
Who is organising the research? 
The research is organised by a team of doctors from Imperial College and Central and North 
West London Mental Health NHS Trust. None of the doctors involved in the research will 
benefit financially from your participation. 
 
Who has reviewed the study? 
This research study has been reviewed and approved the South West Multicentre Research 
Ethics Committee. 
 
Contact for Further Information 
If you would like any further information about the research, please contact Dr Cornelius Ani 
or Dr Matthew Hodes at Academic Unit of Child and Adolescent Psychiatry, Imperial College 
London, St Mary's Campus, Norfolk Place, London W2 1PG, Tel: 02078861145   Fax: 
0207886 6299, e-mail: c.ani@imperial.ac.uk 
 
Thank you for reading this and considering taking part in this study. You will be given a copy 
of this information sheet and a signed consent form to keep for your records. 
